advertisement

WGW-2021

List of abstracts related to

79286 A Worldwide Price Comparison of Glaucoma Medications, Laser Trabeculoplasty, and Trabeculectomy Surgery
Zhao PY; Rahmathullah R; Stagg BC; Almobarak F; Edward DP; Robin AL; Stein JD
JAMA ophthalmology 2018; 136: 1271-1279

Listed by Classification


14 Costing studies; pharmacoeconomics (695 abstracts found)


84205 Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled Trial
Bilger M
Applied health economics and health policy 2019; 17: 841-855 (IGR: 21-1)


84831 Comparing glaucoma medications and general demographics in a sample of glaucoma patients treated in private practice with nationwide registry data in Finland
Parkkari M
Acta Ophthalmologica 2019; 0: (IGR: 21-1)


84575 Improving Patient Access and Reducing Costs for Glaucoma with Integrated Hospital and Community Care: A Case Study from Australia
Ford BK
International journal of integrated care 2019; 19: 5 (IGR: 21-1)


84600 Taking the strain? Impact of glaucoma on patients' informal caregivers
McDonald L
Eye 2020; 34: 197-204 (IGR: 21-1)


84892 Association of sex with the global burden of glaucoma: an analysis from the global burden of disease study 2017
Ye X
Acta Ophthalmologica 2020; 0: (IGR: 21-1)


85226 The Hub-and-Spoke Management of Glaucoma
Nuzzi R
Frontiers in neuroscience 2020; 14: 180 (IGR: 21-1)


84092 Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States
Albini TA
Ocular Immunology and Inflammation 2020; 28: 164-174 (IGR: 21-1)


84906 Modeling the Pharmacotherapy Cost and Outcomes of Primary Open-Angle Glaucoma With Dry Eye
Tachkov K
Frontiers in public health 2019; 7: 363 (IGR: 21-1)


84465 10-year trends in English primary care glaucoma prescribing
Hogg HDJ
Eye 2020; 34: 192-196 (IGR: 21-1)


84920 Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017
Yu L
PLoS ONE 2020; 15: e0227595 (IGR: 21-1)


85198 Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists Focus Group Study
Feldman RM
Clinical Ophthalmology 2020; 14: 729-739 (IGR: 21-1)


84496 Care pathways for glaucoma detection and monitoring in the UK
Harper RA
Eye 2020; 34: 89-102 (IGR: 21-1)


84946 Minimally Invasive Glaucoma Surgery: A Budget Impact Analysis and Evaluation of Patients' Experiences, Preferences, and Values

Ontario health technology assessment series 2019; 19: 1-57 (IGR: 21-1)


85129 Tilted Optic Disc Frequency in Myopia of Different Degree
Dervisevic E
Medicinski arhiv 2019; 73: 391-393 (IGR: 21-1)


84884 North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
Malvankar-Mehta MS
ClinicoEconomics and outcomes research : CEOR 2019; 11: 789-798 (IGR: 21-1)


84920 Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017
Ding K
PLoS ONE 2020; 15: e0227595 (IGR: 21-1)


85198 Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists Focus Group Study
Cioffi GA
Clinical Ophthalmology 2020; 14: 729-739 (IGR: 21-1)


84600 Taking the strain? Impact of glaucoma on patients' informal caregivers
Turnbull P
Eye 2020; 34: 197-204 (IGR: 21-1)


84892 Association of sex with the global burden of glaucoma: an analysis from the global burden of disease study 2017
She X
Acta Ophthalmologica 2020; 0: (IGR: 21-1)


85226 The Hub-and-Spoke Management of Glaucoma
Marolo P
Frontiers in neuroscience 2020; 14: 180 (IGR: 21-1)


84496 Care pathways for glaucoma detection and monitoring in the UK
Gunn PJG
Eye 2020; 34: 89-102 (IGR: 21-1)


84884 North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
Feng L
ClinicoEconomics and outcomes research : CEOR 2019; 11: 789-798 (IGR: 21-1)


84906 Modeling the Pharmacotherapy Cost and Outcomes of Primary Open-Angle Glaucoma With Dry Eye
Vassilev A
Frontiers in public health 2019; 7: 363 (IGR: 21-1)


84575 Improving Patient Access and Reducing Costs for Glaucoma with Integrated Hospital and Community Care: A Case Study from Australia
Angell B
International journal of integrated care 2019; 19: 5 (IGR: 21-1)


85129 Tilted Optic Disc Frequency in Myopia of Different Degree
Ibrisevic N
Medicinski arhiv 2019; 73: 391-393 (IGR: 21-1)


84575 Improving Patient Access and Reducing Costs for Glaucoma with Integrated Hospital and Community Care: A Case Study from Australia
Angell B
International journal of integrated care 2019; 19: 5 (IGR: 21-1)


84831 Comparing glaucoma medications and general demographics in a sample of glaucoma patients treated in private practice with nationwide registry data in Finland
Taipale J
Acta Ophthalmologica 2019; 0: (IGR: 21-1)


84092 Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States
Rice JB
Ocular Immunology and Inflammation 2020; 28: 164-174 (IGR: 21-1)


84205 Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled Trial
Wong TT
Applied health economics and health policy 2019; 17: 841-855 (IGR: 21-1)


84465 10-year trends in English primary care glaucoma prescribing
Connor A
Eye 2020; 34: 192-196 (IGR: 21-1)


84496 Care pathways for glaucoma detection and monitoring in the UK
Spry PGD
Eye 2020; 34: 89-102 (IGR: 21-1)


84575 Improving Patient Access and Reducing Costs for Glaucoma with Integrated Hospital and Community Care: A Case Study from Australia
Liew G
International journal of integrated care 2019; 19: 5 (IGR: 21-1)


85198 Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists Focus Group Study
Liebmann JM
Clinical Ophthalmology 2020; 14: 729-739 (IGR: 21-1)


84831 Comparing glaucoma medications and general demographics in a sample of glaucoma patients treated in private practice with nationwide registry data in Finland
Uusitalo H
Acta Ophthalmologica 2019; 0: (IGR: 21-1)


84920 Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017
Luo L
PLoS ONE 2020; 15: e0227595 (IGR: 21-1)


84884 North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
Hutnik CM
ClinicoEconomics and outcomes research : CEOR 2019; 11: 789-798 (IGR: 21-1)


84092 Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States
White AG
Ocular Immunology and Inflammation 2020; 28: 164-174 (IGR: 21-1)


84205 Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled Trial
Lee JY
Applied health economics and health policy 2019; 17: 841-855 (IGR: 21-1)


84600 Taking the strain? Impact of glaucoma on patients' informal caregivers
Chang L
Eye 2020; 34: 197-204 (IGR: 21-1)


84892 Association of sex with the global burden of glaucoma: an analysis from the global burden of disease study 2017
Shen L
Acta Ophthalmologica 2020; 0: (IGR: 21-1)


84906 Modeling the Pharmacotherapy Cost and Outcomes of Primary Open-Angle Glaucoma With Dry Eye
Kostova S
Frontiers in public health 2019; 7: 363 (IGR: 21-1)


85226 The Hub-and-Spoke Management of Glaucoma
Nuzzi A
Frontiers in neuroscience 2020; 14: 180 (IGR: 21-1)


84575 Improving Patient Access and Reducing Costs for Glaucoma with Integrated Hospital and Community Care: A Case Study from Australia
White AJR
International journal of integrated care 2019; 19: 5 (IGR: 21-1)


84920 Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017
Yu Z
PLoS ONE 2020; 15: e0227595 (IGR: 21-1)


84496 Care pathways for glaucoma detection and monitoring in the UK
Fenerty CH
Eye 2020; 34: 89-102 (IGR: 21-1)


84205 Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled Trial
Howard KL
Applied health economics and health policy 2019; 17: 841-855 (IGR: 21-1)


85198 Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists Focus Group Study
Weinreb RN
Clinical Ophthalmology 2020; 14: 729-739 (IGR: 21-1)


84092 Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States
Johnson M
Ocular Immunology and Inflammation 2020; 28: 164-174 (IGR: 21-1)


84600 Taking the strain? Impact of glaucoma on patients' informal caregivers
Crabb DP
Eye 2020; 34: 197-204 (IGR: 21-1)


84092 Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States
Reiff J
Ocular Immunology and Inflammation 2020; 28: 164-174 (IGR: 21-1)


84205 Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled Trial
Bundoc FG
Applied health economics and health policy 2019; 17: 841-855 (IGR: 21-1)


84575 Improving Patient Access and Reducing Costs for Glaucoma with Integrated Hospital and Community Care: A Case Study from Australia
Keay LJ
International journal of integrated care 2019; 19: 5 (IGR: 21-1)


84496 Care pathways for glaucoma detection and monitoring in the UK
Lawrenson JG
Eye 2020; 34: 89-102 (IGR: 21-1)


84205 Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled Trial
Lamoureux EL
Applied health economics and health policy 2019; 17: 841-855 (IGR: 21-1)


84092 Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States
Lima AF; Bartels-Peculis L
Ocular Immunology and Inflammation 2020; 28: 164-174 (IGR: 21-1)


84205 Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled Trial
Finkelstein EA
Applied health economics and health policy 2019; 17: 841-855 (IGR: 21-1)


84092 Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States
Ciepielewska G; Nelson WW
Ocular Immunology and Inflammation 2020; 28: 164-174 (IGR: 21-1)


82297 Journey to glaucoma care - trusting but uncertain and uninformed: a qualitative study
Lu TC
Clinical and Experimental Optometry 2019; 0: (IGR: 20-4)


82080 Toward Better Health Outcomes in Rural and Under-served Areas: L. V. Prasad Eye Institute's Diagonal Model of Glaucoma Care
Choudhari NS
Ophthalmic Epidemiology 2019; 26: 420-429 (IGR: 20-4)


82201 Determining patient preferences in a glaucoma service: A discrete choice experiment
Lu TC
Clinical and Experimental Ophthalmology 2019; 47: 1146-1155 (IGR: 20-4)


82031 The cost burden of falls in people with glaucoma in National Health Service Hospital Trusts in the UK
McGinley P
Journal of Medical Economics 2020; 23: 106-112 (IGR: 20-4)


82424 Auditing service delivery in glaucoma clinics using visual field records: a feasibility study
Kelly SR
BMJ open ophthalmology 2019; 4: e000352 (IGR: 20-4)


82651 Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement
Delgado MF
ClinicoEconomics and outcomes research : CEOR 2019; 11: 591-604 (IGR: 20-4)


82814 Cost-Utility Analysis of Glaucoma Medication Adherence
Newman-Casey PA
Ophthalmology 2019; 0: (IGR: 20-4)


82297 Journey to glaucoma care - trusting but uncertain and uninformed: a qualitative study
Lu TC
Clinical and Experimental Optometry 2019; 0: (IGR: 20-4)


82201 Determining patient preferences in a glaucoma service: A discrete choice experiment
Lu TC
Clinical and Experimental Ophthalmology 2019; 47: 1146-1155 (IGR: 20-4)


82441 Burden, Positive Aspects, and Predictive Variables of Caregiving: A Study of Caregivers of Patients with Pediatric Glaucoma
Zhu Y
Journal of Ophthalmology 2019; 2019: 6980208 (IGR: 20-4)


82651 Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement
Abdelrahman AM
ClinicoEconomics and outcomes research : CEOR 2019; 11: 591-604 (IGR: 20-4)


82814 Cost-Utility Analysis of Glaucoma Medication Adherence
Salman M
Ophthalmology 2019; 0: (IGR: 20-4)


82080 Toward Better Health Outcomes in Rural and Under-served Areas: L. V. Prasad Eye Institute's Diagonal Model of Glaucoma Care
Mundhe G
Ophthalmic Epidemiology 2019; 26: 420-429 (IGR: 20-4)


82297 Journey to glaucoma care - trusting but uncertain and uninformed: a qualitative study
Semsarian CR
Clinical and Experimental Optometry 2019; 0: (IGR: 20-4)


82201 Determining patient preferences in a glaucoma service: A discrete choice experiment
Angell B
Clinical and Experimental Ophthalmology 2019; 47: 1146-1155 (IGR: 20-4)


82424 Auditing service delivery in glaucoma clinics using visual field records: a feasibility study
Bryan SR
BMJ open ophthalmology 2019; 4: e000352 (IGR: 20-4)


82441 Burden, Positive Aspects, and Predictive Variables of Caregiving: A Study of Caregivers of Patients with Pediatric Glaucoma
Gao J
Journal of Ophthalmology 2019; 2019: 6980208 (IGR: 20-4)


82201 Determining patient preferences in a glaucoma service: A discrete choice experiment
Angell B
Clinical and Experimental Ophthalmology 2019; 47: 1146-1155 (IGR: 20-4)


82031 The cost burden of falls in people with glaucoma in National Health Service Hospital Trusts in the UK
Ansari E
Journal of Medical Economics 2020; 23: 106-112 (IGR: 20-4)


82814 Cost-Utility Analysis of Glaucoma Medication Adherence
Lee PP
Ophthalmology 2019; 0: (IGR: 20-4)


82201 Determining patient preferences in a glaucoma service: A discrete choice experiment
Dunn H
Clinical and Experimental Ophthalmology 2019; 47: 1146-1155 (IGR: 20-4)


82651 Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement
Terahi M
ClinicoEconomics and outcomes research : CEOR 2019; 11: 591-604 (IGR: 20-4)


82031 The cost burden of falls in people with glaucoma in National Health Service Hospital Trusts in the UK
Sandhu H
Journal of Medical Economics 2020; 23: 106-112 (IGR: 20-4)


82080 Toward Better Health Outcomes in Rural and Under-served Areas: L. V. Prasad Eye Institute's Diagonal Model of Glaucoma Care
Khanna R
Ophthalmic Epidemiology 2019; 26: 420-429 (IGR: 20-4)


82441 Burden, Positive Aspects, and Predictive Variables of Caregiving: A Study of Caregivers of Patients with Pediatric Glaucoma
Li X
Journal of Ophthalmology 2019; 2019: 6980208 (IGR: 20-4)


82297 Journey to glaucoma care - trusting but uncertain and uninformed: a qualitative study
White A
Clinical and Experimental Optometry 2019; 0: (IGR: 20-4)


82424 Auditing service delivery in glaucoma clinics using visual field records: a feasibility study
Sparrow JM
BMJ open ophthalmology 2019; 4: e000352 (IGR: 20-4)


82201 Determining patient preferences in a glaucoma service: A discrete choice experiment
Dunn H; Ford B
Clinical and Experimental Ophthalmology 2019; 47: 1146-1155 (IGR: 20-4)


82297 Journey to glaucoma care - trusting but uncertain and uninformed: a qualitative study
Dunn H
Clinical and Experimental Optometry 2019; 0: (IGR: 20-4)


82424 Auditing service delivery in glaucoma clinics using visual field records: a feasibility study
Crabb DP
BMJ open ophthalmology 2019; 4: e000352 (IGR: 20-4)


82441 Burden, Positive Aspects, and Predictive Variables of Caregiving: A Study of Caregivers of Patients with Pediatric Glaucoma
Yang Q
Journal of Ophthalmology 2019; 2019: 6980208 (IGR: 20-4)


82201 Determining patient preferences in a glaucoma service: A discrete choice experiment
Ford B
Clinical and Experimental Ophthalmology 2019; 47: 1146-1155 (IGR: 20-4)


82814 Cost-Utility Analysis of Glaucoma Medication Adherence
Gatwood JD
Ophthalmology 2019; 0: (IGR: 20-4)


82651 Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement
Miro Quesada Woll JJ
ClinicoEconomics and outcomes research : CEOR 2019; 11: 591-604 (IGR: 20-4)


82031 The cost burden of falls in people with glaucoma in National Health Service Hospital Trusts in the UK
Dixon T
Journal of Medical Economics 2020; 23: 106-112 (IGR: 20-4)


82297 Journey to glaucoma care - trusting but uncertain and uninformed: a qualitative study
Dunn H
Clinical and Experimental Optometry 2019; 0: (IGR: 20-4)


82080 Toward Better Health Outcomes in Rural and Under-served Areas: L. V. Prasad Eye Institute's Diagonal Model of Glaucoma Care
Rathi V
Ophthalmic Epidemiology 2019; 26: 420-429 (IGR: 20-4)


82651 Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement
Gil-Carrasco F
ClinicoEconomics and outcomes research : CEOR 2019; 11: 591-604 (IGR: 20-4)


82441 Burden, Positive Aspects, and Predictive Variables of Caregiving: A Study of Caregivers of Patients with Pediatric Glaucoma
Lian Y
Journal of Ophthalmology 2019; 2019: 6980208 (IGR: 20-4)


82297 Journey to glaucoma care - trusting but uncertain and uninformed: a qualitative study
Angell B
Clinical and Experimental Optometry 2019; 0: (IGR: 20-4)


82201 Determining patient preferences in a glaucoma service: A discrete choice experiment
White A
Clinical and Experimental Ophthalmology 2019; 47: 1146-1155 (IGR: 20-4)


82297 Journey to glaucoma care - trusting but uncertain and uninformed: a qualitative study
Angell B
Clinical and Experimental Optometry 2019; 0: (IGR: 20-4)


82080 Toward Better Health Outcomes in Rural and Under-served Areas: L. V. Prasad Eye Institute's Diagonal Model of Glaucoma Care
Garudadri CS
Ophthalmic Epidemiology 2019; 26: 420-429 (IGR: 20-4)


82297 Journey to glaucoma care - trusting but uncertain and uninformed: a qualitative study
Ford B; Ford B
Clinical and Experimental Optometry 2019; 0: (IGR: 20-4)


82201 Determining patient preferences in a glaucoma service: A discrete choice experiment
Keay L
Clinical and Experimental Ophthalmology 2019; 47: 1146-1155 (IGR: 20-4)


82441 Burden, Positive Aspects, and Predictive Variables of Caregiving: A Study of Caregivers of Patients with Pediatric Glaucoma
Xiao H
Journal of Ophthalmology 2019; 2019: 6980208 (IGR: 20-4)


82201 Determining patient preferences in a glaucoma service: A discrete choice experiment
Keay L
Clinical and Experimental Ophthalmology 2019; 47: 1146-1155 (IGR: 20-4)


82651 Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement
Cook C
ClinicoEconomics and outcomes research : CEOR 2019; 11: 591-604 (IGR: 20-4)


82441 Burden, Positive Aspects, and Predictive Variables of Caregiving: A Study of Caregivers of Patients with Pediatric Glaucoma
Huang W
Journal of Ophthalmology 2019; 2019: 6980208 (IGR: 20-4)


82297 Journey to glaucoma care - trusting but uncertain and uninformed: a qualitative study
Keay L; Keay L
Clinical and Experimental Optometry 2019; 0: (IGR: 20-4)


82651 Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement
Benharbit M; Boisseau S; Chung E; Hadjiat Y; Gomes JA
ClinicoEconomics and outcomes research : CEOR 2019; 11: 591-604 (IGR: 20-4)


81033 Caregiver Burden in Primary Congenital Glaucoma
Kantipuly A
American Journal of Ophthalmology 2019; 205: 106-114 (IGR: 20-3)


81466 Ophthalmic Care Utilization and Out-of-Pocket Expenditure in Iran: Kurdistan Eye Health and Economics Survey-2015
Mohammadi SF
Iranian journal of public health 2019; 48: 1301-1309 (IGR: 20-3)


81057 Prevalence of treatment with glaucoma medication in Scotland, 2010-2017
Rotchford AP
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)


80841 Overuse and Underuse of Visual Field Testing Over 15 Years
Ben-Artsi E
Journal of Glaucoma 2019; 28: 660-665 (IGR: 20-3)


81123 Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model
Tang J
The Lancet. Global health 2019; 7: e968-e978 (IGR: 20-3)


81465 Dynamic Monitoring and Control of Irreversible Chronic Diseases with Application to Glaucoma
Kazemian P
Production and operations management 2019; 28: 1082-1107 (IGR: 20-3)


80510 Epidemiological variations and trends in health burden of glaucoma worldwide
Wang W
Acta Ophthalmologica 2019; 97: e349-e355 (IGR: 20-3)


80674 The Cost and Economics of Endoscopic Cyclophotocoagulation in the United Kingdom: A Tertiary Center Experience
Ho H
Journal of Glaucoma 2019; 28: 563-567 (IGR: 20-3)


80508 Evaluation of an Algorithm for Identifying Ocular Conditions in Electronic Health Record Data
Stein JD
JAMA ophthalmology 2019; 137: 491-497 (IGR: 20-3)


81091 Systematic Review of Economic Evaluations in Primary Open-Angle Glaucoma: Decision Analytic Modeling Insights
Bartelt-Hofer J
PharmacoEconomics - open 2019; 0: (IGR: 20-3)


81465 Dynamic Monitoring and Control of Irreversible Chronic Diseases with Application to Glaucoma
Helm JE
Production and operations management 2019; 28: 1082-1107 (IGR: 20-3)


80510 Epidemiological variations and trends in health burden of glaucoma worldwide
He M
Acta Ophthalmologica 2019; 97: e349-e355 (IGR: 20-3)


81466 Ophthalmic Care Utilization and Out-of-Pocket Expenditure in Iran: Kurdistan Eye Health and Economics Survey-2015
Alinia C
Iranian journal of public health 2019; 48: 1301-1309 (IGR: 20-3)


80674 The Cost and Economics of Endoscopic Cyclophotocoagulation in the United Kingdom: A Tertiary Center Experience
Ho J
Journal of Glaucoma 2019; 28: 563-567 (IGR: 20-3)


80508 Evaluation of an Algorithm for Identifying Ocular Conditions in Electronic Health Record Data
Rahman M
JAMA ophthalmology 2019; 137: 491-497 (IGR: 20-3)


81057 Prevalence of treatment with glaucoma medication in Scotland, 2010-2017
Hughes J
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)


81091 Systematic Review of Economic Evaluations in Primary Open-Angle Glaucoma: Decision Analytic Modeling Insights
Ben-Debba L
PharmacoEconomics - open 2019; 0: (IGR: 20-3)


81033 Caregiver Burden in Primary Congenital Glaucoma
Pillai MR
American Journal of Ophthalmology 2019; 205: 106-114 (IGR: 20-3)


80841 Overuse and Underuse of Visual Field Testing Over 15 Years
Goldenfeld M
Journal of Glaucoma 2019; 28: 660-665 (IGR: 20-3)


81123 Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model
Liang Y
The Lancet. Global health 2019; 7: e968-e978 (IGR: 20-3)


81091 Systematic Review of Economic Evaluations in Primary Open-Angle Glaucoma: Decision Analytic Modeling Insights
Flessa S
PharmacoEconomics - open 2019; 0: (IGR: 20-3)


80674 The Cost and Economics of Endoscopic Cyclophotocoagulation in the United Kingdom: A Tertiary Center Experience
Rodrigues I
Journal of Glaucoma 2019; 28: 563-567 (IGR: 20-3)


80508 Evaluation of an Algorithm for Identifying Ocular Conditions in Electronic Health Record Data
Andrews C
JAMA ophthalmology 2019; 137: 491-497 (IGR: 20-3)


81465 Dynamic Monitoring and Control of Irreversible Chronic Diseases with Application to Glaucoma
Lavieri MS
Production and operations management 2019; 28: 1082-1107 (IGR: 20-3)


81033 Caregiver Burden in Primary Congenital Glaucoma
Shroff S
American Journal of Ophthalmology 2019; 205: 106-114 (IGR: 20-3)


80510 Epidemiological variations and trends in health burden of glaucoma worldwide
Li Z
Acta Ophthalmologica 2019; 97: e349-e355 (IGR: 20-3)


81466 Ophthalmic Care Utilization and Out-of-Pocket Expenditure in Iran: Kurdistan Eye Health and Economics Survey-2015
Ghaderi E
Iranian journal of public health 2019; 48: 1301-1309 (IGR: 20-3)


80841 Overuse and Underuse of Visual Field Testing Over 15 Years
Zehavi-Dorin T
Journal of Glaucoma 2019; 28: 660-665 (IGR: 20-3)


81123 Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model
O'Neill C
The Lancet. Global health 2019; 7: e968-e978 (IGR: 20-3)


81057 Prevalence of treatment with glaucoma medication in Scotland, 2010-2017
Agarwal PK
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)


80508 Evaluation of an Algorithm for Identifying Ocular Conditions in Electronic Health Record Data
Ehrlich JR
JAMA ophthalmology 2019; 137: 491-497 (IGR: 20-3)


81123 Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model
Kee F
The Lancet. Global health 2019; 7: e968-e978 (IGR: 20-3)


80510 Epidemiological variations and trends in health burden of glaucoma worldwide
Huang W
Acta Ophthalmologica 2019; 97: e349-e355 (IGR: 20-3)


81465 Dynamic Monitoring and Control of Irreversible Chronic Diseases with Application to Glaucoma
Stein JD
Production and operations management 2019; 28: 1082-1107 (IGR: 20-3)


81466 Ophthalmic Care Utilization and Out-of-Pocket Expenditure in Iran: Kurdistan Eye Health and Economics Survey-2015
Lashay A
Iranian journal of public health 2019; 48: 1301-1309 (IGR: 20-3)


80841 Overuse and Underuse of Visual Field Testing Over 15 Years
Cohen A
Journal of Glaucoma 2019; 28: 660-665 (IGR: 20-3)


81057 Prevalence of treatment with glaucoma medication in Scotland, 2010-2017
Tatham AJ
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)


81033 Caregiver Burden in Primary Congenital Glaucoma
Khatiwala R
American Journal of Ophthalmology 2019; 205: 106-114 (IGR: 20-3)


80674 The Cost and Economics of Endoscopic Cyclophotocoagulation in the United Kingdom: A Tertiary Center Experience
Syrimi M
Journal of Glaucoma 2019; 28: 563-567 (IGR: 20-3)


80841 Overuse and Underuse of Visual Field Testing Over 15 Years
Porath A
Journal of Glaucoma 2019; 28: 660-665 (IGR: 20-3)


81033 Caregiver Burden in Primary Congenital Glaucoma
Raman GV
American Journal of Ophthalmology 2019; 205: 106-114 (IGR: 20-3)


81123 Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model
Jiang J
The Lancet. Global health 2019; 7: e968-e978 (IGR: 20-3)


81465 Dynamic Monitoring and Control of Irreversible Chronic Diseases with Application to Glaucoma
Van Oyen MP
Production and operations management 2019; 28: 1082-1107 (IGR: 20-3)


80674 The Cost and Economics of Endoscopic Cyclophotocoagulation in the United Kingdom: A Tertiary Center Experience
Goyal S
Journal of Glaucoma 2019; 28: 563-567 (IGR: 20-3)


80508 Evaluation of an Algorithm for Identifying Ocular Conditions in Electronic Health Record Data
Kamat S
JAMA ophthalmology 2019; 137: 491-497 (IGR: 20-3)


81466 Ophthalmic Care Utilization and Out-of-Pocket Expenditure in Iran: Kurdistan Eye Health and Economics Survey-2015
Jabbarvand M
Iranian journal of public health 2019; 48: 1301-1309 (IGR: 20-3)


80841 Overuse and Underuse of Visual Field Testing Over 15 Years
Levkovitch-Verbin H
Journal of Glaucoma 2019; 28: 660-665 (IGR: 20-3)


81123 Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model
Congdon N
The Lancet. Global health 2019; 7: e968-e978 (IGR: 20-3)


81466 Ophthalmic Care Utilization and Out-of-Pocket Expenditure in Iran: Kurdistan Eye Health and Economics Survey-2015
Ashrafi E
Iranian journal of public health 2019; 48: 1301-1309 (IGR: 20-3)


80674 The Cost and Economics of Endoscopic Cyclophotocoagulation in the United Kingdom: A Tertiary Center Experience
Lim KS
Journal of Glaucoma 2019; 28: 563-567 (IGR: 20-3)


81033 Caregiver Burden in Primary Congenital Glaucoma
Krishnadas SR
American Journal of Ophthalmology 2019; 205: 106-114 (IGR: 20-3)


80508 Evaluation of an Algorithm for Identifying Ocular Conditions in Electronic Health Record Data
Shah M
JAMA ophthalmology 2019; 137: 491-497 (IGR: 20-3)


81466 Ophthalmic Care Utilization and Out-of-Pocket Expenditure in Iran: Kurdistan Eye Health and Economics Survey-2015
Nourmohammadi N
Iranian journal of public health 2019; 48: 1301-1309 (IGR: 20-3)


81033 Caregiver Burden in Primary Congenital Glaucoma
Lee Robin A
American Journal of Ophthalmology 2019; 205: 106-114 (IGR: 20-3)


80508 Evaluation of an Algorithm for Identifying Ocular Conditions in Electronic Health Record Data
Boese EA
JAMA ophthalmology 2019; 137: 491-497 (IGR: 20-3)


81466 Ophthalmic Care Utilization and Out-of-Pocket Expenditure in Iran: Kurdistan Eye Health and Economics Survey-2015
Shahraz S
Iranian journal of public health 2019; 48: 1301-1309 (IGR: 20-3)


81033 Caregiver Burden in Primary Congenital Glaucoma
Ehrlich JR
American Journal of Ophthalmology 2019; 205: 106-114 (IGR: 20-3)


80508 Evaluation of an Algorithm for Identifying Ocular Conditions in Electronic Health Record Data
Woodward MA; Cowall J; Trager EH; Narayanaswamy P; Hanauer DA
JAMA ophthalmology 2019; 137: 491-497 (IGR: 20-3)


79738 Changes in Australian practice patterns for glaucoma management
Newman AR
Clinical and Experimental Ophthalmology 2019; 47: 571-580 (IGR: 20-2)


79389 Acute primary angle closure-treatment strategies, evidences and economical considerations
Chan PP
Eye 2019; 33: 110-119 (IGR: 20-2)


79934 Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada
Patel V
Journal of Medical Economics 2019; 22: 390-401 (IGR: 20-2)


80009 The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea
Choi JA
Medicine 2019; 98: e14026 (IGR: 20-2)


80016 A Comparison of Resource Use and Costs of Caring for Patients With Exfoliation Syndrome Glaucoma Versus Primary Open-Angle Glaucoma
Rathi S
American Journal of Ophthalmology 2019; 200: 100-109 (IGR: 20-2)


79738 Changes in Australian practice patterns for glaucoma management
Andrew NH; Andrew NH
Clinical and Experimental Ophthalmology 2019; 47: 571-580 (IGR: 20-2)


80009 The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea
Song LD
Medicine 2019; 98: e14026 (IGR: 20-2)


79934 Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada
Ahmed I
Journal of Medical Economics 2019; 22: 390-401 (IGR: 20-2)


80016 A Comparison of Resource Use and Costs of Caring for Patients With Exfoliation Syndrome Glaucoma Versus Primary Open-Angle Glaucoma
Andrews C
American Journal of Ophthalmology 2019; 200: 100-109 (IGR: 20-2)


79389 Acute primary angle closure-treatment strategies, evidences and economical considerations
Pang JC
Eye 2019; 33: 110-119 (IGR: 20-2)


79934 Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada
Podbielski D
Journal of Medical Economics 2019; 22: 390-401 (IGR: 20-2)


80016 A Comparison of Resource Use and Costs of Caring for Patients With Exfoliation Syndrome Glaucoma Versus Primary Open-Angle Glaucoma
Greenfield DS
American Journal of Ophthalmology 2019; 200: 100-109 (IGR: 20-2)


79389 Acute primary angle closure-treatment strategies, evidences and economical considerations
Tham CC
Eye 2019; 33: 110-119 (IGR: 20-2)


80009 The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea
Choi S
Medicine 2019; 98: e14026 (IGR: 20-2)


79934 Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada
Falvey H
Journal of Medical Economics 2019; 22: 390-401 (IGR: 20-2)


80009 The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea
Park SM
Medicine 2019; 98: e14026 (IGR: 20-2)


80016 A Comparison of Resource Use and Costs of Caring for Patients With Exfoliation Syndrome Glaucoma Versus Primary Open-Angle Glaucoma
Stein JD
American Journal of Ophthalmology 2019; 200: 100-109 (IGR: 20-2)


80009 The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea
Kwon JW
Medicine 2019; 98: e14026 (IGR: 20-2)


79934 Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada
Murray J; Goeree R
Journal of Medical Economics 2019; 22: 390-401 (IGR: 20-2)


80009 The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea
Jee D
Medicine 2019; 98: e14026 (IGR: 20-2)


79264 Influence of glaucoma surgery on visual function: a clinical cohort study and meta-analysis
Junoy Montolio FG
Acta Ophthalmologica 2019; 97: 193-199 (IGR: 20-1)


78878 Healthcare Utilization by Glaucoma Patients in a Team Care Model
Damento GM
Seminars in Ophthalmology 2018; 33: 829-837 (IGR: 20-1)


78829 Direct costs of glaucoma: Relationship between cost and severity of the disease
Real JP
Chronic illness 2018; 0: 1742395318803660 (IGR: 20-1)


79080 The Current Status of Glaucoma and Glaucoma Care in Sub-Saharan Africa
Kyari F
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 375-386 (IGR: 20-1)


78447 A cost minimisation analysis comparing iStent accompanying cataract surgery and selective laser trabeculoplasty versus topical glaucoma medications in a public healthcare setting in New Zealand
Ngan K
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 2181-2189 (IGR: 20-1)


78322 Potential Savings from Visit Reduction of Continuous Intraocular Pressure Monitoring
Dong J
Journal of Current Glaucoma Practice 2018; 12: 59-63 (IGR: 20-1)


79080 The Current Status of Glaucoma and Glaucoma Care in Sub-Saharan Africa
Adekoya B
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 375-386 (IGR: 20-1)


78322 Potential Savings from Visit Reduction of Continuous Intraocular Pressure Monitoring
Syed ZA
Journal of Current Glaucoma Practice 2018; 12: 59-63 (IGR: 20-1)


78878 Healthcare Utilization by Glaucoma Patients in a Team Care Model
Winkler NS
Seminars in Ophthalmology 2018; 33: 829-837 (IGR: 20-1)


78829 Direct costs of glaucoma: Relationship between cost and severity of the disease
Lafuente MC
Chronic illness 2018; 0: 1742395318803660 (IGR: 20-1)


79264 Influence of glaucoma surgery on visual function: a clinical cohort study and meta-analysis
Müskens RPHM
Acta Ophthalmologica 2019; 97: 193-199 (IGR: 20-1)


78447 A cost minimisation analysis comparing iStent accompanying cataract surgery and selective laser trabeculoplasty versus topical glaucoma medications in a public healthcare setting in New Zealand
Fraser E
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 2181-2189 (IGR: 20-1)


78322 Potential Savings from Visit Reduction of Continuous Intraocular Pressure Monitoring
Fan K
Journal of Current Glaucoma Practice 2018; 12: 59-63 (IGR: 20-1)


78447 A cost minimisation analysis comparing iStent accompanying cataract surgery and selective laser trabeculoplasty versus topical glaucoma medications in a public healthcare setting in New Zealand
Buller S
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 2181-2189 (IGR: 20-1)


78878 Healthcare Utilization by Glaucoma Patients in a Team Care Model
Hodge DO
Seminars in Ophthalmology 2018; 33: 829-837 (IGR: 20-1)


78829 Direct costs of glaucoma: Relationship between cost and severity of the disease
Palma SD
Chronic illness 2018; 0: 1742395318803660 (IGR: 20-1)


79264 Influence of glaucoma surgery on visual function: a clinical cohort study and meta-analysis
Jansonius NM
Acta Ophthalmologica 2019; 97: 193-199 (IGR: 20-1)


79080 The Current Status of Glaucoma and Glaucoma Care in Sub-Saharan Africa
Abdull MM
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 375-386 (IGR: 20-1)


78829 Direct costs of glaucoma: Relationship between cost and severity of the disease
Tártara LI
Chronic illness 2018; 0: 1742395318803660 (IGR: 20-1)


78878 Healthcare Utilization by Glaucoma Patients in a Team Care Model
Khanna SS
Seminars in Ophthalmology 2018; 33: 829-837 (IGR: 20-1)


78447 A cost minimisation analysis comparing iStent accompanying cataract surgery and selective laser trabeculoplasty versus topical glaucoma medications in a public healthcare setting in New Zealand
Buller A
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 2181-2189 (IGR: 20-1)


79080 The Current Status of Glaucoma and Glaucoma Care in Sub-Saharan Africa
Mohammed AS
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 375-386 (IGR: 20-1)


78322 Potential Savings from Visit Reduction of Continuous Intraocular Pressure Monitoring
Yahya AF
Journal of Current Glaucoma Practice 2018; 12: 59-63 (IGR: 20-1)


78322 Potential Savings from Visit Reduction of Continuous Intraocular Pressure Monitoring
Melki SA
Journal of Current Glaucoma Practice 2018; 12: 59-63 (IGR: 20-1)


78878 Healthcare Utilization by Glaucoma Patients in a Team Care Model
Khanna CL
Seminars in Ophthalmology 2018; 33: 829-837 (IGR: 20-1)


79080 The Current Status of Glaucoma and Glaucoma Care in Sub-Saharan Africa
Garba F
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 375-386 (IGR: 20-1)


77714 Changes in Ocular Hypotensive Drug Usage for Glaucoma Treatment After Cataract Surgery: A Nationwide Population-based Study in Taiwan
Chang PY
Journal of Glaucoma 2018; 27: 600-605 (IGR: 19-4)


78076 Glaucoma in inpatient care in Germany in 2015
Hahn U
Ophthalmologe 2019; 116: 542-552 (IGR: 19-4)


78269 Eye care utilisation in Newfoundland and Labrador: access barriers and vision health outcomes
Lee EY
Canadian Journal of Ophthalmology 2018; 53: 342-348 (IGR: 19-4)


78222 Glaucoma Control Strategies in Sub-Saharan Africa: A Review of the Clinical and Health Economic Evidence
Smith AF
Ophthalmic Epidemiology 2018; 25: 419-435 (IGR: 19-4)


78076 Glaucoma in inpatient care in Germany in 2015
Kretz F
Ophthalmologe 2019; 116: 542-552 (IGR: 19-4)


78222 Glaucoma Control Strategies in Sub-Saharan Africa: A Review of the Clinical and Health Economic Evidence
Negretti G
Ophthalmic Epidemiology 2018; 25: 419-435 (IGR: 19-4)


78269 Eye care utilisation in Newfoundland and Labrador: access barriers and vision health outcomes
Cui K
Canadian Journal of Ophthalmology 2018; 53: 342-348 (IGR: 19-4)


77714 Changes in Ocular Hypotensive Drug Usage for Glaucoma Treatment After Cataract Surgery: A Nationwide Population-based Study in Taiwan
Wang JY
Journal of Glaucoma 2018; 27: 600-605 (IGR: 19-4)


78222 Glaucoma Control Strategies in Sub-Saharan Africa: A Review of the Clinical and Health Economic Evidence
Mascaro A
Ophthalmic Epidemiology 2018; 25: 419-435 (IGR: 19-4)


77714 Changes in Ocular Hypotensive Drug Usage for Glaucoma Treatment After Cataract Surgery: A Nationwide Population-based Study in Taiwan
Chang SW
Journal of Glaucoma 2018; 27: 600-605 (IGR: 19-4)


78076 Glaucoma in inpatient care in Germany in 2015
Koch J
Ophthalmologe 2019; 116: 542-552 (IGR: 19-4)


78269 Eye care utilisation in Newfoundland and Labrador: access barriers and vision health outcomes
Trope GE; Buys YM
Canadian Journal of Ophthalmology 2018; 53: 342-348 (IGR: 19-4)


78222 Glaucoma Control Strategies in Sub-Saharan Africa: A Review of the Clinical and Health Economic Evidence
Bokre D
Ophthalmic Epidemiology 2018; 25: 419-435 (IGR: 19-4)


77714 Changes in Ocular Hypotensive Drug Usage for Glaucoma Treatment After Cataract Surgery: A Nationwide Population-based Study in Taiwan
Chang YC
Journal of Glaucoma 2018; 27: 600-605 (IGR: 19-4)


78222 Glaucoma Control Strategies in Sub-Saharan Africa: A Review of the Clinical and Health Economic Evidence
Baker H
Ophthalmic Epidemiology 2018; 25: 419-435 (IGR: 19-4)


78269 Eye care utilisation in Newfoundland and Labrador: access barriers and vision health outcomes
Chan CH; Thavorn K
Canadian Journal of Ophthalmology 2018; 53: 342-348 (IGR: 19-4)


78222 Glaucoma Control Strategies in Sub-Saharan Africa: A Review of the Clinical and Health Economic Evidence
Dhalla K
Ophthalmic Epidemiology 2018; 25: 419-435 (IGR: 19-4)


78269 Eye care utilisation in Newfoundland and Labrador: access barriers and vision health outcomes
Jin YP
Canadian Journal of Ophthalmology 2018; 53: 342-348 (IGR: 19-4)


78222 Glaucoma Control Strategies in Sub-Saharan Africa: A Review of the Clinical and Health Economic Evidence
Murdoch IE
Ophthalmic Epidemiology 2018; 25: 419-435 (IGR: 19-4)


77309 Health technology assessment: A primer for ophthalmology
Murphy A
European Journal of Ophthalmology 2018; 28: 358-364 (IGR: 19-3)


76301 A Systematic Evaluation of State Laws Governing Optometric Glaucoma Management in the United States Upto 2015
Chodnicki K
Journal of Glaucoma 2018; 27: 233-238 (IGR: 19-3)


76890 Comparative cost evaluation of brand name and generic ophthalmology medications in Ontario
Popovic M
Canadian Journal of Ophthalmology 2018; 53: 173-187 (IGR: 19-3)


76898 Policy implications of regional variations in eye disease detection and treatment on Prince Edward Island: a repeated cross-sectional analysis, 2010-2012
Khan AM
BMC Health Services Research 2018; 18: 273 (IGR: 19-3)


77102 The Association of Socioeconomic Status with Severity of Glaucoma and the Impacts of Both Factors on the Costs of Glaucoma Medications: A Cross-Sectional Study in West Bengal, India
Chakravarti T
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 442-451 (IGR: 19-3)


76974 Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults
Sharafeldin N
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)


76898 Policy implications of regional variations in eye disease detection and treatment on Prince Edward Island: a repeated cross-sectional analysis, 2010-2012
Trope GE
BMC Health Services Research 2018; 18: 273 (IGR: 19-3)


77309 Health technology assessment: A primer for ophthalmology
McElnea E
European Journal of Ophthalmology 2018; 28: 358-364 (IGR: 19-3)


76974 Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults
Kawaguchi A
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)


76301 A Systematic Evaluation of State Laws Governing Optometric Glaucoma Management in the United States Upto 2015
Kalarn S; Kalarn S
Journal of Glaucoma 2018; 27: 233-238 (IGR: 19-3)


76890 Comparative cost evaluation of brand name and generic ophthalmology medications in Ontario
Chan C
Canadian Journal of Ophthalmology 2018; 53: 173-187 (IGR: 19-3)


76301 A Systematic Evaluation of State Laws Governing Optometric Glaucoma Management in the United States Upto 2015
Quinn L
Journal of Glaucoma 2018; 27: 233-238 (IGR: 19-3)


76898 Policy implications of regional variations in eye disease detection and treatment on Prince Edward Island: a repeated cross-sectional analysis, 2010-2012
Wedge R
BMC Health Services Research 2018; 18: 273 (IGR: 19-3)


76890 Comparative cost evaluation of brand name and generic ophthalmology medications in Ontario
Lattanzio N
Canadian Journal of Ophthalmology 2018; 53: 173-187 (IGR: 19-3)


77309 Health technology assessment: A primer for ophthalmology
Byrne S
European Journal of Ophthalmology 2018; 28: 358-364 (IGR: 19-3)


76974 Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults
Sundaram A
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)


76898 Policy implications of regional variations in eye disease detection and treatment on Prince Edward Island: a repeated cross-sectional analysis, 2010-2012
Buys YM
BMC Health Services Research 2018; 18: 273 (IGR: 19-3)


76890 Comparative cost evaluation of brand name and generic ophthalmology medications in Ontario
El-Defrawy S
Canadian Journal of Ophthalmology 2018; 53: 173-187 (IGR: 19-3)


76301 A Systematic Evaluation of State Laws Governing Optometric Glaucoma Management in the United States Upto 2015
Jampel H
Journal of Glaucoma 2018; 27: 233-238 (IGR: 19-3)


76974 Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults
Campbell S
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)


76890 Comparative cost evaluation of brand name and generic ophthalmology medications in Ontario
El-Defrawy S
Canadian Journal of Ophthalmology 2018; 53: 173-187 (IGR: 19-3)


76898 Policy implications of regional variations in eye disease detection and treatment on Prince Edward Island: a repeated cross-sectional analysis, 2010-2012
El-Defrawy S
BMC Health Services Research 2018; 18: 273 (IGR: 19-3)


76974 Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults
Rudnisky C
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)


76301 A Systematic Evaluation of State Laws Governing Optometric Glaucoma Management in the United States Upto 2015
Saeedi O
Journal of Glaucoma 2018; 27: 233-238 (IGR: 19-3)


76890 Comparative cost evaluation of brand name and generic ophthalmology medications in Ontario
Schlenker MB
Canadian Journal of Ophthalmology 2018; 53: 173-187 (IGR: 19-3)


76898 Policy implications of regional variations in eye disease detection and treatment on Prince Edward Island: a repeated cross-sectional analysis, 2010-2012
El-Defrawy S
BMC Health Services Research 2018; 18: 273 (IGR: 19-3)


76974 Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults
Weis E
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)


76898 Policy implications of regional variations in eye disease detection and treatment on Prince Edward Island: a repeated cross-sectional analysis, 2010-2012
Chen Q
BMC Health Services Research 2018; 18: 273 (IGR: 19-3)


76974 Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults
Tennant MTS
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)


76898 Policy implications of regional variations in eye disease detection and treatment on Prince Edward Island: a repeated cross-sectional analysis, 2010-2012
Jin YP
BMC Health Services Research 2018; 18: 273 (IGR: 19-3)


76974 Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults
Damji KF
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)


75437 Patient-Physician Communication on Medication Cost during Glaucoma Visits
Slota C
Optometry and Vision Science 2017; 94: 1095-1101 (IGR: 19-2)


75619 Resource Planning in Glaucoma: A Tool to Evaluate Glaucoma Service Capacity
Batra R
Seminars in Ophthalmology 2017; 0: 1-6 (IGR: 19-2)


75590 Shared Cared for Stable Glaucoma Patients: Economic Benefits and Patient-centered Outcomes of a Feasibility Trial
Goh D
Journal of Glaucoma 2018; 27: 170-175 (IGR: 19-2)


75437 Patient-Physician Communication on Medication Cost during Glaucoma Visits
Davis SA
Optometry and Vision Science 2017; 94: 1095-1101 (IGR: 19-2)


75590 Shared Cared for Stable Glaucoma Patients: Economic Benefits and Patient-centered Outcomes of a Feasibility Trial
de Korne DF
Journal of Glaucoma 2018; 27: 170-175 (IGR: 19-2)


75619 Resource Planning in Glaucoma: A Tool to Evaluate Glaucoma Service Capacity
Sharma HE
Seminars in Ophthalmology 2017; 0: 1-6 (IGR: 19-2)


75437 Patient-Physician Communication on Medication Cost during Glaucoma Visits
Blalock SJ
Optometry and Vision Science 2017; 94: 1095-1101 (IGR: 19-2)


75590 Shared Cared for Stable Glaucoma Patients: Economic Benefits and Patient-centered Outcomes of a Feasibility Trial
Ho H
Journal of Glaucoma 2018; 27: 170-175 (IGR: 19-2)


75619 Resource Planning in Glaucoma: A Tool to Evaluate Glaucoma Service Capacity
Elaraoud I
Seminars in Ophthalmology 2017; 0: 1-6 (IGR: 19-2)


75590 Shared Cared for Stable Glaucoma Patients: Economic Benefits and Patient-centered Outcomes of a Feasibility Trial
Mathur R
Journal of Glaucoma 2018; 27: 170-175 (IGR: 19-2)


75437 Patient-Physician Communication on Medication Cost during Glaucoma Visits
Carpenter DM
Optometry and Vision Science 2017; 94: 1095-1101 (IGR: 19-2)


75619 Resource Planning in Glaucoma: A Tool to Evaluate Glaucoma Service Capacity
Mohamed S
Seminars in Ophthalmology 2017; 0: 1-6 (IGR: 19-2)


75437 Patient-Physician Communication on Medication Cost during Glaucoma Visits
Muir KW
Optometry and Vision Science 2017; 94: 1095-1101 (IGR: 19-2)


75590 Shared Cared for Stable Glaucoma Patients: Economic Benefits and Patient-centered Outcomes of a Feasibility Trial
Chakraborty B; Van Hai N
Journal of Glaucoma 2018; 27: 170-175 (IGR: 19-2)


75437 Patient-Physician Communication on Medication Cost during Glaucoma Visits
Robin AL
Optometry and Vision Science 2017; 94: 1095-1101 (IGR: 19-2)


75590 Shared Cared for Stable Glaucoma Patients: Economic Benefits and Patient-centered Outcomes of a Feasibility Trial
Wai C
Journal of Glaucoma 2018; 27: 170-175 (IGR: 19-2)


75437 Patient-Physician Communication on Medication Cost during Glaucoma Visits
Sleath B
Optometry and Vision Science 2017; 94: 1095-1101 (IGR: 19-2)


75590 Shared Cared for Stable Glaucoma Patients: Economic Benefits and Patient-centered Outcomes of a Feasibility Trial
Perera S; Aung T; Wong TY; Lamoureux EL
Journal of Glaucoma 2018; 27: 170-175 (IGR: 19-2)


74248 Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Trese MGJ
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 591-597 (IGR: 19-1)


74087 Prospective study of glaucoma referrals across Europe: are we using resources wisely?
Founti P
British Journal of Ophthalmology 2018; 102: 329-337 (IGR: 19-1)


74272 Cost-effectiveness of Phacoemulsification Versus Combined Phacotrabeculectomy for Treating Primary Angle Closure Glaucoma
Chan PP; Li EY
Journal of Glaucoma 2017; 26: 911-922 (IGR: 19-1)


74248 Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Lewis AW
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 591-597 (IGR: 19-1)


74087 Prospective study of glaucoma referrals across Europe: are we using resources wisely?
Topouzis F; Holló G
British Journal of Ophthalmology 2018; 102: 329-337 (IGR: 19-1)


74248 Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Blachley TS
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 591-597 (IGR: 19-1)


74272 Cost-effectiveness of Phacoemulsification Versus Combined Phacotrabeculectomy for Treating Primary Angle Closure Glaucoma
Tsoi KKF
Journal of Glaucoma 2017; 26: 911-922 (IGR: 19-1)


74087 Prospective study of glaucoma referrals across Europe: are we using resources wisely?
Cvenkel B
British Journal of Ophthalmology 2018; 102: 329-337 (IGR: 19-1)


74272 Cost-effectiveness of Phacoemulsification Versus Combined Phacotrabeculectomy for Treating Primary Angle Closure Glaucoma
Kwong YY
Journal of Glaucoma 2017; 26: 911-922 (IGR: 19-1)


74248 Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Stein JD; Moroi SE
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 591-597 (IGR: 19-1)


74272 Cost-effectiveness of Phacoemulsification Versus Combined Phacotrabeculectomy for Treating Primary Angle Closure Glaucoma
Tham CC
Journal of Glaucoma 2017; 26: 911-922 (IGR: 19-1)


74087 Prospective study of glaucoma referrals across Europe: are we using resources wisely?
Iester M; Haidich AB; Kóthy P; Kiana A; Kolokotroni D; Viswanathan AC
British Journal of Ophthalmology 2018; 102: 329-337 (IGR: 19-1)


72743 Nonmedical Out-of-Pocket Patient and Companion Expenditures Associated With Glaucoma Care
Schehlein EM
Journal of Glaucoma 2017; 26: 343-348 (IGR: 18-4)


72825 Detection and prevention of blindness in patients with glaucoma is a socio-economical challenge
Kolko M
Ugeskrift for Laeger 2017; 179: (IGR: 18-4)


72624 Proposing new indicators for glaucoma healthcare service
Liang YB
Eye and vision (London, England) 2017; 4: 6 (IGR: 18-4)


72996 Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma
Berdahl JP
Journal of Medical Economics 2017; 20: 760-766 (IGR: 18-4)


72841 Cost-effectiveness and cost utility of community screening for glaucoma in urban India
John D
Public Health 2017; 148: 37-48 (IGR: 18-4)


72743 Nonmedical Out-of-Pocket Patient and Companion Expenditures Associated With Glaucoma Care
Im LT
Journal of Glaucoma 2017; 26: 343-348 (IGR: 18-4)


72996 Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma
Khatana AK
Journal of Medical Economics 2017; 20: 760-766 (IGR: 18-4)


72841 Cost-effectiveness and cost utility of community screening for glaucoma in urban India
Parikh R
Public Health 2017; 148: 37-48 (IGR: 18-4)


72624 Proposing new indicators for glaucoma healthcare service
Zhang Y
Eye and vision (London, England) 2017; 4: 6 (IGR: 18-4)


72996 Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma
Katz LJ
Journal of Medical Economics 2017; 20: 760-766 (IGR: 18-4)


72743 Nonmedical Out-of-Pocket Patient and Companion Expenditures Associated With Glaucoma Care
Robin AL
Journal of Glaucoma 2017; 26: 343-348 (IGR: 18-4)


72624 Proposing new indicators for glaucoma healthcare service
Musch DC; Congdon N
Eye and vision (London, England) 2017; 4: 6 (IGR: 18-4)


72996 Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma
Herndon L
Journal of Medical Economics 2017; 20: 760-766 (IGR: 18-4)


72743 Nonmedical Out-of-Pocket Patient and Companion Expenditures Associated With Glaucoma Care
Onukwugha E
Journal of Glaucoma 2017; 26: 343-348 (IGR: 18-4)


72996 Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma
Layton AJ
Journal of Medical Economics 2017; 20: 760-766 (IGR: 18-4)


72743 Nonmedical Out-of-Pocket Patient and Companion Expenditures Associated With Glaucoma Care
Saeedi OJ
Journal of Glaucoma 2017; 26: 343-348 (IGR: 18-4)


72996 Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma
Yu TM; Bauer MJ; Cantor LB
Journal of Medical Economics 2017; 20: 760-766 (IGR: 18-4)


71610 A cross-sectional study on compliance with topical glaucoma medication and its associated socioeconomic burden for a Chinese population
Lui MH
International Journal of Ophthalmology 2017; 10: 293-299 (IGR: 18-3)


71527 Cost-effectiveness of glaucoma management with monotherapy medications in Egypt
El-Khamery AA
Journal of advanced pharmaceutical technology & research 2017; 8: 25-28 (IGR: 18-3)


71585 Cost and detection rate of glaucoma screening with imaging devices in a primary care center
Anton A; Fallon M
Clinical Ophthalmology 2017; 11: 337-346 (IGR: 18-3)


71610 A cross-sectional study on compliance with topical glaucoma medication and its associated socioeconomic burden for a Chinese population
Lam JC
International Journal of Ophthalmology 2017; 10: 293-299 (IGR: 18-3)


71585 Cost and detection rate of glaucoma screening with imaging devices in a primary care center
Cots F
Clinical Ophthalmology 2017; 11: 337-346 (IGR: 18-3)


71610 A cross-sectional study on compliance with topical glaucoma medication and its associated socioeconomic burden for a Chinese population
Kwong YL
International Journal of Ophthalmology 2017; 10: 293-299 (IGR: 18-3)


71527 Cost-effectiveness of glaucoma management with monotherapy medications in Egypt
Swify HE
Journal of advanced pharmaceutical technology & research 2017; 8: 25-28 (IGR: 18-3)


71585 Cost and detection rate of glaucoma screening with imaging devices in a primary care center
Sebastian MA
Clinical Ophthalmology 2017; 11: 337-346 (IGR: 18-3)


71610 A cross-sectional study on compliance with topical glaucoma medication and its associated socioeconomic burden for a Chinese population
Wong TS
International Journal of Ophthalmology 2017; 10: 293-299 (IGR: 18-3)


71527 Cost-effectiveness of glaucoma management with monotherapy medications in Egypt
Mohamed AI
Journal of advanced pharmaceutical technology & research 2017; 8: 25-28 (IGR: 18-3)


71585 Cost and detection rate of glaucoma screening with imaging devices in a primary care center
Morilla-Grasa A
Clinical Ophthalmology 2017; 11: 337-346 (IGR: 18-3)


71610 A cross-sectional study on compliance with topical glaucoma medication and its associated socioeconomic burden for a Chinese population
Cheung PL; Lai SS
International Journal of Ophthalmology 2017; 10: 293-299 (IGR: 18-3)


71585 Cost and detection rate of glaucoma screening with imaging devices in a primary care center
Mojal S
Clinical Ophthalmology 2017; 11: 337-346 (IGR: 18-3)


71610 A cross-sectional study on compliance with topical glaucoma medication and its associated socioeconomic burden for a Chinese population
Yuen PL
International Journal of Ophthalmology 2017; 10: 293-299 (IGR: 18-3)


71585 Cost and detection rate of glaucoma screening with imaging devices in a primary care center
Castells X
Clinical Ophthalmology 2017; 11: 337-346 (IGR: 18-3)


71610 A cross-sectional study on compliance with topical glaucoma medication and its associated socioeconomic burden for a Chinese population
Lam WY; Chan HY; Wong YF; Lai JS; Shih KC
International Journal of Ophthalmology 2017; 10: 293-299 (IGR: 18-3)


70851 Maximizing cost-effectiveness by adjusting treatment strategy according to glaucoma severity
Guedes RA
Medicine 2016; 95: e5745 (IGR: 18-2)


70409 More frequent, more costly? Health economic modelling aspects of monitoring glaucoma patients in England
Boodhna T
BMC Health Services Research 2016; 16: 611 (IGR: 18-2)


70121 Effectiveness of UK optometric enhanced eye care services: a realist review of the literature
Baker H
Ophthalmic and Physiological Optics 2016; 36: 545-557 (IGR: 18-2)


70512 Increasing healthcare costs: can we influence the costs of glaucoma care?
Töteberg-Harms M
Current Opinions in Ophthalmology 2017; 28: 127-132 (IGR: 18-2)


70373 The Visual Function Questionnaire: Utility Index: Does It Measure Glaucoma-related Preference-based Status?
Goh RL
Journal of Glaucoma 2016; 25: 822-829 (IGR: 18-2)


70624 Cost of glaucoma treatment in a developing country over a 5-year period
Lazcano-Gomez G
Medicine 2016; 95: e5341 (IGR: 18-2)


70512 Increasing healthcare costs: can we influence the costs of glaucoma care?
Berlin MS
Current Opinions in Ophthalmology 2017; 28: 127-132 (IGR: 18-2)


70409 More frequent, more costly? Health economic modelling aspects of monitoring glaucoma patients in England
Crabb DP
BMC Health Services Research 2016; 16: 611 (IGR: 18-2)


70121 Effectiveness of UK optometric enhanced eye care services: a realist review of the literature
Ratnarajan G
Ophthalmic and Physiological Optics 2016; 36: 545-557 (IGR: 18-2)


70851 Maximizing cost-effectiveness by adjusting treatment strategy according to glaucoma severity
Guedes VM
Medicine 2016; 95: e5745 (IGR: 18-2)


70624 Cost of glaucoma treatment in a developing country over a 5-year period
Ramos-Cadena ML
Medicine 2016; 95: e5341 (IGR: 18-2)


70373 The Visual Function Questionnaire: Utility Index: Does It Measure Glaucoma-related Preference-based Status?
Fenwick E
Journal of Glaucoma 2016; 25: 822-829 (IGR: 18-2)


70121 Effectiveness of UK optometric enhanced eye care services: a realist review of the literature
Harper RA
Ophthalmic and Physiological Optics 2016; 36: 545-557 (IGR: 18-2)


70373 The Visual Function Questionnaire: Utility Index: Does It Measure Glaucoma-related Preference-based Status?
Skalicky SE
Journal of Glaucoma 2016; 25: 822-829 (IGR: 18-2)


70851 Maximizing cost-effectiveness by adjusting treatment strategy according to glaucoma severity
Gomes CE
Medicine 2016; 95: e5745 (IGR: 18-2)


70624 Cost of glaucoma treatment in a developing country over a 5-year period
Torres-Tamayo M
Medicine 2016; 95: e5341 (IGR: 18-2)


70512 Increasing healthcare costs: can we influence the costs of glaucoma care?
Meier-Gibbons F
Current Opinions in Ophthalmology 2017; 28: 127-132 (IGR: 18-2)


70851 Maximizing cost-effectiveness by adjusting treatment strategy according to glaucoma severity
Chaoubah A
Medicine 2016; 95: e5745 (IGR: 18-2)


70624 Cost of glaucoma treatment in a developing country over a 5-year period
Hernandez de Oteyza A
Medicine 2016; 95: e5341 (IGR: 18-2)


70121 Effectiveness of UK optometric enhanced eye care services: a realist review of the literature
Edgar DF; Lawrenson JG
Ophthalmic and Physiological Optics 2016; 36: 545-557 (IGR: 18-2)


70624 Cost of glaucoma treatment in a developing country over a 5-year period
Turati-Acosta M; Jimenez-Román J
Medicine 2016; 95: e5341 (IGR: 18-2)


68947 Predictors, Resource Utilization, and Short-term Costs of Laser Trabeculoplasty Versus Medication Management in Open-Angle Glaucoma
Schultz NM
American Journal of Ophthalmology 2016; 168: 78-85 (IGR: 18-1)


69350 Cost of the medical management and prescription pattern for primary open angle glaucoma (POAG) in Ghana-a retrospective cross-sectional study from three referral facilities
Ocansey S
BMC Health Services Research 2016; 16: 282 (IGR: 18-1)


68973 Geographical variation in glaucoma prescribing trends in England 2008-2012: an observational ecological study
Heng JS
BMJ open 2016; 6: e010429 (IGR: 18-1)


69184 Drug-prescribing patterns among optometrists and nonophthalmologist physicians at a tertiary care centre in Kingston, Ontario
Johnson D; El-Defrawy SR
Canadian Journal of Ophthalmology 2016; 51: 168-173 (IGR: 18-1)


68947 Predictors, Resource Utilization, and Short-term Costs of Laser Trabeculoplasty Versus Medication Management in Open-Angle Glaucoma
Wong WB
American Journal of Ophthalmology 2016; 168: 78-85 (IGR: 18-1)


68973 Geographical variation in glaucoma prescribing trends in England 2008-2012: an observational ecological study
Wormald R
BMJ open 2016; 6: e010429 (IGR: 18-1)


69350 Cost of the medical management and prescription pattern for primary open angle glaucoma (POAG) in Ghana-a retrospective cross-sectional study from three referral facilities
Kyei S
BMC Health Services Research 2016; 16: 282 (IGR: 18-1)


68947 Predictors, Resource Utilization, and Short-term Costs of Laser Trabeculoplasty Versus Medication Management in Open-Angle Glaucoma
Coleman AL
American Journal of Ophthalmology 2016; 168: 78-85 (IGR: 18-1)


69350 Cost of the medical management and prescription pattern for primary open angle glaucoma (POAG) in Ghana-a retrospective cross-sectional study from three referral facilities
Diafo A
BMC Health Services Research 2016; 16: 282 (IGR: 18-1)


68973 Geographical variation in glaucoma prescribing trends in England 2008-2012: an observational ecological study
Khaw PT
BMJ open 2016; 6: e010429 (IGR: 18-1)


69184 Drug-prescribing patterns among optometrists and nonophthalmologist physicians at a tertiary care centre in Kingston, Ontario
Hollands S; Hurst J
Canadian Journal of Ophthalmology 2016; 51: 168-173 (IGR: 18-1)


69350 Cost of the medical management and prescription pattern for primary open angle glaucoma (POAG) in Ghana-a retrospective cross-sectional study from three referral facilities
Darfor KN
BMC Health Services Research 2016; 16: 282 (IGR: 18-1)


68947 Predictors, Resource Utilization, and Short-term Costs of Laser Trabeculoplasty Versus Medication Management in Open-Angle Glaucoma
Malone DC
American Journal of Ophthalmology 2016; 168: 78-85 (IGR: 18-1)


69350 Cost of the medical management and prescription pattern for primary open angle glaucoma (POAG) in Ghana-a retrospective cross-sectional study from three referral facilities
Boadi-Kusi SB
BMC Health Services Research 2016; 16: 282 (IGR: 18-1)


69184 Drug-prescribing patterns among optometrists and nonophthalmologist physicians at a tertiary care centre in Kingston, Ontario
Law C; Li C
Canadian Journal of Ophthalmology 2016; 51: 168-173 (IGR: 18-1)


69350 Cost of the medical management and prescription pattern for primary open angle glaucoma (POAG) in Ghana-a retrospective cross-sectional study from three referral facilities
Aglobitse PB
BMC Health Services Research 2016; 16: 282 (IGR: 18-1)


69184 Drug-prescribing patterns among optometrists and nonophthalmologist physicians at a tertiary care centre in Kingston, Ontario
Baxter S; Campbell Ede L; Campbell RJ
Canadian Journal of Ophthalmology 2016; 51: 168-173 (IGR: 18-1)


66936 Treatment of ocular hypertension: is it cost effective?
Tuulonen A
Current Opinions in Ophthalmology 2016; 27: 89-93 (IGR: 17-4)


67296 The Economic Burden of Childhood Glaucoma
Liu D; Huang L; Mukkamala L; Khouri AS
Journal of Glaucoma 2016; 25: 790-797 (IGR: 17-4)


66610 Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D
Blumberg DM
JAMA ophthalmology 2016; 134: 212-220 (IGR: 17-3)


66505 The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy Screening
Sim DA
Journal of diabetes science and technology 2016; 10: 308-317 (IGR: 17-3)


66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Hernández R
British Journal of Ophthalmology 2016; 100: 1263-1268 (IGR: 17-3)


66596 Self-reported Function, Health Resource Use, and Total Health Care Costs Among Medicare Beneficiaries With Glaucoma
Prager AJ
JAMA ophthalmology 2016; 134: 357-365 (IGR: 17-3)


65900 Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma
Queen JH; Feldman RM
American Journal of Ophthalmology 2016; 163: 70-74.e1 (IGR: 17-3)


66505 The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy Screening
Mitry D
Journal of diabetes science and technology 2016; 10: 308-317 (IGR: 17-3)


66596 Self-reported Function, Health Resource Use, and Total Health Care Costs Among Medicare Beneficiaries With Glaucoma
Liebmann JM
JAMA ophthalmology 2016; 134: 357-365 (IGR: 17-3)


66610 Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D
Prager AJ
JAMA ophthalmology 2016; 134: 212-220 (IGR: 17-3)


66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Burr JM
British Journal of Ophthalmology 2016; 100: 1263-1268 (IGR: 17-3)


65900 Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma
Lee DA
American Journal of Ophthalmology 2016; 163: 70-74.e1 (IGR: 17-3)


66596 Self-reported Function, Health Resource Use, and Total Health Care Costs Among Medicare Beneficiaries With Glaucoma
Cioffi GA
JAMA ophthalmology 2016; 134: 357-365 (IGR: 17-3)


66610 Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D
Liebmann JM
JAMA ophthalmology 2016; 134: 212-220 (IGR: 17-3)


66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Vale L
British Journal of Ophthalmology 2016; 100: 1263-1268 (IGR: 17-3)


66505 The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy Screening
Alexander P
Journal of diabetes science and technology 2016; 10: 308-317 (IGR: 17-3)


66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Azuara-Blanco A
British Journal of Ophthalmology 2016; 100: 1263-1268 (IGR: 17-3)


66505 The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy Screening
Mapani A
Journal of diabetes science and technology 2016; 10: 308-317 (IGR: 17-3)


66596 Self-reported Function, Health Resource Use, and Total Health Care Costs Among Medicare Beneficiaries With Glaucoma
Blumberg DM
JAMA ophthalmology 2016; 134: 357-365 (IGR: 17-3)


66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Cook JA
British Journal of Ophthalmology 2016; 100: 1263-1268 (IGR: 17-3)


66505 The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy Screening
Goverdhan S; Aslam T
Journal of diabetes science and technology 2016; 10: 308-317 (IGR: 17-3)


66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Banister K; Tuulonen A
British Journal of Ophthalmology 2016; 100: 1263-1268 (IGR: 17-3)


66505 The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy Screening
Tufail A
Journal of diabetes science and technology 2016; 10: 308-317 (IGR: 17-3)


66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Ryan M
British Journal of Ophthalmology 2016; 100: 1263-1268 (IGR: 17-3)


66505 The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy Screening
Egan CA; Keane PA
Journal of diabetes science and technology 2016; 10: 308-317 (IGR: 17-3)


66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective

British Journal of Ophthalmology 2016; 100: 1263-1268 (IGR: 17-3)


61672 Volumetric and cost evaluation study of glaucoma medical therapy
Banga HK
International journal of applied & basic medical research 2015; 5: 96-99 (IGR: 17-1)


61744 Comparison of United States and canadian glaucoma medication costs and price change from 2006 to 2013
Schlenker MB
Journal of Ophthalmology 2015; 2015: 547960 (IGR: 17-1)


61359 Use of Various Glaucoma Surgeries and Procedures in Medicare Beneficiaries from 1994 to 2012
Arora KS
Ophthalmology 2015; 122: 1615-1624 (IGR: 17-1)


61669 Cost Analysis of Commonly used Combination of Drugs in Primary Open Angle Glaucoma
Kumbar SK
Journal of clinical and diagnostic research : JCDR 2015; 9: FC05-8 (IGR: 17-1)


61303 Trends in Glaucoma Medication Expenditures under Universal Health Coverage: A National Population-Based Longitudinal Survey in Taiwan
Chiu SL
Journal of Ophthalmology 2015; 2015: 243401 (IGR: 17-1)


61429 Cost-Related Medication Nonadherence and Cost-Saving Behaviors Among Patients With Glaucoma Before and After the Implementation of Medicare Part D
Blumberg DM; Prager AJ
JAMA ophthalmology 2015; 133: 985-996 (IGR: 17-1)


61669 Cost Analysis of Commonly used Combination of Drugs in Primary Open Angle Glaucoma
Mirje M
Journal of clinical and diagnostic research : JCDR 2015; 9: FC05-8 (IGR: 17-1)


61303 Trends in Glaucoma Medication Expenditures under Universal Health Coverage: A National Population-Based Longitudinal Survey in Taiwan
Chu CL
Journal of Ophthalmology 2015; 2015: 243401 (IGR: 17-1)


61359 Use of Various Glaucoma Surgeries and Procedures in Medicare Beneficiaries from 1994 to 2012
Robin AL
Ophthalmology 2015; 122: 1615-1624 (IGR: 17-1)


61672 Volumetric and cost evaluation study of glaucoma medical therapy
Gupta AK
International journal of applied & basic medical research 2015; 5: 96-99 (IGR: 17-1)


61744 Comparison of United States and canadian glaucoma medication costs and price change from 2006 to 2013
Trope GE
Journal of Ophthalmology 2015; 2015: 547960 (IGR: 17-1)


61669 Cost Analysis of Commonly used Combination of Drugs in Primary Open Angle Glaucoma
Moharir G
Journal of clinical and diagnostic research : JCDR 2015; 9: FC05-8 (IGR: 17-1)


61359 Use of Various Glaucoma Surgeries and Procedures in Medicare Beneficiaries from 1994 to 2012
Corcoran KJ
Ophthalmology 2015; 122: 1615-1624 (IGR: 17-1)


61429 Cost-Related Medication Nonadherence and Cost-Saving Behaviors Among Patients With Glaucoma Before and After the Implementation of Medicare Part D
Liebmann JM
JAMA ophthalmology 2015; 133: 985-996 (IGR: 17-1)


61672 Volumetric and cost evaluation study of glaucoma medical therapy
Singh G
International journal of applied & basic medical research 2015; 5: 96-99 (IGR: 17-1)


61744 Comparison of United States and canadian glaucoma medication costs and price change from 2006 to 2013
Buys YM
Journal of Ophthalmology 2015; 2015: 547960 (IGR: 17-1)


61303 Trends in Glaucoma Medication Expenditures under Universal Health Coverage: A National Population-Based Longitudinal Survey in Taiwan
Muo CH; Chen CL
Journal of Ophthalmology 2015; 2015: 243401 (IGR: 17-1)


61429 Cost-Related Medication Nonadherence and Cost-Saving Behaviors Among Patients With Glaucoma Before and After the Implementation of Medicare Part D
Cioffi GA
JAMA ophthalmology 2015; 133: 985-996 (IGR: 17-1)


61359 Use of Various Glaucoma Surgeries and Procedures in Medicare Beneficiaries from 1994 to 2012
Corcoran SL
Ophthalmology 2015; 122: 1615-1624 (IGR: 17-1)


61669 Cost Analysis of Commonly used Combination of Drugs in Primary Open Angle Glaucoma
Bharatha A
Journal of clinical and diagnostic research : JCDR 2015; 9: FC05-8 (IGR: 17-1)


61303 Trends in Glaucoma Medication Expenditures under Universal Health Coverage: A National Population-Based Longitudinal Survey in Taiwan
Lan SJ
Journal of Ophthalmology 2015; 2015: 243401 (IGR: 17-1)


61359 Use of Various Glaucoma Surgeries and Procedures in Medicare Beneficiaries from 1994 to 2012
Ramulu PY
Ophthalmology 2015; 122: 1615-1624 (IGR: 17-1)


61429 Cost-Related Medication Nonadherence and Cost-Saving Behaviors Among Patients With Glaucoma Before and After the Implementation of Medicare Part D
De Moraes CG
JAMA ophthalmology 2015; 133: 985-996 (IGR: 17-1)


60129 Improving patient access to prevent sight loss: ophthalmic electronic referrals and communication (Scotland)
Khan AA
Public Health 2015; 129: 117-123 (IGR: 16-4)


60337 A Quantitative Analysis of the Relationship between Medicare Payment and Service Volume for Glaucoma Procedures from 2005 through 2009
Gong D
Ophthalmology 2015; 122: 1049-1055 (IGR: 16-4)


60594 Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment
Kaplan RI
JAMA ophthalmology 2015; 0: (IGR: 16-4)


60087 The impact of lack of government-insured routine eye examinations on the incidence of self-reported glaucoma, cataracts, and vision loss
Chan CH
Investigative Ophthalmology and Visual Science 2014; 55: 8544-8549 (IGR: 16-4)


60122 Different strategies and cost-effectiveness in the treatment of primary open angle glaucoma
Ting NS
ClinicoEconomics and outcomes research : CEOR 2014; 6: 523-530 (IGR: 16-4)


60251 A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension
Natt NK
Indian Journal of Ophthalmology 2014; 62: 1136-1140 (IGR: 16-4)


60478 Socioeconomics of long-term glaucoma therapy in India
Nayak B
Indian Journal of Ophthalmology 2015; 63: 20-24 (IGR: 16-4)


60394 Incremental Healthcare Service Utilization for Open-angle Glaucoma: A Population-based Study
Chung SD; Ho J
Journal of Glaucoma 2015; 24: e116-e120 (IGR: 16-4)


60478 Socioeconomics of long-term glaucoma therapy in India
Gupta S
Indian Journal of Ophthalmology 2015; 63: 20-24 (IGR: 16-4)


60251 A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension
Gupta A
Indian Journal of Ophthalmology 2014; 62: 1136-1140 (IGR: 16-4)


60594 Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment
De Moraes CG
JAMA ophthalmology 2015; 0: (IGR: 16-4)


60087 The impact of lack of government-insured routine eye examinations on the incidence of self-reported glaucoma, cataracts, and vision loss
Trope GE
Investigative Ophthalmology and Visual Science 2014; 55: 8544-8549 (IGR: 16-4)


60129 Improving patient access to prevent sight loss: ophthalmic electronic referrals and communication (Scotland)
Mustafa MZ
Public Health 2015; 129: 117-123 (IGR: 16-4)


60337 A Quantitative Analysis of the Relationship between Medicare Payment and Service Volume for Glaucoma Procedures from 2005 through 2009
Jun L
Ophthalmology 2015; 122: 1049-1055 (IGR: 16-4)


60122 Different strategies and cost-effectiveness in the treatment of primary open angle glaucoma
Li Yim JF
ClinicoEconomics and outcomes research : CEOR 2014; 6: 523-530 (IGR: 16-4)


60594 Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment
Cioffi GA
JAMA ophthalmology 2015; 0: (IGR: 16-4)


60122 Different strategies and cost-effectiveness in the treatment of primary open angle glaucoma
Ng JY
ClinicoEconomics and outcomes research : CEOR 2014; 6: 523-530 (IGR: 16-4)


60251 A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension
Singh G
Indian Journal of Ophthalmology 2014; 62: 1136-1140 (IGR: 16-4)


60129 Improving patient access to prevent sight loss: ophthalmic electronic referrals and communication (Scotland)
Sanders R
Public Health 2015; 129: 117-123 (IGR: 16-4)


60337 A Quantitative Analysis of the Relationship between Medicare Payment and Service Volume for Glaucoma Procedures from 2005 through 2009
Tsai JC
Ophthalmology 2015; 122: 1049-1055 (IGR: 16-4)


60394 Incremental Healthcare Service Utilization for Open-angle Glaucoma: A Population-based Study
Lin HC
Journal of Glaucoma 2015; 24: e116-e120 (IGR: 16-4)


60478 Socioeconomics of long-term glaucoma therapy in India
Kumar G
Indian Journal of Ophthalmology 2015; 63: 20-24 (IGR: 16-4)


60087 The impact of lack of government-insured routine eye examinations on the incidence of self-reported glaucoma, cataracts, and vision loss
Badley EM; Buys YM
Investigative Ophthalmology and Visual Science 2014; 55: 8544-8549 (IGR: 16-4)


60594 Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment
Al-Aswad LA
JAMA ophthalmology 2015; 0: (IGR: 16-4)


60478 Socioeconomics of long-term glaucoma therapy in India
Dada T
Indian Journal of Ophthalmology 2015; 63: 20-24 (IGR: 16-4)


60394 Incremental Healthcare Service Utilization for Open-angle Glaucoma: A Population-based Study
Kao LT
Journal of Glaucoma 2015; 24: e116-e120 (IGR: 16-4)


60251 A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension
Singh T
Indian Journal of Ophthalmology 2014; 62: 1136-1140 (IGR: 16-4)


60478 Socioeconomics of long-term glaucoma therapy in India
Gupta V
Indian Journal of Ophthalmology 2015; 63: 20-24 (IGR: 16-4)


60394 Incremental Healthcare Service Utilization for Open-angle Glaucoma: A Population-based Study
Tsai MC
Journal of Glaucoma 2015; 24: e116-e120 (IGR: 16-4)


60087 The impact of lack of government-insured routine eye examinations on the incidence of self-reported glaucoma, cataracts, and vision loss
Jin YP
Investigative Ophthalmology and Visual Science 2014; 55: 8544-8549 (IGR: 16-4)


60594 Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment
Blumberg DM
JAMA ophthalmology 2015; 0: (IGR: 16-4)


60478 Socioeconomics of long-term glaucoma therapy in India
Sihota R
Indian Journal of Ophthalmology 2015; 63: 20-24 (IGR: 16-4)


59342 The Peterborough Scheme for Community Specialist Optometrists in Glaucoma: Results of 4 Years of a Two-Tiered Community-Based Assessment and Follow-up Service
Roberts HW; Rughani K; Syam P; Dhingra S; Ramirez-Florez S
Current Eye Research 2014; 0: 1-7 (IGR: 16-3)


58859 Economic analysis of the Ex-PRESS miniature glaucoma device versus trabeculectomy
Patel HY; Wagschal LD; Trope GE; Buys YM
Journal of Glaucoma 2014; 23: 385-390 (IGR: 16-3)


58996 Burden of undetected and untreated glaucoma in the United States
Shaikh Y; Yu F; Coleman AL
American Journal of Ophthalmology 2014; 158: 1121-1129.e1 (IGR: 16-3)


58907 Does government assistance improve utilization of eye care services by low-income individuals?
Hong CJ; Trope GE; Buys YM; Robinson BE; Jin YP
Canadian Journal of Ophthalmology 2014; 49: 320-325 (IGR: 16-3)


59132 Ophthalmic digital image transfer: benefits to triage, patient care and resource
Goudie C; Lunt D; Reid S; Sanders R
Ophthalmic and Physiological Optics 2014; 34: 628-635 (IGR: 16-3)


59589 Addressing inequalities in eye health with subsidies and increased fees for General Ophthalmic Services in socio-economically deprived communities: a sensitivity analysis
Shickle D; Todkill D; Chisholm C; Rughani S; Griffin M; Cassels-Brown A; May H; Slade SV; Davey CJ
Public Health 2015; 129: 131-137 (IGR: 16-3)


59150 Global Burden of Eye and Vision Disease as Reflected in the Cochrane Database of Systematic Reviews
Boyers LN; Karimkhani C; Hilton J; Richheimer W; Dellavalle RP
JAMA ophthalmology 2015; 133: 25-31 (IGR: 16-3)


59163 The short-sighted perspective of long-term eye health-care
Jamous KF; Kalloniatis M; Boon MY; Jalbert I; Zangerl B
Clinical and Experimental Optometry 2014; 97: 565-567 (IGR: 16-3)


59131 Drug Utilization Study in Ophthalmology Out-patient Department of a Medical College in India
Banerjee I; Bhadury T; Sengupta T; Roy D
Annals of medical and health sciences research 2014; 4: 667-670 (IGR: 16-3)


59564 Evaluating the validity of clinical codes to identify cataract and glaucoma in the UK Clinical Practice Research Datalink
Kang EM; Pinheiro SP; Hammad TA; Abou-Ali A
Pharmacoepidemiology and Drug Safety 2015; 24: 38-44 (IGR: 16-3)


57473 Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040: A Systematic Review and Meta-Analysis
Tham YC; Li X; Wong TY; Quigley HA; Aung T; Cheng CY
Ophthalmology 2014; 121: 2081-2090 (IGR: 16-2)


56991 Visual impairment registration: evaluation of agreement among ophthalmologists
Guerin E; Bouliotis G; King A
Eye 2014; 28: 808-813 (IGR: 16-2)


57254 Glaucoma prescribing trends in England 2000 to 2012
Connor AJ; Fraser SG
Eye 2014; 28: 863-869 (IGR: 16-2)


57057 Trends over time and regional variations in the rate of laser trabeculoplasty in the Medicare population
Jampel HD; Cassard SD; Friedman DS; Shekhawat NS; Whiteside-De Vos J; Quigley HA; Gower EW
JAMA ophthalmology 2014; 132: 685-690 (IGR: 16-2)


56934 Financial return-on-investment of ophthalmic interventions: a new paradigm
Brown MM; Brown GC; Lieske HB; Lieske PA
Current Opinions in Ophthalmology 2014; 25: 171-176 (IGR: 16-2)


57223 Macroeconomic costs of eye diseases
Hirneiß C; Kampik A; Neubauer AS
Ophthalmologe 2014; 111: 420-427 (IGR: 16-2)


55519 Increase in examinations for cataracts, glaucoma, diabetic retinopathy and age-related macular degeneration : Comparative cross-sectional study between 2010 and 1997 in ophthalmological practices
Bertram B; Gante C; Hilgers RD
Ophthalmologe 2014; 111: 757-764 (IGR: 15-4)


55497 Vision problems are a leading source of modifiable health expenditures
Rein DB
Investigative Ophthalmology and Visual Science 2013; 54: ORSF18-22 (IGR: 15-4)


55490 The long term effectiveness and cost-effectiveness of initiating treatment for ocular hypertension
Van Gestel A; Schouten JS; Beckers HJ; Severens JL; Hendrikse F; Webers CA
Acta Ophthalmologica 2014; 92: 513-523 (IGR: 15-4)


54878 Screening for glaucoma: U.S. Preventive Services Task Force Recommendation Statement
Moyer VA
Annals of Internal Medicine 2013; 159: 484-489 (IGR: 15-3)


54771 Global rates of glaucoma surgery
Mansouri K; Medeiros FA; Weinreb RN
Graefe's Archive for Clinical and Experimental Ophthalmology 2013; 251: 2609-2615 (IGR: 15-3)


54434 Topical glaucoma therapy cost in Mexico
Lazcano-Gomez G; Hernandez-Oteyza A; Iriarte-Barbosa MJ; Hernandez-Garciadiego C
International Ophthalmology 2014; 34: 241-249 (IGR: 15-3)


54460 An adherence based cost-consequence model comparing bimatoprost 0.01% to bimatoprost 0.03%
Wong WB; Patel VD; Kowalski JW; Schwartz G
Current Medical Research and Opinion 2013; 29: 1191-1200 (IGR: 15-3)


54628 Identification of persons with incident ocular diseases using health care claims databases
Stein JD; Blachley TS; Musch DC
American Journal of Ophthalmology 2013; 156: 1169-1175 (IGR: 15-3)


53983 Projected Cost Comparison of Trabectome, iStent, and Endoscopic Cyclophotocoagulation Versus Glaucoma Medication in the Ontario Health Insurance Plan
Iordanous Y; Kent JS; Hutnik CM; Malvankar-Mehta MS
Journal of Glaucoma 2014; 23: e112-e118 (IGR: 15-2)


53918 The Cost of Glaucoma Care Provided to Medicare Beneficiaries from 2002 to 2009
Quigley HA; Cassard SD; Gower EW; Ramulu PY; Jampel HD; Friedman DS
Ophthalmology 2013; 120: 2249-2257 (IGR: 15-2)


53821 Managed care implications of age-related ocular conditions
Cardarelli WJ; Smith RA
American Journal of Managed Care 2013; 19: s85-91 (IGR: 15-2)


53557 Direct healthcare costs of glaucoma treatment
Rahman MQ; Beard SM; Discombe R; Sharma R; Montgomery DM
British Journal of Ophthalmology 2013; 97: 720-724 (IGR: 15-2)


53628 Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany
Lorenz K; Wolfram C; Breitscheidel L; Shlaen M; Verboven Y; Pfeiffer N
Graefe's Archive for Clinical and Experimental Ophthalmology 2013; 251: 2019-2028 (IGR: 15-2)


53618 Comparison of resource utilization in the treatment of open-angle glaucoma between two cities in Finland: is more better?
Hagman J
Acta Ophthalmologica 2013; 91: 1-47 (IGR: 15-2)


53577 Cost-effectiveness of treating normal tension glaucoma
Li EY; Tham CC; Chi SC; Lam DS
Investigative Ophthalmology and Visual Science 2013; 54: 3394-3399 (IGR: 15-2)


52440 Accounting for Costs, QALYs, and Capacity Constraints: Using Discrete-Event Simulation to Evaluate Alternative Service Delivery and Organizational Scenarios for Hospital-Based Glaucoma Services
Crane GJ; Kymes SM; Hiller JE; Casson R; Martin A; Karnon JD
Medical decision making : an international journal of the Society for Medical Decision Making 2013; 33: 986-997 (IGR: 15-1)


52895 Caregiver burden assessment in primary congenital glaucoma
Dada T; Aggarwal A; Bali SJ; Wadhwani M; Tinwala S; Sagar R
European Journal of Ophthalmology 2013; 23: 324-328 (IGR: 15-1)


52619 Why a successful task substitution in glaucoma care could not be transferred from a hospital setting to a primary care setting: a qualitative study
Holtzer-Goor KM; Plochg T; Lemij HG; van Sprundel E; Koopmanschap MA; Klazinga NS
Implementation science : IS 2013; 8: 14 (IGR: 15-1)


52769 Trends in inpatient treatment in ophthalmology in Germany
Finger RP; Köberlein-Neu J; Gass P; Holz FG; Bertram B
Ophthalmologe 2013; 110: 224-229 (IGR: 15-1)


52657 Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany
Thelen U; Schnober D; Schölzel S; Kristoffersen MS; Nelson LA; Stewart JA; Stewart WC
International Journal of Ophthalmology 2013; 6: 155-159 (IGR: 15-1)


52803 Glaucoma costs in Denmark in treatment naive patients
Olsen J; Berdeaux G; Skov J
Acta Ophthalmologica 2013; 91: 25-31 (IGR: 15-1)


52715 The impact of glaucoma referral refinement criteria on referral to, and first-visit discharge rates from, the hospital eye service: the Health Innovation & Education Cluster (HIEC) Glaucoma Pathways project
Ratnarajan G; Newsom W; French K; Kean J; Chang L; Parker M; Garway-Heath DF; Bourne RR
Ophthalmic and Physiological Optics 2013; 33: 183-189 (IGR: 15-1)


52735 Glaucoma management in Sweden -- results from a nationwide survey
Lindén C; Bengtsson B; Alm A; Calissendorff B; Eckerlund I; Heijl A
Acta Ophthalmologica 2013; 91: 20-24 (IGR: 15-1)


51801 Medical service encounters and payments associated with topical adjunctive therapy use of timolol for glaucoma
Schmier JK; Covert DW; Lau EC
Clinical Drug Investigation 2012; 32: 835-842 (IGR: 14-4)


51927 Comparison of Acquisition Costs of Surgical Supplies in Different Health Care Systems for Cataract and Glaucoma Procedures
Valentine J; Zurakowski D; Ayyala RS
Journal of Glaucoma 2014; 23: 355-359 (IGR: 14-4)


51949 Racial disparities in the use of ancillary testing to evaluate individuals with open-angle glaucoma
Stein JD; Talwar N; Laverne AM; Nan B; Lichter PR
Archives of Ophthalmology 2012; 130: 1579-1588 (IGR: 14-4)


51999 Economic burden of glaucoma in Rivers State, Nigeria
Adio AO; Onua AA
Clinical Ophthalmology 2012; 6: 2023-2031 (IGR: 14-4)


51948 Vision Insurance, Eye Care Visits, and Vision Impairment Among Working-Age Adults in the United States
Li YJ; Xirasagar S; Pumkam C; Krishnaswamy M; Bennett CL
Archives of Ophthalmology 2012; 0: 1-8 (IGR: 14-4)


51720 Medical record validation of self-reported eye diseases and eye care utilization among older adults
MacLennan PA; McGwin G; Searcey K; Owsley C
Current Eye Research 2013; 38: 1-8 (IGR: 14-4)


51760 The effect of changes in referral behaviour following NICE guideline publication on agreement of examination findings between professionals in an established glaucoma referral refinement pathway: the Health Innovation & Education Cluster (HIEC) Glaucoma P
Ratnarajan G; Newsom W; French K; Kean J; Chang L; Parker M; Garway-Heath DF; Bourne RR
British Journal of Ophthalmology 2013; 97: 210-214 (IGR: 14-4)


51238 Trabeculectomy versus Canaloplasty - Utility and Cost-Effectiveness Analysis
Brüggemann A; Müller M
Klinische Monatsblätter für Augenheilkunde 2012; 229: 1118-1123 (IGR: 14-3)


50688 Long-term medical management of primary open-angle glaucoma and ocular hypertension in the UK: optimizing cost-effectiveness and clinic resources by minimizing therapy switches
Orme M; Collins S; Loftus J
Journal of Glaucoma 2012; 21: 433-449 (IGR: 14-3)


50964 Longitudinal trends in resource use in an incident cohort of open-angle glaucoma patients: resource use in open-angle glaucoma
Stein JD; Niziol LM; Musch DC; Lee PP; Kotak SV; Peters CM; Kymes SM
American Journal of Ophthalmology 2012; 154: 452-459.e2 (IGR: 14-3)


51010 Surgical Output and Clinic Burden of Glaucoma in Lagos, Nigeria
Adekoya BJ; Onakoya AO; Shah SP; Adepoju FG
Journal of Glaucoma 2014; 23: 41-45 (IGR: 14-3)


50286 Validity of Self-reported Eye Disease and Treatment in a Population-based Study: The Los Angeles Latino Eye Study
Patty L; Wu C; Torres M; Azen S; Varma R;
Ophthalmology 2012; 119: 1725-1730 (IGR: 14-2)


50515 Surveillance for ocular hypertension: an evidence synthesis and economic evaluation
Burr JM; Botello-Pinzon P; Takwoingi Y; Herná,ndez R; Vazquez-Montes M; Elders A; Asaoka R; Banister K; van der Schoot J; Fraser C; King A; Lemij H; Sanders R; Vernon S; Tuulonen A; Kotecha A; Glasziou P; Garway-Heath D; Crabb D; Vale L; Azuara-Blanco A; Perera R; Ryan M; Deeks J; Cook J.
Health Technol Assess 2012; 16: 1-271 (IGR: 14-2)


50320 An economic comparison of hospital-based and community-based glaucoma clinics
Sharma A; Jofre-Bonet M; Panca M; Lawrenson JG; Murdoch I
Eye 2012; 26: 967-971 (IGR: 14-2)


49037 Cost-effectiveness of Medications Compared With Laser Trabeculoplasty in Patients With Newly Diagnosed Open-Angle Glaucoma
Stein JD; Kim DD; Peck WW; Giannetti SM; Hutton DW
Archives of Ophthalmology 2012; 130: 497-505 (IGR: 14-1)


48981 The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma
Van Gestel A; Webers CA; Severens JL; Beckers HJ; Jansonius NM; Hendrikse F; Schouten JS
Acta Ophthalmologica 2012; 90: 20-31 (IGR: 14-1)


48930 The role of the expected value of individualized care in cost-effectiveness analyses and decision making
Van Gestel A; Grutters J; Schouten J; Webers C; Beckers H; Joore M; Severens J
Value in Health 2012; 15: 13-21 (IGR: 14-1)


48868 Shared care of patients with ocular hypertension in the Community and Hospital Allied Network Glaucoma Evaluation Scheme (CHANGES)
Mandalos A; Bourne R; French K; Newsom W; Chang L
Eye 2012; 26: 564-567 (IGR: 14-1)


47842 Identification of diseases for EQ-5d bolt-on item development: An empirical approach
Solem CT; Gu NY; Pickard AS
Value in Health 2011; 14: A428 (IGR: 13-4)


48296 Community optometrist referral of those aged 65 and over for raised IOP post-NICE: AOP guidance versus joint college guidance--an epidemiological model using BEAP
Vernon SA; Hillman JG; Macnab HK; Bacon P; van der Hoek J; Vernon OK; Bhargarva A
British Journal of Ophthalmology 2011; 95: 1534-1546 (IGR: 13-4)


48031 Gene patents related to common diseases of the eye
Sahebjada S; Cantsileris S; Baird PN
Recent Patents on DNA and Gene Sequences 2011; 5: 185-193 (IGR: 13-4)


47832 Economic outcomes of glaucoma treatment with prostaglandin eye drops preserved with polyquad(registered trademark) instead of benzalkonium chloride in Germany
Gerlier L; Lamotte M; Lorenz K; Berdeaux G; Verboven Y; Pfeiffer N
Value in Health 2011; 14: A503 (IGR: 13-4)


47841 Cost-effectiveness of the ex-press glaucoma filtration device in France
de Jong L; Lafuma A; Clement O; Aguade AS; Berdeaux G
Value in Health 2011; 14: A250-A251 (IGR: 13-4)


47831 Cost of blindness in Austria
Brennig C; Schollbauer V; Walter E
Value in Health 2011; 14: A504-A505 (IGR: 13-4)


47820 Cost-offset analysis: Bimatoprost versus other prostaglandin analogues in open-angle glaucoma
Berenson KL; Kymes S; Hollander DA; Fiscella R; Burk C; Patel VD
American Journal of Managed Care 2011; 17: e365-e374 (IGR: 13-4)


47546 Eye care utilization in Canada: Disparity in the publicly funded health care system
Jin Y-P; Trope GE
Canadian Journal of Ophthalmology 2011; 46: 133-138 (IGR: 13-4)


47611 Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review
Sarnes E; Crofford L; Watson M; Dennis G; Kan H; Bass D
Clinical Therapeutics 2011; 33: 1413-1432 (IGR: 13-4)


47839 Cost-effectiveness of the ex-press glaucoma filtration device in the Netherlands
de Jong L; Lafuma A; Aguade AS; Clement O; Berdeaux G
Value in Health 2011; 14: A250 (IGR: 13-4)


47836 Glaucoma management cost as a function of disease stage and treatment changes
Gerlier L; Shlaen R; Lorenz K; Lamotte M; Verboven Y; Pfeiffer N
Value in Health 2011; 14: A505 (IGR: 13-4)


48360 An assessment of the health and economic burdens of glaucoma
Varma R; Lee PP; Goldberg I; Kotak S
American Journal of Ophthalmology 2011; 152: 515-522 (IGR: 13-4)


47810 Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in Europe
Hollo G; Thelen U; Teus MA; Quaranta L; Ferkova S; Babic N; Misiuk-Hojlo M; Mikropoulos DG; Kaluzny BJ; Kozobolis V
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 493-498 (IGR: 13-4)


47902 Health economical aspects of telemedical glaucoma monitoring
Swierk T; Jurgens C; Grossjohann R; Flessa S; Tost F
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2011; 108: 342-350 (IGR: 13-4)


46989 Economic impact of primary open-angle glaucoma in Australia
Dirani M; Crowston JG; Taylor PS; Moore PT; Rogers S; Pezzullo ML; Keeffe JE; Taylor HR
Clinical and Experimental Ophthalmology 2011; (IGR: 13-3)


46874 A discrete event simulation to optimise the allocation of constrained hospital resources for glaucoma
Crane GJ; Karnon J; Kymes S; Casson R; Metcalfe A; Hiller JE
Value in Health 2011; 14: A55 (IGR: 13-3)


47090 Glaucoma costs in Denmark in treatment naive patients
Olsen J; Berdeaux G; Skov J
Acta Ophthalmologica 2011; (IGR: 13-3)


46878 Cost of glaucoma in the United Kingdom according to the UK GPRD
Salmon J; Lafuma A; Robert J; Berdeaux G
Value in Health 2010; 13: 398 (IGR: 13-3)


46876 Cost-effectiveness analysis of travoprost followed by fixed combination travoprost/timolol treatment sequence (T-TTFC) compared to latanoprost followed by latanoprost/timolol fixed combination (L-LTFC) for patients with open angle glaucoma or ocular hyper
Taylor M; Tan R
Value in Health 2010; 13: 509 (IGR: 13-3)


46471 National Clinical Guideline Centre cost-effectiveness assessment for the National Institute for Health and Clinical Excellence
Wonderling D; Sawyer L; Fenu E; Lovibond K; Laramee P
Annals of Internal Medicine 2011; 154: 758-765 (IGR: 13-3)


46871 Cost-effectiveness analysis of formulary management strategies for first-line agents used in open-angle glaucoma and ocular hypertension
Blaser DA; Ousterhout MM; Gagnon JM; Calabrese D
Value in Health 2011; 14: A55 (IGR: 13-3)


46875 Burden of disease in patients with glaucoma in China: Results from 2009 national health and wellness survey
Tang B; Annunziata K; Zhong Z; Dong P; Xuan J
Value in Health 2010; 13: 562-563 (IGR: 13-3)


46877 Costs and effects of fixed combination therapies in open angle glaucoma
Wickstrom J; Centofanti M; Johnson M
Value in Health 2010; 13: 399-400 (IGR: 13-3)


46879 Costs of glaucoma in Sweden - A pilot study
Svensson J; Berdeaux G; Bergstrom A; Forsby M; Ghatnekar O
Value in Health 2010; 13: 399 (IGR: 13-3)


46880 Development of a multiattribute instrument for estimating utilities (preference weights) in people with glaucoma from the national eye institute visual functioning questionnaire (NEI-VFQ)
Kymes S; Peters CM; Beusterien K; Kotak S; Grinspan J; Stwalley D; Pleil A
Value in Health 2011; 14: 56 (IGR: 13-3)


46882 Glaucoma disease progression states: Establishing a direct, quantitative link between visual field defects and utility loss
Gerlier L; Lamotte M; Verboven Y
Value in Health 2010; 13: 248 (IGR: 13-3)


46883 Predictive factors of glaucoma treatment cost in Germany
Lorenz K; Wolfram C; Claus V; Plesnila-Frank C; Verboven Y; Pfeiffer N
Value in Health 2010; 13: 398-399 (IGR: 13-3)


46881 Cost-effectiveness of brinzolamide/timolol fixed combination (BTFC) versus dorzolamide/timolol fixed combination (DTFC) for patients with open angle glaucoma in Korea and Taiwan
Tan R
Value in Health 2010; 13: 563 (IGR: 13-3)


46118 Treatment persistence and cost-effectiveness of latanoprost/latanoprost-timolol, bimatoprost/bimatoprost-timolol, and travoprost/travoprost-timolol in glaucoma: An analysis based on the United Kingdom general practitioner research database
Lafuma A; Salmon JF; Robert J; Berdeaux G
Clinical Ophthalmology 2011; 5: 361-367 (IGR: 13-2)


45522 Trends in Glaucoma Medication Expenditure: Medical Expenditure Panel Survey 2001-2006
Lam BL; Zheng DD; Davila EP; Arheart KL; Ocasio MA; McCollister KE; Caban-Martinez AJ; Lee DJ
Archives of Ophthalmology 2011; (IGR: 13-2)


46198 Cost-effectiveness of glaucoma interventions in Barbados and Ghana
Wittenborn JS; Rein DB
Optometry and Vision Science 2011; 88: 155-163 (IGR: 13-2)


45976 Efficiency of glaucoma drug regulation in 5 European countries: A 1995-2006 longitudinal prescription analysis
De Natale R; Le Pen C; Berdeaux G
Journal of Glaucoma 2011; 20: 234-239 (IGR: 13-2)


28058 Economic considerations of the diagnosis and management for glaucoma in the developed world
Tuulonen A
Current Opinions in Ophthalmology 2011; 22: 102-109 (IGR: 13-1)


28140 Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs
Schmier JK; Lau EC; Covert DW
Clinical Ophthalmology 2010; 4: 1137-1143 (IGR: 13-1)


27704 Evaluation of compliance with the EGS Guidelines in Spain, using Achievable Benchmarks of Care (ABC®) methodology: The IMCA Study
Castejón-Cervero MA; Jiménez-Parras R; Fernandez-Arias I; Teus-Guezala MA; IMCA Study Group
European Journal of Ophthalmology 2011; 21: 149-155 (IGR: 13-1)


27124 A Canadian population-based study of vision problems: Assessing the significance of socioeconomic status
Perruccio AV; Badley EM; Trope GE
Canadian Journal of Ophthalmology 2010; 45: 477-483 (IGR: 12-4)


27551 Modeling complex treatment strategies: construction and validation of a discrete event simulation model for glaucoma
Van Gestel A; Severens JL; Webers CA; Beckers HJ; Jansonius NM; Schouten JS
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2010; 13:4 358-367 (IGR: 12-4)


27224 A comparative study on the efficacy, safety, and cost-effectiveness of bimatoprost/timolol and dorzolamide/timolol combinations in glaucoma patients
Jothi R; Ismail AM; Senthamarai R; Pal S
Indian Journal of Pharmacology 2010; 42: 362-365 (IGR: 12-4)


27247 First-year treatment costs among new initiators of topical prostaglandin analog identified from November 2007 through April 2008
Schmier JK; Covert DW; Robin AL
Current Medical Research and Opinion 2010; 26: 2769-2777 (IGR: 12-4)


27406 Effect of physician remuneration fees on glaucoma procedure rates in Canada
Buys YM; Austin PC; Campbell RJ
Journal of Glaucoma 2010; (IGR: 12-4)


27185 Setting priorities for comparative effectiveness research: A case study using primary open-angle glaucoma
Li T; Ervin A-M; Scherer R; Jampel H; Dickersin K
Ophthalmology 2010; 117: 1937-1945 (IGR: 12-4)


26599 Value-based medicine for glaucoma
Hirneiss C; Kampik A; Neubauer AS
Ophthalmologe 2010; 107: 223-227 (IGR: 12-3)


26644 Glaucoma in India: Estimated burden of disease
George R; Ve RS; Vijaya L
Journal of Glaucoma 2010; 19: 391-397 (IGR: 12-3)


26722 Modeling complex treatment strategies: Construction and validation of a discrete event simulation model for glaucoma
Van Gestel A; Severens JL; Webers CAB; Beckers HJM; Jansonius NM; Schouten JSAG
Value in Health 2010; 13: 359-367 (IGR: 12-3)


26601 Health-economic aspects of glaucoma screening
Hirneiss C; Niedermaier A; Kernt M; Kampik A; Neubauer AS
Ophthalmologe 2010; 107: 143-149 (IGR: 12-3)


26608 The Peterborough scheme for community specialist optometrists in glaucoma: A feasibility study
Syam P; Rughani K; Vardy SJ; Rimmer T; Fitt A; Husain T; McInerney L; Broome D; Driver R; Wormald R
Eye 2010; 24: 1156-1164 (IGR: 12-3)


26413 The Increased Cost of Medical Services for People Diagnosed With Primary Open-Angle Glaucoma: A Decision Analytic Approach
Kymes SM; Plotzke MR; Li JZ; Nichol MB; Wu J; Fain J
American Journal of Ophthalmology 2010; 150: 74-81 (IGR: 12-3)


25841 Cost benefit analysis of bimatoprost compared with other prostaglandin analogues in patients with primary open angle glaucoma (POAG) in the United States: A payer's perspective
Berenson K; Arora S; Kymes S; Hollander DA; Fiscella R; Burk C; Patel V
Journal of Managed Care Pharmacy 2010; 16: 146 (IGR: 12-2)


26119 Treatment of Glaucoma in Clinical Practice: Four-year Results From a Patient Registry in France
Kobelt G; Texier-Richard B; Buchholz P; Bron A; Renard JP; Rouland JF; Nordmann JP
Journal of Glaucoma 2010; 19: 199-206 (IGR: 12-2)


26223 Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension
Kymes SM; Plotzke MR; Kass MA; Boland MV; Gordon MO
Archives of Ophthalmology 2010; 128: 613-618 (IGR: 12-2)


25823 Epidemiology of glaucoma and drug utilization in UK primary care
Maguire A; Thompson M
Pharmacoepidemiology and Drug Safety 2009; 18: S143 (IGR: 12-2)


25891 First-year treatment costs among new initiators of topical prostaglandin analogs: Pooled results
Schmier JK; Covert DW
Clinical Ophthalmology 2010; 4: 437-445 (IGR: 12-2)


26228 Hospital-based glaucoma clinics: what are the costs to patients?
Sharma A; Jofre-Bonet M; Panca M; Lawrenson JG; Murdoch I
Eye 2010; 24: 999-1005 (IGR: 12-2)


25018 Shared care in glaucoma: a national study of secondary care lead schemes in England
Vernon SA; Adair A
Eye 2010; 24: 265-269 (IGR: 12-1)


25460 First-year treatment costs among new initiators of topical prostaglandin analogs
Schmier J K; Covert D W; Robin A L
Clinical Ophthalmology 2009; 3: 637-644 (IGR: 12-1)


25455 Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden
Bergstrom A; Maurel F; Le Pen C; Lamure E; Kent M; Bardoulat I; Berdeaux G
Clinical Ophthalmology 2009; 3: 471-481 (IGR: 12-1)


25014 The precautionary principle: what is the risk of reusing disposable drops in routine ophthalmology consultations and what are the costs of reducing this risk to zero?
Somner JE; Cavanagh DJ; Wong KK; Whitelaw M; Thomson T; Mansfield D
Eye 2010; 24: 361-363 (IGR: 12-1)


25419 Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs
Schwartz G F; Tan J; Kotak S
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 555-561 (IGR: 12-1)


25361 Healthcare charges in patients with glaucoma who undergo laser trabeculoplasty
Pasquale L R; Walt J G; Stern L S; Wiederkehr D; Malangone E; Dolgitser M
Advances in Therapy 2009; 1-13 (IGR: 12-1)


25066 Association between the use of glaucoma medications and mortality
Stein JD; Newman-Casey PA; Niziol LM; Gillespie BW; Lichter PR; Musch DC
Archives of Ophthalmology 2010; 128: 235-240 (IGR: 12-1)


24821 Direct and indirect effects of visual impairment on mortality risk in older persons
Karpa MJ; Mitchell P; Beath K; Rochtchina E; Cumming RG; Wang JJ; Blue Mountains Eye Study
Archives of Ophthalmology 2009; 127: 1347-1353 (IGR: 11-4)


24655 A french economic model comparing cost-effectiveness of duotrav and xalacom in Glaucoma
Lafuma A; Laurendeau C; Berdeaux G
Value in Health 2009; 12: A455 (IGR: 11-4)


24650 Interventional procedures in glaucoma: resources and costs in five european countries
Lafuma A; Verboven Y; Darba J; Brueggenjuergen B; Gylee E; Berto P
Value in Health 2009; 12: A460 (IGR: 11-4)


24659 Cost effectiveness analysis of tafluprost compared with latanoprost on the treatment of primary open angle glaucoma in South Korea
Song HJ; Kang SH; Heo JH; Lee EK
Value in Health 2009; 12: A456-A457 (IGR: 11-4)


24649 The application of discrete event simulation to quantitative risk benefit analysis
Maguire A; Douglas I; Blak BT
Value in Health 2009; 12: A453 (IGR: 11-4)


24596 Healthcare charges in patients who transition from ocular hypertension to primary open-angle glaucoma based on ophthalmic coding data
Pasquale LR; Walt JG; Stern LS; Wiederkehr D; Malangone E; Dolgitser M
Advances in Therapy 2009; 1-12 (IGR: 11-4)


24657 Costs of glaucoma in Denmark
Olsen J; Berdeaux G
Value in Health 2009; 12: A455 (IGR: 11-4)


24865 The cost of care for people with impaired vision in Australia
Keeffe JE; Chou SL; Lamoureux EL
Archives of Ophthalmology 2009; 127: 1377-1381 (IGR: 11-4)


24656 An economic analysis to evaluate anti-glaucoma pharmacotherapy
Bhowmik D; Sansgiry SS
Value in Health 2009; 12: A75 (IGR: 11-4)


25005 Impact of the Activity-Based Financing (11(th) Version) on glaucoma surgery payment in hospital resources
Muselier A; Mathieu B; Aube H; Creuzot-Garcher C; Bron A
Journal Français d'Ophtalmologie 2009; 32: 701-706 (IGR: 11-4)


24651 How and why automated medical databases should be used to create background occurrences for drug outcomes and safety studies: Glaucoma in thin (UK)
Maguire A; Blak BT
Value in Health 2009; 12: A489 (IGR: 11-4)


24654 Micro-costing vs gross-costing in the estimation of costs for the pharmoeconomic evaluation of glaucoma in Korea
Kang SH; Lee EK
Value in Health 2009; 12: A234 (IGR: 11-4)


24227 The impact of a glaucoma nurse specialist role on glaucoma waiting lists
Slight C; Marsden J; Raynel S
Nursing praxis in New Zealand inc 2009; 25: 38-47 (IGR: 11-3)


24299 Creating patient value in glaucoma care: applying quality costing and care delivery value chain approaches--a five-year case study in the Rotterdam Eye Hospital
de Korne DF; Sol K; Custers T; van Sprundel E; van Ineveld BM; Lemij HG; Klazinga NS
International journal of health care quality assurance 2009; 22: 232-251 (IGR: 11-3)


24377 A critical review of the full economic evaluations of pharmacological treatments for glaucoma
Koleva D; De Compadri P; Virgili G; Nobili A; Garattini L
Journal of Medical Economics 2008; 11: 719-741 (IGR: 11-3)


24376 Modelling the lifetime economic consequences of glaucoma in France
Nordmann JP; Lafuma A; Berdeaux G
Journal of Medical Economics 2009; 12: 9-16 (IGR: 11-3)


24027 Trends in annual medicare expenditures for glaucoma surgical procedures from 1997 to 2006
Schmier JK; Covert DW; Lau EC; Robin AL
Archives of Ophthalmology 2009; 127: 900-905 (IGR: 11-3)


24256 First-year treatment patterns among new initiators of topical prostaglandin analogs
Schmier JK; Covert DW; Robin AL
Current Medical Research and Opinion 2009; 25: 851-858 (IGR: 11-3)


24447 Cost-effectiveness of latanoprost, travoprost and bimatoprost for the treatment of glaucoma in Norway, Sweden and Denmark, using a decision-analytic health economic model
Stewart WC; Stewart JA; Mychaskiw MA
International Journal of Ophthalmology 2009; 9: 812-816 (IGR: 11-3)


23859 The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology 2009; 116: 823-832 (IGR: 11-2)


23540 Cost of illness of glaucoma: A critical and systematic review
Fiscella RG; Lee J; Davis EJH; Walt J
PharmacoEconomics 2009; 27: 189-198 (IGR: 11-2)


24003 The relationship of mean deviation scores and resource utilization among patients with glaucoma: a retrospective United States and European chart review analysis
Berenson K; Kymes S; Walt JG; Siegartel LR
Journal of Glaucoma 2009; 18: 390-394 (IGR: 11-2)


22759 Population-Based Studies in Ophthalmology
Wong TY; Hyman L
American Journal of Ophthalmology 2008; 146: 656-663 (IGR: 11-1)


22502 Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model
Stewart WC; Stewart JA; Mychaskiw MA
Eye 2009; 23: 132-140 (IGR: 11-1)


22849 Economic evaluation of medication, laser trabeculoplasty and filtering surgeries in treating patients with glaucoma in the US
Cantor LB; Katz LJ; Cheng JW; Chen E; Tong KB; Peabody JW
Current Medical Research and Opinion 2008; 24: 2905-2918 (IGR: 11-1)


22919 The impact of co-payment increases on dispensings of government-subsidised medicines in Australia
Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
Pharmacoepidemiology and Drug Safety 2008; 17: 1091-1099 (IGR: 11-1)


22944 Cost effectiveness of travoprost versus a fixed combination of latanoprost/timolol in patients with ocular hypertension or glaucoma: Analysis based on the UK general practitioner research database
De Natale R; Lafuma A; Berdeaux G
Clinical Drug Investigation 2009; 29: 111-120 (IGR: 11-1)


21468 Costs and persistence of carbonic anhydrase inhibitor versus α-2 agonists, associated with β-blockers, in glaucoma and ocular hypertension: An analysis of the UK-GPRD database
Lafuma A; Berdeaux G
Current Medical Research and Opinion 2008; 24: 1519-1527 (IGR: 10-3)


21472 Late-stage, primary open-angle glaucoma in Europe: social and health care maintenance costs and quality of life of patients from 4 countries
Thygesen J; Aagren M; Arnavielle S; Bron A; Frohlich SJ; Baggesen K; Azuara-Blanco A; Buchholz P; Walt JG
Current Medical Research and Opinion 2008; 24: 1763-1770 (IGR: 10-3)


20983 Screening for open angle glaucoma: Systematic review of cost-effectiveness studies
Hernández R; Rabindranath K; Fraser C; Vale L; Blanco AA; Burr JM; OAG Screening Project Group
Journal of Glaucoma 2008; 17: 159-168 (IGR: 10-2)


21161 Disease progression and the need for neuroprotection in glaucoma management
Varma R; Peeples P; Walt JG; Bramley TJ
American Journal of Managed Care 2008; 14: S15-S19 (IGR: 10-2)


21097 Economic evaluation of screening for open-angle glaucoma
Hernandez RA; Burr JM; Vale LD
International Journal of Technology Assessment in Health Care 2008; 24: 203-211 (IGR: 10-2)


21159 Managed care and the impact of glaucoma
Reeder CE; Franklin M; Bramley TJ
American Journal of Managed Care 2008; 14: S5-S10 (IGR: 10-2)


21115 A cost-effectiveness analysis of fixed-combination therapies in patients with open-angle glaucoma: A European perspective
Hommer A; Wickstrom J; Friis MM; Steeds C; Thygesen J; Ferreras A; Gouws P; Buchholz P
Current Medical Research and Opinion 2008; 24: 1057-1063 (IGR: 10-2)


20959 Health care charges for patients with ocular hypertension or primary open-angle glaucoma
Pasquale LR; Dolgitser M; Wentzloff JN; Stern LS; Doyle JJ; Chiang TH; Walt JG
Ophthalmology 2008; 115: 633-638 (IGR: 10-2)


21316 Impact of vision loss on costs and outcomes in medicare beneficiaries with glaucoma
Bramley T; Peeples P; Walt JG; Juhasz M; Hansen JE
Archives of Ophthalmology 2008; 126: 849-856 (IGR: 10-2)


21134 An introduction to decision analysis in the economic evaluation of the prevention and treatment of vision-related diseases
Kymes SM
Ophthalmic Epidemiology 2008; 15: 76-83 (IGR: 10-2)


20531 Costs and effectiveness of travoprost versus a dorzolamide + timolol fixed combination in first-line treatment of glaucoma: Analysis conducted on the United Kingdom General Practitioner Research Database
Lafuma A; Berdeaux G
Current Medical Research and Opinion 2007; 23: 3009-3016 (IGR: 10-1)


20692 Costs of vision impairment: Present and future issues
Keeffe JE
Expert Review of Pharmacoeconomics and Outcomes Research 2007; 7: 523-527 (IGR: 10-1)


20689 Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension.
Frenkel RE; Frenkel M; Toler A
BMC Ophthalmology 2007; 7: 16 (IGR: 10-1)


20310 Prostaglandin analogues for ophthalmic use: a cost-effectiveness analysis
Lachaine J; Hodge WG; Steffensen I; Murray C; Barnes D; Foerster V; Ducruet T; Mensinkai S
Canadian Journal of Ophthalmology 2008; 43: 33-41 (IGR: 10-1)


20643 Assessment of the cost effectiveness of travoprost versus latanoprost as single agents for treatment of glaucoma in France
Payet S; Denis P; Berdeaux G; Launois R
Clinical Drug Investigation 2008; 28: 183-198 (IGR: 10-1)


20392 Direct costs of blindness experienced by patients enrolled in managed care
Frick KD; Walt JG; Chiang TH; Doyle JJ; Stern LS; Katz LM; Dolgitser M; Hendlish SK
Ophthalmology 2008; 115: 11-17 (IGR: 10-1)


20322 The costs of treating glaucoma with combinations of topical drugs in Spain
Neymark N; Buchholz P; Honrubia F; Kobelt G
European Journal of Ophthalmology 2008; 18: 52-59 (IGR: 10-1)


20660 The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: A systematic review and economic evaluation
Burr JM; Mowatt G; Hernandez R; Siddiqui MAR; Cook J; Lourenco T; Ramsay C; Vale L; Fraser C; Azuara-Blanco A
Health Technol Assess 2007; 11: iii-170 (IGR: 10-1)


20530 Estimated first-year costs of prostaglandin analogs with/without adjunctive therapy for glaucoma management: A United States perspective
Schmier JK; Covert DW; Robin AL
Current Medical Research and Opinion 2007; 23: 2867-2875 (IGR: 10-1)


20827 Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist
Peeters A; Schouten JS; Webers CA; Prins MH; Hendrikse F; Severens JL
Eye 2008; 22: 354-362 (IGR: 10-1)


20389 Cost-effectiveness of treating ocular hypertension
Stewart WC; Stewart JA; Nassar QJ; Mychaskiw MA
Ophthalmology 2008; 115: 94-98 (IGR: 10-1)


20341 Cost analysis of glaucoma medications
Rylander NR; Vold SD
American Journal of Ophthalmology 2008; 145: 106-113 (IGR: 10-1)


19789 Disease management programs for glaucoma: Has the vision become a reality?
Goldberg LD
Disease Management and Health Outcomes 2007; 15: 199-205 (IGR: 9-4)


19932 The socioeconomic impact among Egyptian glaucoma patients
Eldaly M; Hunter M; Khafagy M
British Journal of Ophthalmology 2007; 91: 1274-1275 (IGR: 9-4)


19812 Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension
Frenkel REP; Frenkel M; Toler A
BMC Ophthalmology 2007; 7: Article Number: 16 (IGR: 9-4)


20121 Daily cost of glaucoma medications in China
Gao Y; Wu L; Li A
Journal of Glaucoma 2007; 16: 594-597 (IGR: 9-4)


20082 Pharmacoeconomics of new medications for common chronic ophthalmic diseases
Hirsch JD; Morello C; Singh R; Robbins SL
Survey of Ophthalmology 2007; 52: 618-633 (IGR: 9-4)


19681 Practice of pharmaceutical care - Therapeutic drug monitoring and pharmacoeconomics of glaucoma
Ikeda H
Yakugaku Zasshi 2007; 127: 1441-1448 (IGR: 9-4)


19788 Refill rates and budget impact of glaucoma lipid therapy: A retrospective database analysis
Walt JG; Wilensky JT; Fiscella R; Chiang TH; Guckian A
Clinical Drug Investigation 2007; 27: 819-825 (IGR: 9-4)


19548 Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma
Jayawant SS; Bhosle MJ; Anderson RT; Balkrishnan R
Journal of Glaucoma 2007; 16: 513-520 (IGR: 9-3)


19592 Medical costs of glaucoma and ocular hypertension in Italian referral centres: a prospective study
Koleva D; Motterlini N; Schiavone M; Garattini L
Ophthalmologica 2007; 221: 340-347 (IGR: 9-3)


19566 Glaucoma in the United States and Europe: Predicting costs and surgical rates based upon stage of disease
Lee PP; Kelly SP; Mills RP; Traverso CE; Walt JG; Doyle JJ; Katz LM; Siegartel LR; Costs of Glaucoma Study Group
Journal of Glaucoma 2007; 16: 471-478 (IGR: 9-3)


19575 Cost of patients with primary open-angle glaucoma: A retrospective study of commercial insurance claims data
Lee PP; Levin LA; Walt JG; Chiang T; Katz LM; Dolgitser M; Doyle JJ; Stern LS
Ophthalmology 2007; 114: 1241-1247 (IGR: 9-3)


19506 Cost effectiveness and cost utility of an organized screening programme for glaucoma
Vaahtoranta-Lehtonen H; Tuulonen A; Aronen P; Sintonen H; Suoranta L; Kovanen N; Linna M; Läärä E; Malmivaara A
Acta Ophthalmologica Scandinavica 2007; 85: 508-518 (IGR: 9-3)


17972 Primary angle closure glaucoma: a developing world perspective
Thomas R; Sekhar GC; Parikh R
Clinical and Experimental Ophthalmology 2007; 35: 374-378 (IGR: 9-2)


18029 Rates of glaucoma medication utilization among older adults with suspected glaucoma, 1992 to 2002
Stein JD; Sloan FA; Lee PP
American Journal of Ophthalmology 2007; 143: 870-872 (IGR: 9-2)


17544 The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries
Mendis S; Fukino K; Cameron A; Laing R; Filipe Jr A; Khatib O; Leowski J; Ewen M
Bulletin of the World Health Organisation 2007; 85: 279-288 (IGR: 9-2)


17526 The economic implications of glaucoma: A literature review
Schmier JK; Halpern MT; Jones ML
PharmacoEconomics 2007; 25: 287-308 (IGR: 9-2)


18063 Costs of interventions for visual impairment
Taylor HR; Pezzullo ML; Nesbitt SJ; Keeffe JE
American Journal of Ophthalmology 2007; 143: 561-565 (IGR: 9-2)


18030 The impact of glaucoma coding in a large claims database
Lee PP; Levin LA; Walt JG; Chiang TH; Doyle JJ; Stern LS; Dolgitser M
American Journal of Ophthalmology 2007; 143: 867-870 (IGR: 9-2)


16810 The projected increase in glaucoma due to the aging population in Austria from 2001 to 2031: results based on data of the Salzburg-Moorfields Collaborative Glaucoma Study
Hitzl W; Bunce C; Reitsamer HA; Grabner G; Hornykewycz K
European Journal of Ophthalmology 2007; 17: 45-52 (IGR: 9-1)


16778 Cost-effective evaluation of the glaucoma suspect
Doshi A; Singh K
Current Opinions in Ophthalmology 2007; 18: 97-103 (IGR: 9-1)


16950 Association between vision loss and higher medical care costs in medicare beneficiaries. Costs are greater for those with progressive vision loss
Javitt JC; Zhou Z; Willke RJ
Ophthalmology 2007; 114: 238-245 (IGR: 9-1)


17188 Economic evaluation for ophthalmologists
Kuper H; Jofre-Bonet M; Gilbert C
Ophthalmic Epidemiology 2006; 13: 393-401 (IGR: 9-1)


16865 LXIII Edward Jackson Memorial Lecture: Eye care: dollars and sense
Taylor HR
American Journal of Ophthalmology 2007; 143: 1-8 (IGR: 9-1)


15159 Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study
Gieser DK; Tracy Williams R; O'Connell W; Pasquale LR; Rosenthal BP; Walt JG; Katz LM; Siegartel LR; Wang L; Rosenblatt LC
Journal of Glaucoma 2006; 15: 419-425 (IGR: 8-4)


15068 Screening for glaucoma in Canada: a systematic review of the literature
Einarson TR; Vicente C; Machado M; Covert D; Trope GE; Iskedjian M
Canadian Journal of Ophthalmology 2006; 41: 709-721 (IGR: 8-4)


14515 Aniridie: Study of the treatments and orientatives costs
Andres Lazaro AM; Bel Prieto E
Ciencia y Tecnologia Pharmaceutica 2006; 16: 47-60 (IGR: 8-4)


14633 Treating patients with primary open angle glaucoma or ocular hypertension with domestic and imported latanoprost drop: Comparison on efficacy and cost
Ma J-X
International Journal of Ophthalmology 2006; 6: 895-897 (IGR: 8-4)


15154 On the socio-economic relevance of glaucoma
Grub M; Rohrbach JM
Klinische Monatsblätter für Augenheilkunde 2006; 223: 793-795 (IGR: 8-4)


14850 Prostaglandin analogues for the treatment of glaucoma and ocular hypertension: A systematic review of economic evidence
Orme M; Boler A
PharmacoEconomics 2006; 24: 743-750 (IGR: 8-4)


15250 Trends in cost of major eye diseases to medicare, 1991 to 2000
Salm M; Belsky D; Sloan FA
American Journal of Ophthalmology 2006; 142: 976-982 (IGR: 8-4)


14304 Compare of daily cost of ophthalmic solutions for glaucoma
Gao Y; Wu L-L; Li A-J
Ophthalmology in China 2006; 15: 127-129 (IGR: 8-3)


14224 The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries
Holmstrom S; Buchholz P; Walt J; Wickstrom J; Aagren M
Current Medical Research and Opinion 2006; 22: 897-905 (IGR: 8-3)


13995 Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario Health Insurance Plan
Lee R; Hutnik CM
Canadian Journal of Ophthalmology 2006; 41: 449-456 (IGR: 8-3)


13979 Medicare prescription drug cards: effectiveness for patients with glaucoma
Mahadevia AA; Nundy S; Frick KD; Jampel HD
Archives of Ophthalmology 2006; 124: 1175-1179 (IGR: 8-3)


14255 Volume of one drop and daily cost of ophthalmic solution for glaucoma
Tomita T; Ikeda H; Tsukamoto H; Sugimoto A; Mishima HK; Kihira K
Japanese Journal of Clinical Ophthalmology 2006; 60: 817-820 (IGR: 8-3)


13582 Estimated comparative costs of achieving a 20% reduction in intraocular pressure with bimatoprost or latanoprost in patients with glaucoma or ocular hypertension
Fiscella R; Walt J
Drugs and Aging 2006; 23: 39-47 (IGR: 8-2)


13720 Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications
Goldberg LD; Walt J
PharmacoEconomics 2006; 24: 251-264 (IGR: 8-2)


13940 Update on utilities and cost-utility analyses
Hollands H; Sharma S
Current Opinions in Ophthalmology 2006; 17: 223-227 (IGR: 8-2)


13938 Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden
Kobelt G; Jonsson B; Bergstrom A; Chen E; Linden C; Alm A
Acta Ophthalmologica Scandinavica 2006; 84: 363-371 (IGR: 8-2)


13939 Management of ocular hypertension: A cost-effectiveness approach from the Ocular Hypertension Treatment Study
Kymes SM; Kass MA; Anderson DR; Miller JP; Gordon MO; Ocular Hypertension Treatment Study Group (OHTS)
American Journal of Ophthalmology 2006; 141: 997-1008 (IGR: 8-2)


13651 Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK
Lafuma A; Brezin A; Lopatriello S; Hieke K; Hutchinson J; Mimaud V; Berdeaux G
PharmacoEconomics 2006; 24: 193-205 (IGR: 8-2)


13266 A Markov modelled pharmacoeconomic analysis of bimatoprost 0.03% in the treatment of glaucoma as an alternative to filtration surgery in Italy
Christensen TL; Poulsen PB; Holmstrom S; Walt JG; Vetrugno M
Current Medical Research and Opinion 2005; 21: 1837-1843 (IGR: 8-1)


13267 The cost-effectiveness of bimatoprost 0.03% in the treatment of glaucoma in adult patients - a European perspective
Tuil E; Hommer AB; Poulsen PB; Christensen TL; Buchholz P; Walt J; Holmstrom S
International Journal of Clinical Pract 2005; 59: 1011-1016 (IGR: 8-1)


13351 Can the number of primary open angle glaucoma in Austria within 2001 to 2031 be estimated?
Hitzl W; Reitsamer HA; Grabner G; Hornykewcyz K
Spektrum der Augenheilkunde 2005; 19: 290-293 (IGR: 8-1)


13437 The rising cost of glaucoma drugs in Ireland 1996-2003
Knox FA; Barry M; McGowan B; O'Brien C
British Journal of Ophthalmology 2006; 90: 162-165 (IGR: 8-1)


13452 A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma
Lee PP; Walt JG; Doyle JJ; Kotak SV; Evans SJ; Budenz DL; Chen PP; Coleman AL; Feldman RM; Jampel HD
Archives of Ophthalmology 2006; 124: 12-19 (IGR: 8-1)


13429 A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden
Lindblom B; Nordmann JP; Sellem E; Chen E; Gold R; Polland W; Williamson W; Buchholz P; Walt JG; Groleau D
Acta Ophthalmologica Scandinavica 2006; 84: 74-83 (IGR: 8-1)


13411 Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications
Noecker RJ; Walt JG
American Journal of Ophthalmology 2006; 141: S15-S21 (IGR: 8-1)


13068 Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe
Traverso CE; Walt JG; Kelly SP; Hommer AH; Bron AM; Denis P; Nordmann JP; Renard JP; Bayer A; Grehn F
British Journal of Ophthalmology 2005; 89: 1245-1249 (IGR: 7-3)


12193 Health economical evaluation of the 'Salzburg-Moorfields-Collaborative-Glaucoma-Study': Present and future costs for a glaucoma screening program
Hitzl W; Hornykewycz K; Ortner C; Reitsamer H; Stollinger M; Grabner G
Spektrum der Augenheilkunde 2005; 19: 23-27 (IGR: 7-2)


12216 Cost-effectiveness and cost-utility analysis of travoprost versus latanoprost and timolol in the treatment of advanced glaucoma in five European countries: Austria, France, Germany, The Netherlands and the United Kingdom
Le Pen C; Ligier M; Berdeaux G
Journal of Medical Economics 2005; 8: 67-84 (IGR: 7-2)


12270 The economic burden of glaucoma and ocular hypertension: Implications for patient management: A review
Rouland J-F; Berdeaux G; Lafuma A
Drugs and Aging 2005; 22: 315-321 (IGR: 7-2)


12298 Cost considerations of the new fixed combinations for glaucoma medical therapy
Ventura MP; Saheb NE; Solari HP; Saraiva VS; Vianna RN; Burnier MN Jr
Journal of Clinical Pharmacy and Therapeutics 2005; 30: 251-254 (IGR: 7-2)


12302 Association between corneal thickness, mean intraocular pressure, disease stability and severity, and cost of treatment in glaucoma: a Canadian analysis
Walker JH; Buys Y; Trope G; Vicente C; Einarson TR; Covert D; Iskedjian M
Current Medical Research and Opinion 2005; 21: 489-494 (IGR: 7-2)


11566 Association between mean intraocular pressure, disease stability and cost of treating glaucoma in Canada
Vicente C; Walker J; Buys Y; Einarson TR; Covert D; Iskedjian M
Current Medical Research and Opinion 2004; 20: 1245-1251 (IGR: 6-3)


11468 What is the direct cost of treatment of acute primary angle closure glaucoma? The Singapore model
Wang JC; Chew PT
Clinical and Experimental Ophthalmology 2004; 32: 578-583 (IGR: 6-3)


10611 Medical predictive factors of glaucoma treatment costs
Denis P; Lafuma A; Berdeaux G
Journal of Glaucoma 2004; 13: 283-90 (IGR: 6-2)


10840 Glaucoma therapy: Prescribing pattern and cost analysis
Sharma R; Khajuria R; Sharma P; Sadhotra P; Kapoor B; Kohli K; Sharma CL
JK Science 2004; 6: 88-92 (IGR: 6-2)


9882 Prescription of topical antiglaucoma agents for patients with contraindications to beta-blockers
Houde M; Castilloux AM; Tingey D; Assalian A; LeLorier J
Canadian Journal of Ophthalmology 2003; 38: 469-475 (IGR: 5-3)


9904 Assessing the cost-effectiveness of switching from a β-blocker to latanoprost in the treatment of ocular hypertension
Costagliola C; Parmeggiani F; Sebastiani A
Expert Opinion in Pharmacotherapy 2003; 4: 1775-1788 (IGR: 5-3)


9073 Clinical and economic impacts of latanoprost 0.005% in first-line treatment of open-angle glaucoma and ocular hypertension in France
Bernard LM; Althin R; Dhawan R; Grima DT; Lam A; Aballéa S
European Journal of Ophthalmology 2003; 13 (Suppl 4): S30-S43 (IGR: 5-2)


9072 Persistency and clinical outcomes associated with latanoprost and beta-blocker monotherapy: evidence from a European retrospective cohort study
Diestelhorst M; Schaefer CP; Beusterien KM; Plante KM; Fain JM; Mozaffari E; Dhawan R
European Journal of Ophthalmology 2003; 13 (Suppl 4): S21-S29 (IGR: 5-2)


9070 Medical therapy cost considerations for glaucoma
Fiscella RG; Green A; Patuszynski DH; Wilensky JT
American Journal of Ophthalmology 2003; 136: 18-25 (IGR: 5-2)


9074 Patient persistency with pharmacotherapy in the management of glaucoma
Reardon G; Schwartz GF; Mozaffari E
European Journal of Ophthalmology 2003; 13 (Suppl 4): S44-S52 (IGR: 5-2)


9071 Naturalistic, prospective study of glaucoma and ocular hypertension treatment in France: strategies, clinical outcomes, and costs at 1 year
Rouland JF; Le Pen C; Ophthalmologists of the Glaucoma Study
European Journal of Ophthalmology 2003; 13 (Suppl 4): S5-S20 (IGR: 5-2)


8073 A cost analysis of the prostaglandin analogs
Mick AB; Gonzalez S; Dunbar MT; McSoley J
Optometry 2002; 73: 614-619 (IGR: 4-3)


8078 An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension
Stewart WC; Leech J; Sharpe ED; Kulze J; Ellyn J; Day DG
American Journal of Management Care 2002; 8 S240-248 (IGR: 4-3)


8248 Health economics, economic evaluation, and glaucoma
Kobelt G
Journal of Glaucoma 2002; 11: 531-539 (IGR: 4-3)


8009 Incidence of iris colour change in latanoprost treated eyes
Teus MA; Arranz-Marquez E; Lucea-Suescun P
British Journal of Ophthalmology 2002; 86: 1085-1088 (IGR: 4-3)


3691 Trends in glaucoma surgery incidence and reimbursement for physician services in the Medicare population from 1995 to 1998
Paikal D; Yu F; Coleman AL
Ophthalmology 2002; 109: 1372-1376 (IGR: 4-2)


3692 Cost analysis of glaucoma medications: a three-year review
Vold SD; Riggs WL; Jackimiec J
Journal of Glaucoma 2002; 11: 354-358 (IGR: 4-2)


18389 Clinical spectrum of posterior ischemic optic neuropathy
Sadda SR; Nee M; Miller NR; Biousse V; Newman NJ; Kouzis A
American Journal of Ophthalmology 2001; 132: 743-750 (IGR: 3-3)


6418 An observational, retrospective two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients
Rouland JF; Peigne G; Sellem E; Renard JP; Williamson W; Filippi JM; Cohn H; Hamard P; Abellan P; Chagnon A
Journal Français d'Ophtalmologie 2001; 24: 233-243 (IGR: 3-2)


6585 Costs of medical and surgical treatment of glaucoma
Calissendorff BM
Acta Ophthalmologica Scandinavica 2001; 79: 286-288 (IGR: 3-2)


6586 Resource use and costs of patients with glaucoma or ocular hypertension: a one-year study based on retrospective chart review in the Netherlands
Oostenbrink JB; Rutten-van Mölken MPMH; Sluyter-Opdenoordt TS
Journal of Glaucoma 2001; 10: 184-191 (IGR: 3-2)


19233 Daily cost of ophthalmic solutions for treating glaucoma in Japan
Ikeda H; Sato E; Kitaura T; Fukuchi H; Kimura Y; Kihira K
Japanese Journal of Ophthalmology 2001; 45: 99-102 (IGR: 3-1)


6287 The treatment of newly diagnosed patients with glaucoma or with ocular hypertension in the Netherlands: an observational study of costs and initial treatment success based on retrospective chart review
Oostenbrink JB; Rutten-van Moelken MP; Opdenoordt TS
Documenta Ophthalmologica 1999; 98: 285-299 (IGR: 2-2)


5920 Cost analysis of glaucoma medications
Vold SD; Wiggins DA; Jackimiec J
Journal of Glaucoma 2000; 9: 150-153 (IGR: 2-1)


15622 Cost considerations of medical therapy for glaucoma
Fiscella RG; Geller JL; Gryz LL; Wilensky J; Viana M
American Journal of Ophthalmology 1999; 128: 426-433 (IGR: 1-3)



1.5 Glaucomas as cause of blindness (899 abstracts found)


84703 Findings from a Rapid Assessment of Avoidable Blindness (RAAB) in the Southwest Region of Kyrgyzstan
Mueller B
Ophthalmic Epidemiology 2020; 27: 141-147 (IGR: 21-1)


84985 Open-angle glaucoma in a rural and urban population in Eastern India-the Hooghly river glaucoma study
Paul C
Indian Journal of Ophthalmology 2020; 68: 371-374 (IGR: 21-1)


84564 Advanced glaucoma at diagnosis: current perspectives
Kastner A
Eye 2020; 34: 116-128 (IGR: 21-1)


84678 Visual impairment among adults in Saudi Arabia
Zeried FM
Clinical and Experimental Optometry 2019; 0: (IGR: 21-1)


85202 Seeing other perspectives: evaluating the use of virtual and augmented reality to simulate visual impairments (OpenVisSim)
Jones PR
NPJ digital medicine 2020; 3: 32 (IGR: 21-1)


84484 Low rates of eye care utilization among visually impaired subsidized senior housing residents
Elliott AF
Aging & mental health 2019; 0: 1-7 (IGR: 21-1)


84546 Eye clinic liaison officers service in the United Kingdom
Papastefanou VP
The International journal of health planning and management 2020; 35: 506-519 (IGR: 21-1)


84518 Effects of an Aging Population and Racial Demographics on Eye Disease Prevalence: Projections for Georgia Through 2050
Kelly E
American Journal of Ophthalmology 2020; 210: 35-40 (IGR: 21-1)


84555 Open-Angle Glaucoma: Burden of Illness, Current Therapies, and the Management of Nocturnal IOP Variation
Sheybani A
Ophthalmology and therapy 2020; 9: 1-14 (IGR: 21-1)


84654 Epidemiology of Childhood Blindness and Low Vision in Kinshasa-democratic Republic of the Congo
Kilangalanga NJ; Nsiangani LN
Ophthalmic Epidemiology 2020; 27: 45-51 (IGR: 21-1)


84678 Visual impairment among adults in Saudi Arabia
Alshalan FA
Clinical and Experimental Optometry 2019; 0: (IGR: 21-1)


84484 Low rates of eye care utilization among visually impaired subsidized senior housing residents
Heskett M
Aging & mental health 2019; 0: 1-7 (IGR: 21-1)


84546 Eye clinic liaison officers service in the United Kingdom
Kang S
The International journal of health planning and management 2020; 35: 506-519 (IGR: 21-1)


84555 Open-Angle Glaucoma: Burden of Illness, Current Therapies, and the Management of Nocturnal IOP Variation
Scott R
Ophthalmology and therapy 2020; 9: 1-14 (IGR: 21-1)


84703 Findings from a Rapid Assessment of Avoidable Blindness (RAAB) in the Southwest Region of Kyrgyzstan
Ibraimova S
Ophthalmic Epidemiology 2020; 27: 141-147 (IGR: 21-1)


84518 Effects of an Aging Population and Racial Demographics on Eye Disease Prevalence: Projections for Georgia Through 2050
Wen Q
American Journal of Ophthalmology 2020; 210: 35-40 (IGR: 21-1)


84985 Open-angle glaucoma in a rural and urban population in Eastern India-the Hooghly river glaucoma study
Sengupta S
Indian Journal of Ophthalmology 2020; 68: 371-374 (IGR: 21-1)


84564 Advanced glaucoma at diagnosis: current perspectives
King AJ
Eye 2020; 34: 116-128 (IGR: 21-1)


85202 Seeing other perspectives: evaluating the use of virtual and augmented reality to simulate visual impairments (OpenVisSim)
Somoskeöy T
NPJ digital medicine 2020; 3: 32 (IGR: 21-1)


84484 Low rates of eye care utilization among visually impaired subsidized senior housing residents
Spiker C
Aging & mental health 2019; 0: 1-7 (IGR: 21-1)


84985 Open-angle glaucoma in a rural and urban population in Eastern India-the Hooghly river glaucoma study
Banerjee S
Indian Journal of Ophthalmology 2020; 68: 371-374 (IGR: 21-1)


84546 Eye clinic liaison officers service in the United Kingdom
Simkiss P
The International journal of health planning and management 2020; 35: 506-519 (IGR: 21-1)


84703 Findings from a Rapid Assessment of Avoidable Blindness (RAAB) in the Southwest Region of Kyrgyzstan
Mamutalieva E
Ophthalmic Epidemiology 2020; 27: 141-147 (IGR: 21-1)


84518 Effects of an Aging Population and Racial Demographics on Eye Disease Prevalence: Projections for Georgia Through 2050
Haddad D
American Journal of Ophthalmology 2020; 210: 35-40 (IGR: 21-1)


85202 Seeing other perspectives: evaluating the use of virtual and augmented reality to simulate visual impairments (OpenVisSim)
Chow-Wing-Bom H
NPJ digital medicine 2020; 3: 32 (IGR: 21-1)


84654 Epidemiology of Childhood Blindness and Low Vision in Kinshasa-democratic Republic of the Congo
Dilu AA
Ophthalmic Epidemiology 2020; 27: 45-51 (IGR: 21-1)


84678 Visual impairment among adults in Saudi Arabia
Simmons D
Clinical and Experimental Optometry 2019; 0: (IGR: 21-1)


84555 Open-Angle Glaucoma: Burden of Illness, Current Therapies, and the Management of Nocturnal IOP Variation
Samuelson TW
Ophthalmology and therapy 2020; 9: 1-14 (IGR: 21-1)


84484 Low rates of eye care utilization among visually impaired subsidized senior housing residents
McGwin G
Aging & mental health 2019; 0: 1-7 (IGR: 21-1)


84555 Open-Angle Glaucoma: Burden of Illness, Current Therapies, and the Management of Nocturnal IOP Variation
Kahook MY
Ophthalmology and therapy 2020; 9: 1-14 (IGR: 21-1)


84654 Epidemiology of Childhood Blindness and Low Vision in Kinshasa-democratic Republic of the Congo
Moanda KA
Ophthalmic Epidemiology 2020; 27: 45-51 (IGR: 21-1)


84703 Findings from a Rapid Assessment of Avoidable Blindness (RAAB) in the Southwest Region of Kyrgyzstan
Limburg H
Ophthalmic Epidemiology 2020; 27: 141-147 (IGR: 21-1)


84678 Visual impairment among adults in Saudi Arabia
Osuagwu UL
Clinical and Experimental Optometry 2019; 0: (IGR: 21-1)


85202 Seeing other perspectives: evaluating the use of virtual and augmented reality to simulate visual impairments (OpenVisSim)
Crabb DP
NPJ digital medicine 2020; 3: 32 (IGR: 21-1)


84546 Eye clinic liaison officers service in the United Kingdom
Zambarakji H
The International journal of health planning and management 2020; 35: 506-519 (IGR: 21-1)


84985 Open-angle glaucoma in a rural and urban population in Eastern India-the Hooghly river glaucoma study
Choudhury S
Indian Journal of Ophthalmology 2020; 68: 371-374 (IGR: 21-1)


84518 Effects of an Aging Population and Racial Demographics on Eye Disease Prevalence: Projections for Georgia Through 2050
O'Banion J
American Journal of Ophthalmology 2020; 210: 35-40 (IGR: 21-1)


84555 Open-Angle Glaucoma: Burden of Illness, Current Therapies, and the Management of Nocturnal IOP Variation
Bettis DI
Ophthalmology and therapy 2020; 9: 1-14 (IGR: 21-1)


84654 Epidemiology of Childhood Blindness and Low Vision in Kinshasa-democratic Republic of the Congo
Ilunga MJ
Ophthalmic Epidemiology 2020; 27: 45-51 (IGR: 21-1)


84703 Findings from a Rapid Assessment of Avoidable Blindness (RAAB) in the Southwest Region of Kyrgyzstan
Ibraimova A
Ophthalmic Epidemiology 2020; 27: 141-147 (IGR: 21-1)


84484 Low rates of eye care utilization among visually impaired subsidized senior housing residents
Owsley C
Aging & mental health 2019; 0: 1-7 (IGR: 21-1)


84703 Findings from a Rapid Assessment of Avoidable Blindness (RAAB) in the Southwest Region of Kyrgyzstan
Paduca A
Ophthalmic Epidemiology 2020; 27: 141-147 (IGR: 21-1)


84654 Epidemiology of Childhood Blindness and Low Vision in Kinshasa-democratic Republic of the Congo
Makwanga ME
Ophthalmic Epidemiology 2020; 27: 45-51 (IGR: 21-1)


84555 Open-Angle Glaucoma: Burden of Illness, Current Therapies, and the Management of Nocturnal IOP Variation
Ahmed IIK; Stephens JD
Ophthalmology and therapy 2020; 9: 1-14 (IGR: 21-1)


84654 Epidemiology of Childhood Blindness and Low Vision in Kinshasa-democratic Republic of the Congo
Stahnke T
Ophthalmic Epidemiology 2020; 27: 45-51 (IGR: 21-1)


84555 Open-Angle Glaucoma: Burden of Illness, Current Therapies, and the Management of Nocturnal IOP Variation
Kent D
Ophthalmology and therapy 2020; 9: 1-14 (IGR: 21-1)


84654 Epidemiology of Childhood Blindness and Low Vision in Kinshasa-democratic Republic of the Congo
Guthoff R
Ophthalmic Epidemiology 2020; 27: 45-51 (IGR: 21-1)


84555 Open-Angle Glaucoma: Burden of Illness, Current Therapies, and the Management of Nocturnal IOP Variation
Ferguson TJ; Herndon LW
Ophthalmology and therapy 2020; 9: 1-14 (IGR: 21-1)


82194 Using registry data to characterize the incidence and causes of blindness in Oregon
Brinks MV
PLoS ONE 2019; 14: e0220983 (IGR: 20-4)


82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Cheng CY
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82828 Global Blindness: The Progress We Are Making and Still Need to Make
Taylor HR
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2019; 8: 424-428 (IGR: 20-4)


82771 The Frequency and Causes of Blindness in a Rural Region of Central Anatolia of Turkey
Mirza E
The Eurasian journal of medicine 2019; 51: 242-246 (IGR: 20-4)


82165 Older Drivers and Glaucoma in India: Driving Habits and Crash Risks
Deshmukh AV
Journal of Glaucoma 2019; 28: 896-900 (IGR: 20-4)


81585 Glaucoma care in Nigeria: Is the current practice poised to tackle this emerging sight-threatening disease?
Onwubiko SN
International Ophthalmology 2019; 39: 2385-2390 (IGR: 20-4)


82629 Impact of Visual Impairment and Blindness on Quality of Life of Patients in Owerri, Imo State, Nigeria
Ejiakor I
Middle East African Journal of Ophthalmology 2019; 26: 127-132 (IGR: 20-4)


82356 Prevalence and causes of blindness and visual impairment; and cataract surgical services in Katsina state of Nigeria
Taryam MO
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82771 The Frequency and Causes of Blindness in a Rural Region of Central Anatolia of Turkey
Mirza GD
The Eurasian journal of medicine 2019; 51: 242-246 (IGR: 20-4)


82165 Older Drivers and Glaucoma in India: Driving Habits and Crash Risks
Murthy GJ
Journal of Glaucoma 2019; 28: 896-900 (IGR: 20-4)


82629 Impact of Visual Impairment and Blindness on Quality of Life of Patients in Owerri, Imo State, Nigeria
Achigbu E
Middle East African Journal of Ophthalmology 2019; 26: 127-132 (IGR: 20-4)


81585 Glaucoma care in Nigeria: Is the current practice poised to tackle this emerging sight-threatening disease?
Udeh NN
International Ophthalmology 2019; 39: 2385-2390 (IGR: 20-4)


82194 Using registry data to characterize the incidence and causes of blindness in Oregon
Redd T
PLoS ONE 2019; 14: e0220983 (IGR: 20-4)


82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Wang N
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82356 Prevalence and causes of blindness and visual impairment; and cataract surgical services in Katsina state of Nigeria
Rabiu MM; Muhammad N
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


81585 Glaucoma care in Nigeria: Is the current practice poised to tackle this emerging sight-threatening disease?
Nkwegu O
International Ophthalmology 2019; 39: 2385-2390 (IGR: 20-4)


82629 Impact of Visual Impairment and Blindness on Quality of Life of Patients in Owerri, Imo State, Nigeria
Onyia O
Middle East African Journal of Ophthalmology 2019; 26: 127-132 (IGR: 20-4)


82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Wong TY
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82771 The Frequency and Causes of Blindness in a Rural Region of Central Anatolia of Turkey
Oltulu R
The Eurasian journal of medicine 2019; 51: 242-246 (IGR: 20-4)


82165 Older Drivers and Glaucoma in India: Driving Habits and Crash Risks
Reddy A
Journal of Glaucoma 2019; 28: 896-900 (IGR: 20-4)


82194 Using registry data to characterize the incidence and causes of blindness in Oregon
Lambert WE
PLoS ONE 2019; 14: e0220983 (IGR: 20-4)


82629 Impact of Visual Impairment and Blindness on Quality of Life of Patients in Owerri, Imo State, Nigeria
Edema O
Middle East African Journal of Ophthalmology 2019; 26: 127-132 (IGR: 20-4)


82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Congdon N
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82194 Using registry data to characterize the incidence and causes of blindness in Oregon
Zaback T
PLoS ONE 2019; 14: e0220983 (IGR: 20-4)


82356 Prevalence and causes of blindness and visual impairment; and cataract surgical services in Katsina state of Nigeria
Oladigbolu K
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


81585 Glaucoma care in Nigeria: Is the current practice poised to tackle this emerging sight-threatening disease?
Ukwu DO
International Ophthalmology 2019; 39: 2385-2390 (IGR: 20-4)


82771 The Frequency and Causes of Blindness in a Rural Region of Central Anatolia of Turkey
Okka M
The Eurasian journal of medicine 2019; 51: 242-246 (IGR: 20-4)


82165 Older Drivers and Glaucoma in India: Driving Habits and Crash Risks
Murthy PR; Kattige J
Journal of Glaucoma 2019; 28: 896-900 (IGR: 20-4)


82629 Impact of Visual Impairment and Blindness on Quality of Life of Patients in Owerri, Imo State, Nigeria
Florence UN
Middle East African Journal of Ophthalmology 2019; 26: 127-132 (IGR: 20-4)


82356 Prevalence and causes of blindness and visual impairment; and cataract surgical services in Katsina state of Nigeria
Abdurrahman H
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82194 Using registry data to characterize the incidence and causes of blindness in Oregon
Randall J
PLoS ONE 2019; 14: e0220983 (IGR: 20-4)


82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
He M
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82771 The Frequency and Causes of Blindness in a Rural Region of Central Anatolia of Turkey
Ozkagnici A
The Eurasian journal of medicine 2019; 51: 242-246 (IGR: 20-4)


81585 Glaucoma care in Nigeria: Is the current practice poised to tackle this emerging sight-threatening disease?
Nwachukwu NZ
International Ophthalmology 2019; 39: 2385-2390 (IGR: 20-4)


82165 Older Drivers and Glaucoma in India: Driving Habits and Crash Risks
Murthy VR
Journal of Glaucoma 2019; 28: 896-900 (IGR: 20-4)


82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Wang YX
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82194 Using registry data to characterize the incidence and causes of blindness in Oregon
Field T
PLoS ONE 2019; 14: e0220983 (IGR: 20-4)


82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Braithwaite T
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


82194 Using registry data to characterize the incidence and causes of blindness in Oregon
Wilson D
PLoS ONE 2019; 14: e0220983 (IGR: 20-4)


82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Casson RJ; Cicinelli MV; Das A; Flaxman SR; Jonas JB; Keeffe JE; Kempen JH; Leasher J; Limburg H; Naidoo K; Pesudovs K; Resnikoff S; Silvester AJ; Tahhan N; Taylor HR; Bourne RRA;
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)


81470 Impact of a 10-Year Eye Care Program in Sokoto, Nigeria: Changing Pattern of Prevalence and Causes of Blindness and Visual Impairment
Muhammad N
Middle East African Journal of Ophthalmology 2019; 26: 101-106 (IGR: 20-3)


80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Braithwaite T
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)


80662 Precision medicine to prevent glaucoma-related blindness
Moroi SE
Current Opinions in Ophthalmology 2019; 30: 187-198 (IGR: 20-3)


81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Furtado JM
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)


81075 Understanding Visual Impairment and Its Impact on Patients: A Simulation-Based Training in Undergraduate Medical Education
Juniat V
Journal of medical education and curricular development 2019; 6: 2382120519843854 (IGR: 20-3)


81390 Postural changes in patients with visual deficits
Serin-Brackman V
Journal Français d'Ophtalmologie 2019; 42: 1078-1084 (IGR: 20-3)


80447 Current profile of secondary glaucoma in a Northern India tertiary eye care hospital
Dubey S
Ophthalmic Epidemiology 2019; 26: 200-207 (IGR: 20-3)


81075 Understanding Visual Impairment and Its Impact on Patients: A Simulation-Based Training in Undergraduate Medical Education
Bourkiza R
Journal of medical education and curricular development 2019; 6: 2382120519843854 (IGR: 20-3)


81470 Impact of a 10-Year Eye Care Program in Sokoto, Nigeria: Changing Pattern of Prevalence and Causes of Blindness and Visual Impairment
Adamu MD
Middle East African Journal of Ophthalmology 2019; 26: 101-106 (IGR: 20-3)


80447 Current profile of secondary glaucoma in a Northern India tertiary eye care hospital
Jain K
Ophthalmic Epidemiology 2019; 26: 200-207 (IGR: 20-3)


80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Verlander NQ
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)


80662 Precision medicine to prevent glaucoma-related blindness
Reed DM
Current Opinions in Ophthalmology 2019; 30: 187-198 (IGR: 20-3)


81390 Postural changes in patients with visual deficits
Pezet Poux J
Journal Français d'Ophtalmologie 2019; 42: 1078-1084 (IGR: 20-3)


81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Berezovsky A
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)


80662 Precision medicine to prevent glaucoma-related blindness
Sanders DS
Current Opinions in Ophthalmology 2019; 30: 187-198 (IGR: 20-3)


81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Ferraz NN
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)


81390 Postural changes in patients with visual deficits
Quintyn JC
Journal Français d'Ophtalmologie 2019; 42: 1078-1084 (IGR: 20-3)


81075 Understanding Visual Impairment and Its Impact on Patients: A Simulation-Based Training in Undergraduate Medical Education
Das A
Journal of medical education and curricular development 2019; 6: 2382120519843854 (IGR: 20-3)


80447 Current profile of secondary glaucoma in a Northern India tertiary eye care hospital
Mukherjee S
Ophthalmic Epidemiology 2019; 26: 200-207 (IGR: 20-3)


80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Peto T
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)


81470 Impact of a 10-Year Eye Care Program in Sokoto, Nigeria: Changing Pattern of Prevalence and Causes of Blindness and Visual Impairment
Mpyet C
Middle East African Journal of Ophthalmology 2019; 26: 101-106 (IGR: 20-3)


80447 Current profile of secondary glaucoma in a Northern India tertiary eye care hospital
Sharma N
Ophthalmic Epidemiology 2019; 26: 200-207 (IGR: 20-3)


81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Muñoz S
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)


80662 Precision medicine to prevent glaucoma-related blindness
Almazroa A
Current Opinions in Ophthalmology 2019; 30: 187-198 (IGR: 20-3)


81470 Impact of a 10-Year Eye Care Program in Sokoto, Nigeria: Changing Pattern of Prevalence and Causes of Blindness and Visual Impairment
Bounce C
Middle East African Journal of Ophthalmology 2019; 26: 101-106 (IGR: 20-3)


81075 Understanding Visual Impairment and Its Impact on Patients: A Simulation-Based Training in Undergraduate Medical Education
Das-Bhaumik R
Journal of medical education and curricular development 2019; 6: 2382120519843854 (IGR: 20-3)


80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Bartholomew D
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)


81470 Impact of a 10-Year Eye Care Program in Sokoto, Nigeria: Changing Pattern of Prevalence and Causes of Blindness and Visual Impairment
Maishanu NM
Middle East African Journal of Ophthalmology 2019; 26: 101-106 (IGR: 20-3)


80447 Current profile of secondary glaucoma in a Northern India tertiary eye care hospital
Pegu J
Ophthalmic Epidemiology 2019; 26: 200-207 (IGR: 20-3)


80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Deomansingh F
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)


81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Fernandes AG
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)


80662 Precision medicine to prevent glaucoma-related blindness
Kagemann L
Current Opinions in Ophthalmology 2019; 30: 187-198 (IGR: 20-3)


81075 Understanding Visual Impairment and Its Impact on Patients: A Simulation-Based Training in Undergraduate Medical Education
Founti P; Yeo C
Journal of medical education and curricular development 2019; 6: 2382120519843854 (IGR: 20-3)


81470 Impact of a 10-Year Eye Care Program in Sokoto, Nigeria: Changing Pattern of Prevalence and Causes of Blindness and Visual Impairment
Jabo AM
Middle East African Journal of Ophthalmology 2019; 26: 101-106 (IGR: 20-3)


80662 Precision medicine to prevent glaucoma-related blindness
Shah N
Current Opinions in Ophthalmology 2019; 30: 187-198 (IGR: 20-3)


81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Watanabe SS
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)


80447 Current profile of secondary glaucoma in a Northern India tertiary eye care hospital
Gandhi M
Ophthalmic Epidemiology 2019; 26: 200-207 (IGR: 20-3)


80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Bridgemohan P
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)


81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Cunha CC
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)


81075 Understanding Visual Impairment and Its Impact on Patients: A Simulation-Based Training in Undergraduate Medical Education
Mathew R
Journal of medical education and curricular development 2019; 6: 2382120519843854 (IGR: 20-3)


80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Saei A
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)


81470 Impact of a 10-Year Eye Care Program in Sokoto, Nigeria: Changing Pattern of Prevalence and Causes of Blindness and Visual Impairment
Rabiu MM
Middle East African Journal of Ophthalmology 2019; 26: 101-106 (IGR: 20-3)


80662 Precision medicine to prevent glaucoma-related blindness
Shekhawat N
Current Opinions in Ophthalmology 2019; 30: 187-198 (IGR: 20-3)


80447 Current profile of secondary glaucoma in a Northern India tertiary eye care hospital
Bhoot M
Ophthalmic Epidemiology 2019; 26: 200-207 (IGR: 20-3)


80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Sharma S
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)


81075 Understanding Visual Impairment and Its Impact on Patients: A Simulation-Based Training in Undergraduate Medical Education
Okhravi N
Journal of medical education and curricular development 2019; 6: 2382120519843854 (IGR: 20-3)


81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Vasconcelos GC
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)


81470 Impact of a 10-Year Eye Care Program in Sokoto, Nigeria: Changing Pattern of Prevalence and Causes of Blindness and Visual Impairment
Bascaran C
Middle East African Journal of Ophthalmology 2019; 26: 101-106 (IGR: 20-3)


80662 Precision medicine to prevent glaucoma-related blindness
Richards JE
Current Opinions in Ophthalmology 2019; 30: 187-198 (IGR: 20-3)


81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Sacai PY
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)


80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Singh D
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)


81470 Impact of a 10-Year Eye Care Program in Sokoto, Nigeria: Changing Pattern of Prevalence and Causes of Blindness and Visual Impairment
Isiyaku S
Middle East African Journal of Ophthalmology 2019; 26: 101-106 (IGR: 20-3)


80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Ramsewak SS
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)


81470 Impact of a 10-Year Eye Care Program in Sokoto, Nigeria: Changing Pattern of Prevalence and Causes of Blindness and Visual Impairment
Foster A
Middle East African Journal of Ophthalmology 2019; 26: 101-106 (IGR: 20-3)


81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Cypel M
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)


80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Bourne RRA
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)


81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Mitsuhiro MH; Morales PH; Cohen MJ; Campos M; Cohen JM; Belfort R; Salomão SR
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)


79918 Causes of visual impairment in applications for blindness certificates in a tertiary center of Bihar and its role in health planning
Ambastha A
Indian Journal of Ophthalmology 2019; 67: 204-208 (IGR: 20-2)


79481 Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia
Nangia V
British Journal of Ophthalmology 2019; 103: 871-877 (IGR: 20-2)


79918 Causes of visual impairment in applications for blindness certificates in a tertiary center of Bihar and its role in health planning
Kusumesh R
Indian Journal of Ophthalmology 2019; 67: 204-208 (IGR: 20-2)


79481 Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia
Jonas JB; George R
British Journal of Ophthalmology 2019; 103: 871-877 (IGR: 20-2)


79918 Causes of visual impairment in applications for blindness certificates in a tertiary center of Bihar and its role in health planning
Sinha S; Sinha BP
Indian Journal of Ophthalmology 2019; 67: 204-208 (IGR: 20-2)


79481 Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia
Lingam V; Ellwein L
British Journal of Ophthalmology 2019; 103: 871-877 (IGR: 20-2)


79918 Causes of visual impairment in applications for blindness certificates in a tertiary center of Bihar and its role in health planning
Bhasker G
Indian Journal of Ophthalmology 2019; 67: 204-208 (IGR: 20-2)


79481 Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia
Cicinelli MV; Das A; Flaxman SR; Keeffe JE; Kempen JH; Leasher J; Limburg H; Naidoo K; Pesudovs K; Resnikoff S; Silvester AJ; Tahhan N; Taylor HR; Wong TY; Bourne RRA;
British Journal of Ophthalmology 2019; 103: 871-877 (IGR: 20-2)


78887 What Is the Amount of Visual Field Loss Associated With Disability in Glaucoma?
Jammal AA
American Journal of Ophthalmology 2019; 197: 45-52 (IGR: 20-1)


79080 The Current Status of Glaucoma and Glaucoma Care in Sub-Saharan Africa
Kyari F
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 375-386 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Keeffe JE
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


78853 Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals
Morizane Y
Japanese Journal of Ophthalmology 2019; 63: 26-33 (IGR: 20-1)


78966 Prevalence and associated factors of low vision and blindness among patients attending St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia
Cherinet FM
BMC Ophthalmology 2018; 18: 232 (IGR: 20-1)


79212 Leveraging Electronic Health Records to Identify and Characterize Patients with Low Vision
Swenor BK
Ophthalmic Epidemiology 2019; 26: 132-139 (IGR: 20-1)


78520 Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014
Lopez-Ramos A
Ophthalmic Epidemiology 2018; 25: 412-418 (IGR: 20-1)


79266 Registered blindness in Kuwait - 15 years of dynamic changes
Pandova MG
Ophthalmic Epidemiology 2019; 26: 75-83 (IGR: 20-1)


79288 Measuring Disability in Glaucoma
Sotimehin AE
Journal of Glaucoma 2018; 27: 939-949 (IGR: 20-1)


78855 ReGAE 12: preventing glaucoma blindness in the Caribbean through implementation of the Moorfields Safer Surgery System and skills transfer from the UK to Trinidad and Tobago
Murray D
Clinical Ophthalmology 2018; 12: 1775-1784 (IGR: 20-1)


78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Kahloun R; Khairallah M
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)


79288 Measuring Disability in Glaucoma
Ramulu PY
Journal of Glaucoma 2018; 27: 939-949 (IGR: 20-1)


78855 ReGAE 12: preventing glaucoma blindness in the Caribbean through implementation of the Moorfields Safer Surgery System and skills transfer from the UK to Trinidad and Tobago
Shah P
Clinical Ophthalmology 2018; 12: 1775-1784 (IGR: 20-1)


78966 Prevalence and associated factors of low vision and blindness among patients attending St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia
Tekalign SY
BMC Ophthalmology 2018; 18: 232 (IGR: 20-1)


78853 Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals
Morimoto N
Japanese Journal of Ophthalmology 2019; 63: 26-33 (IGR: 20-1)


78887 What Is the Amount of Visual Field Loss Associated With Disability in Glaucoma?
Ogata NG
American Journal of Ophthalmology 2019; 197: 45-52 (IGR: 20-1)


78520 Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014
Gomez-Bastar PA
Ophthalmic Epidemiology 2018; 25: 412-418 (IGR: 20-1)


79080 The Current Status of Glaucoma and Glaucoma Care in Sub-Saharan Africa
Adekoya B
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 375-386 (IGR: 20-1)


79266 Registered blindness in Kuwait - 15 years of dynamic changes
Al-Merjan JI
Ophthalmic Epidemiology 2019; 26: 75-83 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Casson RJ
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


79212 Leveraging Electronic Health Records to Identify and Characterize Patients with Low Vision
Guo X
Ophthalmic Epidemiology 2019; 26: 132-139 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Pesudovs K
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


79266 Registered blindness in Kuwait - 15 years of dynamic changes
Sadeq NA
Ophthalmic Epidemiology 2019; 26: 75-83 (IGR: 20-1)


79080 The Current Status of Glaucoma and Glaucoma Care in Sub-Saharan Africa
Abdull MM
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 375-386 (IGR: 20-1)


78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Resnikoff S
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)


78520 Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014
Lansingh VC
Ophthalmic Epidemiology 2018; 25: 412-418 (IGR: 20-1)


78853 Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals
Fujiwara A
Japanese Journal of Ophthalmology 2019; 63: 26-33 (IGR: 20-1)


78887 What Is the Amount of Visual Field Loss Associated With Disability in Glaucoma?
Daga FB
American Journal of Ophthalmology 2019; 197: 45-52 (IGR: 20-1)


79212 Leveraging Electronic Health Records to Identify and Characterize Patients with Low Vision
Boland MV
Ophthalmic Epidemiology 2019; 26: 132-139 (IGR: 20-1)


78966 Prevalence and associated factors of low vision and blindness among patients attending St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia
Anbesse DH
BMC Ophthalmology 2018; 18: 232 (IGR: 20-1)


79212 Leveraging Electronic Health Records to Identify and Characterize Patients with Low Vision
Goldstein JE
Ophthalmic Epidemiology 2019; 26: 132-139 (IGR: 20-1)


78520 Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014
Rodriguez-Gomez JA
Ophthalmic Epidemiology 2018; 25: 412-418 (IGR: 20-1)


78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Cicinelli MV
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)


79080 The Current Status of Glaucoma and Glaucoma Care in Sub-Saharan Africa
Mohammed AS
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 375-386 (IGR: 20-1)


78966 Prevalence and associated factors of low vision and blindness among patients attending St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia
Bizuneh ZY
BMC Ophthalmology 2018; 18: 232 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Taylor HR
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


78853 Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals
Kawasaki R
Japanese Journal of Ophthalmology 2019; 63: 26-33 (IGR: 20-1)


78887 What Is the Amount of Visual Field Loss Associated With Disability in Glaucoma?
Abe RY; Costa VP
American Journal of Ophthalmology 2019; 197: 45-52 (IGR: 20-1)


78520 Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014
Vargas-Fragoso V
Ophthalmic Epidemiology 2018; 25: 412-418 (IGR: 20-1)


79080 The Current Status of Glaucoma and Glaucoma Care in Sub-Saharan Africa
Garba F
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 375-386 (IGR: 20-1)


78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Flaxman SR
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)


78853 Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals
Yamashita H
Japanese Journal of Ophthalmology 2019; 63: 26-33 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Cicinelli MV
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Das A
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


78853 Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals
Ogura Y
Japanese Journal of Ophthalmology 2019; 63: 26-33 (IGR: 20-1)


78887 What Is the Amount of Visual Field Loss Associated With Disability in Glaucoma?
Medeiros FA
American Journal of Ophthalmology 2019; 197: 45-52 (IGR: 20-1)


78520 Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014
Soria-Arellano FA
Ophthalmic Epidemiology 2018; 25: 412-418 (IGR: 20-1)


78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Das A
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)


78853 Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals
Shiraga F
Japanese Journal of Ophthalmology 2019; 63: 26-33 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Flaxman SR
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Jonas JB
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)


78520 Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014
Silva-Camacho SH
Ophthalmic Epidemiology 2018; 25: 412-418 (IGR: 20-1)


78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Keeffe JE
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Jonas JB
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


78520 Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014
Castillo-Velazquez J; Zepeda-Romero LC
Ophthalmic Epidemiology 2018; 25: 412-418 (IGR: 20-1)


78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Kempen JH
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Kempen JH
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Leasher J
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Leasher J
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


78520 Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014
Limburg H
Ophthalmic Epidemiology 2018; 25: 412-418 (IGR: 20-1)


78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Limburg H
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Limburg H
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Naidoo K
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Naidoo K; Silvester AJ
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Pesudovs K
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Stevens GA
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Silvester AJ
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Tahhan N
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Tahhan N
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Wong TY
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Taylor HR; Wong TY
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Resnikoff S
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Bourne RRA
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)


78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Bourne RRA
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)


77691 Referral to Low Vision Services for Glaucoma Patients: Referral Criteria and Barriers
Kaleem MA
Journal of Glaucoma 2018; 27: 653-655 (IGR: 19-4)


78155 Global prevalence and causes of visual impairment with special reference to the general population of Saudi Arabia
Alswailmi FK
Pakistan journal of medical sciences 2018; 34: 751-756 (IGR: 19-4)


78009 Estimates of visual impairment and its causes from the National Eye Survey in Malaysia (NESII)
Chew FLM
PLoS ONE 2018; 13: e0198799 (IGR: 19-4)


77727 Preference-based Glaucoma-specific Health-related Quality of Life Instrument: Development of the Health Utility for Glaucoma
Muratov S; Podbielski DW
Journal of Glaucoma 2018; 27: 585-591 (IGR: 19-4)


77691 Referral to Low Vision Services for Glaucoma Patients: Referral Criteria and Barriers
West SK
Journal of Glaucoma 2018; 27: 653-655 (IGR: 19-4)


78009 Estimates of visual impairment and its causes from the National Eye Survey in Malaysia (NESII)
Salowi MA
PLoS ONE 2018; 13: e0198799 (IGR: 19-4)


77691 Referral to Low Vision Services for Glaucoma Patients: Referral Criteria and Barriers
Im L
Journal of Glaucoma 2018; 27: 653-655 (IGR: 19-4)


77727 Preference-based Glaucoma-specific Health-related Quality of Life Instrument: Development of the Health Utility for Glaucoma
Kennedy K
Journal of Glaucoma 2018; 27: 585-591 (IGR: 19-4)


78009 Estimates of visual impairment and its causes from the National Eye Survey in Malaysia (NESII)
Mustari Z
PLoS ONE 2018; 13: e0198799 (IGR: 19-4)


77727 Preference-based Glaucoma-specific Health-related Quality of Life Instrument: Development of the Health Utility for Glaucoma
Jack SM
Journal of Glaucoma 2018; 27: 585-591 (IGR: 19-4)


78009 Estimates of visual impairment and its causes from the National Eye Survey in Malaysia (NESII)
Husni MA
PLoS ONE 2018; 13: e0198799 (IGR: 19-4)


77691 Referral to Low Vision Services for Glaucoma Patients: Referral Criteria and Barriers
Swenor BK
Journal of Glaucoma 2018; 27: 653-655 (IGR: 19-4)


78009 Estimates of visual impairment and its causes from the National Eye Survey in Malaysia (NESII)
Hussein E
PLoS ONE 2018; 13: e0198799 (IGR: 19-4)


77727 Preference-based Glaucoma-specific Health-related Quality of Life Instrument: Development of the Health Utility for Glaucoma
Pemberton J; Ahmed IIK
Journal of Glaucoma 2018; 27: 585-591 (IGR: 19-4)


78009 Estimates of visual impairment and its causes from the National Eye Survey in Malaysia (NESII)
Adnan TH; Ngah NF
PLoS ONE 2018; 13: e0198799 (IGR: 19-4)


77727 Preference-based Glaucoma-specific Health-related Quality of Life Instrument: Development of the Health Utility for Glaucoma
Baltaziak M
Journal of Glaucoma 2018; 27: 585-591 (IGR: 19-4)


78009 Estimates of visual impairment and its causes from the National Eye Survey in Malaysia (NESII)
Limburg H
PLoS ONE 2018; 13: e0198799 (IGR: 19-4)


77727 Preference-based Glaucoma-specific Health-related Quality of Life Instrument: Development of the Health Utility for Glaucoma
Xie F
Journal of Glaucoma 2018; 27: 585-591 (IGR: 19-4)


78009 Estimates of visual impairment and its causes from the National Eye Survey in Malaysia (NESII)
Goh PP
PLoS ONE 2018; 13: e0198799 (IGR: 19-4)


76708 Age-related Changes in Eye, Brain and Visuomotor Behavior in the DBA/2J Mouse Model of Chronic Glaucoma
Yang XL
Scientific reports 2018; 8: 4643 (IGR: 19-3)


76621 Twenty-year outcomes in patients with newly diagnosed glaucoma: mortality and visual function
King C
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)


76696 Caring for Hereditary Childhood Retinal Blindness
Jauregui R
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 183-191 (IGR: 19-3)


77069 Causes of low vision and blindness in a Turkish adult population: the Izmir eye study
Koç F
Eastern Mediterranean health journal 2018; 24: 161-168 (IGR: 19-3)


76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Bourne RRA
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)


76621 Twenty-year outcomes in patients with newly diagnosed glaucoma: mortality and visual function
Sherwin JC
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)


76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Jonas JB
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)


76708 Age-related Changes in Eye, Brain and Visuomotor Behavior in the DBA/2J Mouse Model of Chronic Glaucoma
van der Merwe Y
Scientific reports 2018; 8: 4643 (IGR: 19-3)


76696 Caring for Hereditary Childhood Retinal Blindness
Cho GY
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 183-191 (IGR: 19-3)


77069 Causes of low vision and blindness in a Turkish adult population: the Izmir eye study
Erden V
Eastern Mediterranean health journal 2018; 24: 161-168 (IGR: 19-3)


76708 Age-related Changes in Eye, Brain and Visuomotor Behavior in the DBA/2J Mouse Model of Chronic Glaucoma
Sims J
Scientific reports 2018; 8: 4643 (IGR: 19-3)


76696 Caring for Hereditary Childhood Retinal Blindness
Takahashi VKL
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 183-191 (IGR: 19-3)


76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Bron AM
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)


77069 Causes of low vision and blindness in a Turkish adult population: the Izmir eye study
Sefi-Yurdakul N
Eastern Mediterranean health journal 2018; 24: 161-168 (IGR: 19-3)


76621 Twenty-year outcomes in patients with newly diagnosed glaucoma: mortality and visual function
Ratnarajan G
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)


76708 Age-related Changes in Eye, Brain and Visuomotor Behavior in the DBA/2J Mouse Model of Chronic Glaucoma
Parra C
Scientific reports 2018; 8: 4643 (IGR: 19-3)


76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Cicinelli MV
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)


76621 Twenty-year outcomes in patients with newly diagnosed glaucoma: mortality and visual function
Salmon JF
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)


76696 Caring for Hereditary Childhood Retinal Blindness
Takiuti JT
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 183-191 (IGR: 19-3)


76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Das A
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)


76708 Age-related Changes in Eye, Brain and Visuomotor Behavior in the DBA/2J Mouse Model of Chronic Glaucoma
Ho LC
Scientific reports 2018; 8: 4643 (IGR: 19-3)


76696 Caring for Hereditary Childhood Retinal Blindness
Bassuk AG; Mahajan VB
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 183-191 (IGR: 19-3)


76708 Age-related Changes in Eye, Brain and Visuomotor Behavior in the DBA/2J Mouse Model of Chronic Glaucoma
Schuman JS
Scientific reports 2018; 8: 4643 (IGR: 19-3)


76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Flaxman SR
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)


76708 Age-related Changes in Eye, Brain and Visuomotor Behavior in the DBA/2J Mouse Model of Chronic Glaucoma
Wollstein G
Scientific reports 2018; 8: 4643 (IGR: 19-3)


76696 Caring for Hereditary Childhood Retinal Blindness
Tsang SH
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 183-191 (IGR: 19-3)


76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Friedman DS; Keeffe JE
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)


76708 Age-related Changes in Eye, Brain and Visuomotor Behavior in the DBA/2J Mouse Model of Chronic Glaucoma
Lathrop KL
Scientific reports 2018; 8: 4643 (IGR: 19-3)


76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Kempen JH
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)


76708 Age-related Changes in Eye, Brain and Visuomotor Behavior in the DBA/2J Mouse Model of Chronic Glaucoma
Chan KC
Scientific reports 2018; 8: 4643 (IGR: 19-3)


76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Leasher J; Limburg H; Naidoo K; Pesudovs K; Peto T; Saadine J; Silvester AJ; Tahhan N; Taylor HR; Varma R; Wong TY; Resnikoff S;
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)


75265 Coordination of Gaze Behavior and Foot Placement During Walking in Persons With Glaucoma
Miller AB
Journal of Glaucoma 2018; 27: 55-63 (IGR: 19-2)


75347 Retrospective data on causes of childhood vision impairment in Eritrea
Gyawali R
BMC Ophthalmology 2017; 17: 209 (IGR: 19-2)


75377 Causes and Three-year Incidence of Irreversible Visual Impairment in Jing-An District, Shanghai, China from 2010-2015
Xia F
BMC Ophthalmology 2017; 17: 216 (IGR: 19-2)


75265 Coordination of Gaze Behavior and Foot Placement During Walking in Persons With Glaucoma
Lajoie K
Journal of Glaucoma 2018; 27: 55-63 (IGR: 19-2)


75347 Retrospective data on causes of childhood vision impairment in Eritrea
Bhayal BK
BMC Ophthalmology 2017; 17: 209 (IGR: 19-2)


75377 Causes and Three-year Incidence of Irreversible Visual Impairment in Jing-An District, Shanghai, China from 2010-2015
Wu L
BMC Ophthalmology 2017; 17: 216 (IGR: 19-2)


75265 Coordination of Gaze Behavior and Foot Placement During Walking in Persons With Glaucoma
Strath RA
Journal of Glaucoma 2018; 27: 55-63 (IGR: 19-2)


75347 Retrospective data on causes of childhood vision impairment in Eritrea
Adhikary R
BMC Ophthalmology 2017; 17: 209 (IGR: 19-2)


75377 Causes and Three-year Incidence of Irreversible Visual Impairment in Jing-An District, Shanghai, China from 2010-2015
Weng C
BMC Ophthalmology 2017; 17: 216 (IGR: 19-2)


75265 Coordination of Gaze Behavior and Foot Placement During Walking in Persons With Glaucoma
Neima DR
Journal of Glaucoma 2018; 27: 55-63 (IGR: 19-2)


75377 Causes and Three-year Incidence of Irreversible Visual Impairment in Jing-An District, Shanghai, China from 2010-2015
Zhou X
BMC Ophthalmology 2017; 17: 216 (IGR: 19-2)


75347 Retrospective data on causes of childhood vision impairment in Eritrea
Shrestha A; Sah RP
BMC Ophthalmology 2017; 17: 209 (IGR: 19-2)


75265 Coordination of Gaze Behavior and Foot Placement During Walking in Persons With Glaucoma
Marigold DS
Journal of Glaucoma 2018; 27: 55-63 (IGR: 19-2)


74498 Public awareness of common eye diseases in Jordan
Haddad MF
BMC Ophthalmology 2017; 17: 177 (IGR: 19-1)


74497 Pattern of Ocular Morbidity in the Elderly Population of Northern India
Baldev VF
Journal of clinical and diagnostic research : JCDR 2017; 11: NC20-NC23 (IGR: 19-1)


74596 Predicting Vision-Related Disability in Glaucoma
Abe RY
Ophthalmology 2018; 125: 22-30 (IGR: 19-1)


74451 International Vision Care: Issues and Approaches
Khanna RC
Annual review of vision science 2017; 3: 53-68 (IGR: 19-1)


74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Salonikiou A
British Journal of Ophthalmology 2018; 102: 916-921 (IGR: 19-1)


74209 Visual impairment and blindness in Hungary
Szabó D
Acta Ophthalmologica 2018; 96: 168-173 (IGR: 19-1)


74716 Spectrum of Eye Disorders Seen in a Pediatric Eye Clinic South East Nigeria
Achigbu EO
Nigerian journal of surgery : official publication of the Nigerian Surgical Research Society 2017; 23: 125-129 (IGR: 19-1)


74828 Prevalence and Major Causes of Visual Impairment in Iranian Adults: A Systematic Review
Mohammadi SF
Middle East African Journal of Ophthalmology 2017; 24: 148-155 (IGR: 19-1)


74787 Characterization of Eyeball Loss in Four Cities of Colombia
Moreno-Caviedes FH
Cureus 2017; 9: e1677 (IGR: 19-1)


74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Flaxman SR
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)


74179 Ocular morbidity patterns among children in schools for the blind in Chennai
Prakash MV
Indian Journal of Ophthalmology 2017; 65: 733-737 (IGR: 19-1)


74404 Outcomes of severe uveitic glaucoma treated with Baerveldt implant: can blindness be prevented?
Tan AN
Acta Ophthalmologica 2018; 96: 24-30 (IGR: 19-1)


74738 Multiple Deprivation, Vision Loss, and Ophthalmic Disease in Adults: Global Perspectives
Lane M
Survey of Ophthalmology 2018; 63: 406-436 (IGR: 19-1)


74404 Outcomes of severe uveitic glaucoma treated with Baerveldt implant: can blindness be prevented?
Cornelissen MF
Acta Ophthalmologica 2018; 96: 24-30 (IGR: 19-1)


74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Founti P
British Journal of Ophthalmology 2018; 102: 916-921 (IGR: 19-1)


74596 Predicting Vision-Related Disability in Glaucoma
Diniz-Filho A
Ophthalmology 2018; 125: 22-30 (IGR: 19-1)


74451 International Vision Care: Issues and Approaches
Marmamula S
Annual review of vision science 2017; 3: 53-68 (IGR: 19-1)


74787 Characterization of Eyeball Loss in Four Cities of Colombia
Velez Cuellar N
Cureus 2017; 9: e1677 (IGR: 19-1)


74828 Prevalence and Major Causes of Visual Impairment in Iranian Adults: A Systematic Review
Saeedi-Anari G
Middle East African Journal of Ophthalmology 2017; 24: 148-155 (IGR: 19-1)


74498 Public awareness of common eye diseases in Jordan
Bakkar MM
BMC Ophthalmology 2017; 17: 177 (IGR: 19-1)


74738 Multiple Deprivation, Vision Loss, and Ophthalmic Disease in Adults: Global Perspectives
Lane V
Survey of Ophthalmology 2018; 63: 406-436 (IGR: 19-1)


74497 Pattern of Ocular Morbidity in the Elderly Population of Northern India
Chopra R
Journal of clinical and diagnostic research : JCDR 2017; 11: NC20-NC23 (IGR: 19-1)


74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Bourne RRA
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)


74209 Visual impairment and blindness in Hungary
Sándor GL
Acta Ophthalmologica 2018; 96: 168-173 (IGR: 19-1)


74716 Spectrum of Eye Disorders Seen in a Pediatric Eye Clinic South East Nigeria
Oguego NC
Nigerian journal of surgery : official publication of the Nigerian Surgical Research Society 2017; 23: 125-129 (IGR: 19-1)


74179 Ocular morbidity patterns among children in schools for the blind in Chennai
Sivakumar S
Indian Journal of Ophthalmology 2017; 65: 733-737 (IGR: 19-1)


74209 Visual impairment and blindness in Hungary
Tóth G
Acta Ophthalmologica 2018; 96: 168-173 (IGR: 19-1)


74596 Predicting Vision-Related Disability in Glaucoma
Costa VP
Ophthalmology 2018; 125: 22-30 (IGR: 19-1)


74787 Characterization of Eyeball Loss in Four Cities of Colombia
Caicedo Zapata M
Cureus 2017; 9: e1677 (IGR: 19-1)


74497 Pattern of Ocular Morbidity in the Elderly Population of Northern India
Batra N
Journal of clinical and diagnostic research : JCDR 2017; 11: NC20-NC23 (IGR: 19-1)


74828 Prevalence and Major Causes of Visual Impairment in Iranian Adults: A Systematic Review
Ashrafi E
Middle East African Journal of Ophthalmology 2017; 24: 148-155 (IGR: 19-1)


74179 Ocular morbidity patterns among children in schools for the blind in Chennai
Dayal A
Indian Journal of Ophthalmology 2017; 65: 733-737 (IGR: 19-1)


74716 Spectrum of Eye Disorders Seen in a Pediatric Eye Clinic South East Nigeria
Achigbu K
Nigerian journal of surgery : official publication of the Nigerian Surgical Research Society 2017; 23: 125-129 (IGR: 19-1)


74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Resnikoff S
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)


74404 Outcomes of severe uveitic glaucoma treated with Baerveldt implant: can blindness be prevented?
Webers CAB
Acta Ophthalmologica 2018; 96: 24-30 (IGR: 19-1)


74738 Multiple Deprivation, Vision Loss, and Ophthalmic Disease in Adults: Global Perspectives
Abbott J
Survey of Ophthalmology 2018; 63: 406-436 (IGR: 19-1)


74451 International Vision Care: Issues and Approaches
Rao GN
Annual review of vision science 2017; 3: 53-68 (IGR: 19-1)


74498 Public awareness of common eye diseases in Jordan
Abdo N
BMC Ophthalmology 2017; 17: 177 (IGR: 19-1)


74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Kilintzis V
British Journal of Ophthalmology 2018; 102: 916-921 (IGR: 19-1)


74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Ackland P
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)


74209 Visual impairment and blindness in Hungary
Pék A
Acta Ophthalmologica 2018; 96: 168-173 (IGR: 19-1)


74738 Multiple Deprivation, Vision Loss, and Ophthalmic Disease in Adults: Global Perspectives
Braithwaite T
Survey of Ophthalmology 2018; 63: 406-436 (IGR: 19-1)


74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Antoniadis A
British Journal of Ophthalmology 2018; 102: 916-921 (IGR: 19-1)


74404 Outcomes of severe uveitic glaucoma treated with Baerveldt implant: can blindness be prevented?
Erckens RJ
Acta Ophthalmologica 2018; 96: 24-30 (IGR: 19-1)


74179 Ocular morbidity patterns among children in schools for the blind in Chennai
Chitra A
Indian Journal of Ophthalmology 2017; 65: 733-737 (IGR: 19-1)


74787 Characterization of Eyeball Loss in Four Cities of Colombia
Triana Reina G
Cureus 2017; 9: e1677 (IGR: 19-1)


74828 Prevalence and Major Causes of Visual Impairment in Iranian Adults: A Systematic Review
Mohammadi SM
Middle East African Journal of Ophthalmology 2017; 24: 148-155 (IGR: 19-1)


74596 Predicting Vision-Related Disability in Glaucoma
Wu Z
Ophthalmology 2018; 125: 22-30 (IGR: 19-1)


74497 Pattern of Ocular Morbidity in the Elderly Population of Northern India
Singh S
Journal of clinical and diagnostic research : JCDR 2017; 11: NC20-NC23 (IGR: 19-1)


74738 Multiple Deprivation, Vision Loss, and Ophthalmic Disease in Adults: Global Perspectives
Shah P
Survey of Ophthalmology 2018; 63: 406-436 (IGR: 19-1)


74596 Predicting Vision-Related Disability in Glaucoma
Medeiros FA
Ophthalmology 2018; 125: 22-30 (IGR: 19-1)


74787 Characterization of Eyeball Loss in Four Cities of Colombia
Sánchez A
Cureus 2017; 9: e1677 (IGR: 19-1)


74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Anastasopoulos E
British Journal of Ophthalmology 2018; 102: 916-921 (IGR: 19-1)


74209 Visual impairment and blindness in Hungary
Lukács R
Acta Ophthalmologica 2018; 96: 168-173 (IGR: 19-1)


74404 Outcomes of severe uveitic glaucoma treated with Baerveldt implant: can blindness be prevented?
Berendschot TTJM
Acta Ophthalmologica 2018; 96: 24-30 (IGR: 19-1)


74179 Ocular morbidity patterns among children in schools for the blind in Chennai
Subramaniam S
Indian Journal of Ophthalmology 2017; 65: 733-737 (IGR: 19-1)


74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Braithwaite T
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)


74828 Prevalence and Major Causes of Visual Impairment in Iranian Adults: A Systematic Review
Farzadfar F
Middle East African Journal of Ophthalmology 2017; 24: 148-155 (IGR: 19-1)


74404 Outcomes of severe uveitic glaucoma treated with Baerveldt implant: can blindness be prevented?
Beckers HJM
Acta Ophthalmologica 2018; 96: 24-30 (IGR: 19-1)


74209 Visual impairment and blindness in Hungary
Szalai I
Acta Ophthalmologica 2018; 96: 168-173 (IGR: 19-1)


74828 Prevalence and Major Causes of Visual Impairment in Iranian Adults: A Systematic Review
Lashay A
Middle East African Journal of Ophthalmology 2017; 24: 148-155 (IGR: 19-1)


74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Cicinelli MV
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)


74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Pappas T
British Journal of Ophthalmology 2018; 102: 916-921 (IGR: 19-1)


74738 Multiple Deprivation, Vision Loss, and Ophthalmic Disease in Adults: Global Perspectives
Denniston AK
Survey of Ophthalmology 2018; 63: 406-436 (IGR: 19-1)


74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Raptou A
British Journal of Ophthalmology 2018; 102: 916-921 (IGR: 19-1)


74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Das A
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)


74209 Visual impairment and blindness in Hungary
Tóth GZ
Acta Ophthalmologica 2018; 96: 168-173 (IGR: 19-1)


74828 Prevalence and Major Causes of Visual Impairment in Iranian Adults: A Systematic Review
Hashemi H
Middle East African Journal of Ophthalmology 2017; 24: 148-155 (IGR: 19-1)


74209 Visual impairment and blindness in Hungary
Papp A
Acta Ophthalmologica 2018; 96: 168-173 (IGR: 19-1)


74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Jonas JB
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)


74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Topouzis F
British Journal of Ophthalmology 2018; 102: 916-921 (IGR: 19-1)


74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Keeffe J
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)


74209 Visual impairment and blindness in Hungary
Nagy ZZ; Limburg H
Acta Ophthalmologica 2018; 96: 168-173 (IGR: 19-1)


74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Kempen JH; Leasher J
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)


74209 Visual impairment and blindness in Hungary
Németh J
Acta Ophthalmologica 2018; 96: 168-173 (IGR: 19-1)


74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Limburg H; Naidoo K; Pesudovs K; Silvester A; Stevens GA; Tahhan N; Wong TY; Taylor HR;
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)


72832 The role of specific visual subfields in collisions with oncoming cars during simulated driving in patients with advanced glaucoma
Kunimatsu-Sanuki S
British Journal of Ophthalmology 2017; 101: 896-901 (IGR: 18-4)


73050 The prevalence of blindness caused by primary angle closure glaucoma in middle-aged Chinese population: a systematic review and meta-analysis
Liu ML
Chinese Journal of Ophthalmology 2017; 53: 373-377 (IGR: 18-4)


72946 Annual incidences of visual impairment during 10-year period in Mie prefecture, Japan
Ikesugi K
Japanese Journal of Ophthalmology 2017; 61: 293-298 (IGR: 18-4)


72610 Does the World Health Organization criterion adequately define glaucoma blindness?
Mokhles P
Clinical Ophthalmology 2017; 11: 473-480 (IGR: 18-4)


72913 Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss
Patodia Y
Clinical Ophthalmology 2017; 11: 683-687 (IGR: 18-4)


72640 Eye-Tracking as a Tool to Evaluate Functional Ability in Everyday Tasks in Glaucoma
Kasneci E
Journal of Ophthalmology 2017; 2017: 6425913 (IGR: 18-4)


72350 Elderly people need an eye examination before entering nursing homes
Jensen H
Danish medical journal 2017; 64: (IGR: 18-4)


72913 Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss
Golesic E
Clinical Ophthalmology 2017; 11: 683-687 (IGR: 18-4)


72640 Eye-Tracking as a Tool to Evaluate Functional Ability in Everyday Tasks in Glaucoma
Black AA
Journal of Ophthalmology 2017; 2017: 6425913 (IGR: 18-4)


72832 The role of specific visual subfields in collisions with oncoming cars during simulated driving in patients with advanced glaucoma
Iwase A
British Journal of Ophthalmology 2017; 101: 896-901 (IGR: 18-4)


73050 The prevalence of blindness caused by primary angle closure glaucoma in middle-aged Chinese population: a systematic review and meta-analysis
Wang YX
Chinese Journal of Ophthalmology 2017; 53: 373-377 (IGR: 18-4)


72350 Elderly people need an eye examination before entering nursing homes
Tubæk G
Danish medical journal 2017; 64: (IGR: 18-4)


72610 Does the World Health Organization criterion adequately define glaucoma blindness?
Schouten J
Clinical Ophthalmology 2017; 11: 473-480 (IGR: 18-4)


72946 Annual incidences of visual impairment during 10-year period in Mie prefecture, Japan
Ichio T
Japanese Journal of Ophthalmology 2017; 61: 293-298 (IGR: 18-4)


72610 Does the World Health Organization criterion adequately define glaucoma blindness?
Beckers H
Clinical Ophthalmology 2017; 11: 473-480 (IGR: 18-4)


72946 Annual incidences of visual impairment during 10-year period in Mie prefecture, Japan
Tsukitome H
Japanese Journal of Ophthalmology 2017; 61: 293-298 (IGR: 18-4)


72832 The role of specific visual subfields in collisions with oncoming cars during simulated driving in patients with advanced glaucoma
Araie M
British Journal of Ophthalmology 2017; 101: 896-901 (IGR: 18-4)


72913 Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss
Mao A
Clinical Ophthalmology 2017; 11: 683-687 (IGR: 18-4)


72640 Eye-Tracking as a Tool to Evaluate Functional Ability in Everyday Tasks in Glaucoma
Wood JM
Journal of Ophthalmology 2017; 2017: 6425913 (IGR: 18-4)


72610 Does the World Health Organization criterion adequately define glaucoma blindness?
Webers C
Clinical Ophthalmology 2017; 11: 473-480 (IGR: 18-4)


72913 Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss
Hutnik CM
Clinical Ophthalmology 2017; 11: 683-687 (IGR: 18-4)


72946 Annual incidences of visual impairment during 10-year period in Mie prefecture, Japan
Kondo M
Japanese Journal of Ophthalmology 2017; 61: 293-298 (IGR: 18-4)


72832 The role of specific visual subfields in collisions with oncoming cars during simulated driving in patients with advanced glaucoma
Aoki Y; Hara T; Fukuchi T; Udagawa S; Ohkubo S; Sugiyama K; Matsumoto C; Nakazawa T; Yamaguchi T; Ono H
British Journal of Ophthalmology 2017; 101: 896-901 (IGR: 18-4)


71004 Patient-Centered Outcome Measures to Assess Functioning in Randomized Controlled Trials of Low-Vision Rehabilitation: A Review
Ehrlich JR
Patient 2017; 10: 39-49 (IGR: 18-3)


71635 Focus on popular science education of glaucoma and reduce glaucomatous low vision and blindness
Sun XH
Chinese Journal of Ophthalmology 2017; 53: 81-84 (IGR: 18-3)


71513 Visual impairment in older institutionalised Canadian seniors with dementia
Chriqui E
Ophthalmic and Physiological Optics 2017; 37: 225-233 (IGR: 18-3)


71501 Improving services for glaucoma care in Nigeria: implications for policy and programmes to achieve universal health coverage
Kyari F
British Journal of Ophthalmology 2017; 101: 543-547 (IGR: 18-3)


71357 Surveillance of sight loss due to delay in ophthalmic treatment or review: frequency, cause and outcome
Foot B
Eye 2017; 31: 771-775 (IGR: 18-3)


71587 Stage of visual field loss and age at diagnosis in 1988 patients with different glaucomas: implications for glaucoma screening and driving ability
Gramer G
International Ophthalmology 2018; 38: 429-441 (IGR: 18-3)


71357 Surveillance of sight loss due to delay in ophthalmic treatment or review: frequency, cause and outcome
MacEwen C
Eye 2017; 31: 771-775 (IGR: 18-3)


71004 Patient-Centered Outcome Measures to Assess Functioning in Randomized Controlled Trials of Low-Vision Rehabilitation: A Review
Spaeth GL
Patient 2017; 10: 39-49 (IGR: 18-3)


71513 Visual impairment in older institutionalised Canadian seniors with dementia
Law C
Ophthalmic and Physiological Optics 2017; 37: 225-233 (IGR: 18-3)


71587 Stage of visual field loss and age at diagnosis in 1988 patients with different glaucomas: implications for glaucoma screening and driving ability
Gramer E
International Ophthalmology 2018; 38: 429-441 (IGR: 18-3)


71501 Improving services for glaucoma care in Nigeria: implications for policy and programmes to achieve universal health coverage
Gilbert C; Blanchet K
British Journal of Ophthalmology 2017; 101: 543-547 (IGR: 18-3)


71513 Visual impairment in older institutionalised Canadian seniors with dementia
Kergoat MJ
Ophthalmic and Physiological Optics 2017; 37: 225-233 (IGR: 18-3)


71004 Patient-Centered Outcome Measures to Assess Functioning in Randomized Controlled Trials of Low-Vision Rehabilitation: A Review
Carlozzi NE
Patient 2017; 10: 39-49 (IGR: 18-3)


71513 Visual impairment in older institutionalised Canadian seniors with dementia
Leclerc BS
Ophthalmic and Physiological Optics 2017; 37: 225-233 (IGR: 18-3)


71004 Patient-Centered Outcome Measures to Assess Functioning in Randomized Controlled Trials of Low-Vision Rehabilitation: A Review
Lee PP
Patient 2017; 10: 39-49 (IGR: 18-3)


71501 Improving services for glaucoma care in Nigeria: implications for policy and programmes to achieve universal health coverage
Wormald R
British Journal of Ophthalmology 2017; 101: 543-547 (IGR: 18-3)


71513 Visual impairment in older institutionalised Canadian seniors with dementia
Kergoat H
Ophthalmic and Physiological Optics 2017; 37: 225-233 (IGR: 18-3)


70529 Activity Limitation in Glaucoma: Objective Assessment by the Cambridge Glaucoma Visual Function Test
Skalicky SE
Investigative Ophthalmology and Visual Science 2016; 57: 6158-6166 (IGR: 18-2)


70096 Vision impairment and major eye diseases reduce vision-specific emotional well-being in a Chinese population
Fenwick EK
British Journal of Ophthalmology 2017; 101: 686-690 (IGR: 18-2)


69881 Glaucoma-a common disease
Oberacher-Velten I
Ophthalmologe 2016; 113: 746-751 (IGR: 18-2)


70690 So let me find my way, whatever it will cost me, rather than leaving myself in darkness: experiences of glaucoma in Nigeria
Kyari F
Global health action 2016; 9: 31886 (IGR: 18-2)


70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Bourne RR
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)


70588 Cases of advanced visual field loss at referral to glaucoma clinics - more men than women?
Crabb DP
Ophthalmic and Physiological Optics 2017; 37: 82-87 (IGR: 18-2)


69915 Ethnicity and Deprivation are Associated With Blindness Among Adults With Primary Glaucoma in Nigeria: Results From the Nigeria National Blindness and Visual Impairment Survey
Kyari F
Journal of Glaucoma 2016; 25: e861-e872 (IGR: 18-2)


70367 Incidence and causes of visual impairment in the district of Mahdia, in east Tunisia: Retrospective study of 1487 cases
Ammari W
Journal Français d'Ophtalmologie 2016; 39: 771-779 (IGR: 18-2)


70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Taylor HR
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)


70588 Cases of advanced visual field loss at referral to glaucoma clinics - more men than women?
Saunders LJ
Ophthalmic and Physiological Optics 2017; 37: 82-87 (IGR: 18-2)


70367 Incidence and causes of visual impairment in the district of Mahdia, in east Tunisia: Retrospective study of 1487 cases
Harrath S
Journal Français d'Ophtalmologie 2016; 39: 771-779 (IGR: 18-2)


69915 Ethnicity and Deprivation are Associated With Blindness Among Adults With Primary Glaucoma in Nigeria: Results From the Nigeria National Blindness and Visual Impairment Survey
Wormald R
Journal of Glaucoma 2016; 25: e861-e872 (IGR: 18-2)


69881 Glaucoma-a common disease
Hoffmann E
Ophthalmologe 2016; 113: 746-751 (IGR: 18-2)


70529 Activity Limitation in Glaucoma: Objective Assessment by the Cambridge Glaucoma Visual Function Test
McAlinden C
Investigative Ophthalmology and Visual Science 2016; 57: 6158-6166 (IGR: 18-2)


70096 Vision impairment and major eye diseases reduce vision-specific emotional well-being in a Chinese population
Ong PG
British Journal of Ophthalmology 2017; 101: 686-690 (IGR: 18-2)


70690 So let me find my way, whatever it will cost me, rather than leaving myself in darkness: experiences of glaucoma in Nigeria
Chandler CI
Global health action 2016; 9: 31886 (IGR: 18-2)


70588 Cases of advanced visual field loss at referral to glaucoma clinics - more men than women?
Edwards LA
Ophthalmic and Physiological Optics 2017; 37: 82-87 (IGR: 18-2)


70529 Activity Limitation in Glaucoma: Objective Assessment by the Cambridge Glaucoma Visual Function Test
Khatib T
Investigative Ophthalmology and Visual Science 2016; 57: 6158-6166 (IGR: 18-2)


69881 Glaucoma-a common disease
Helbig H
Ophthalmologe 2016; 113: 746-751 (IGR: 18-2)


70690 So let me find my way, whatever it will cost me, rather than leaving myself in darkness: experiences of glaucoma in Nigeria
Martin M
Global health action 2016; 9: 31886 (IGR: 18-2)


70096 Vision impairment and major eye diseases reduce vision-specific emotional well-being in a Chinese population
Man RE
British Journal of Ophthalmology 2017; 101: 686-690 (IGR: 18-2)


70367 Incidence and causes of visual impairment in the district of Mahdia, in east Tunisia: Retrospective study of 1487 cases
Mbarek S
Journal Français d'Ophtalmologie 2016; 39: 771-779 (IGR: 18-2)


69915 Ethnicity and Deprivation are Associated With Blindness Among Adults With Primary Glaucoma in Nigeria: Results From the Nigeria National Blindness and Visual Impairment Survey
Murthy GV
Journal of Glaucoma 2016; 25: e861-e872 (IGR: 18-2)


70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Flaxman SR
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)


69915 Ethnicity and Deprivation are Associated With Blindness Among Adults With Primary Glaucoma in Nigeria: Results From the Nigeria National Blindness and Visual Impairment Survey
Evans JR
Journal of Glaucoma 2016; 25: e861-e872 (IGR: 18-2)


70367 Incidence and causes of visual impairment in the district of Mahdia, in east Tunisia: Retrospective study of 1487 cases
Mahmoud A
Journal Français d'Ophtalmologie 2016; 39: 771-779 (IGR: 18-2)


70096 Vision impairment and major eye diseases reduce vision-specific emotional well-being in a Chinese population
Sabanayagam C
British Journal of Ophthalmology 2017; 101: 686-690 (IGR: 18-2)


70529 Activity Limitation in Glaucoma: Objective Assessment by the Cambridge Glaucoma Visual Function Test
Anthony LM
Investigative Ophthalmology and Visual Science 2016; 57: 6158-6166 (IGR: 18-2)


70690 So let me find my way, whatever it will cost me, rather than leaving myself in darkness: experiences of glaucoma in Nigeria
Gilbert CE
Global health action 2016; 9: 31886 (IGR: 18-2)


70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Keeffe J
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)


69915 Ethnicity and Deprivation are Associated With Blindness Among Adults With Primary Glaucoma in Nigeria: Results From the Nigeria National Blindness and Visual Impairment Survey
Gilbert CE
Journal of Glaucoma 2016; 25: e861-e872 (IGR: 18-2)


70367 Incidence and causes of visual impairment in the district of Mahdia, in east Tunisia: Retrospective study of 1487 cases
Chebbi W
Journal Français d'Ophtalmologie 2016; 39: 771-779 (IGR: 18-2)


70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Leasher J
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)


70529 Activity Limitation in Glaucoma: Objective Assessment by the Cambridge Glaucoma Visual Function Test
Sim SY
Investigative Ophthalmology and Visual Science 2016; 57: 6158-6166 (IGR: 18-2)


70096 Vision impairment and major eye diseases reduce vision-specific emotional well-being in a Chinese population
Cheng CY; Wong TY
British Journal of Ophthalmology 2017; 101: 686-690 (IGR: 18-2)


70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Naidoo K
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)


69915 Ethnicity and Deprivation are Associated With Blindness Among Adults With Primary Glaucoma in Nigeria: Results From the Nigeria National Blindness and Visual Impairment Survey

Journal of Glaucoma 2016; 25: e861-e872 (IGR: 18-2)


70367 Incidence and causes of visual impairment in the district of Mahdia, in east Tunisia: Retrospective study of 1487 cases
Messaoud R
Journal Français d'Ophtalmologie 2016; 39: 771-779 (IGR: 18-2)


70529 Activity Limitation in Glaucoma: Objective Assessment by the Cambridge Glaucoma Visual Function Test
Martin KR
Investigative Ophthalmology and Visual Science 2016; 57: 6158-6166 (IGR: 18-2)


70367 Incidence and causes of visual impairment in the district of Mahdia, in east Tunisia: Retrospective study of 1487 cases
Khairallah M
Journal Français d'Ophtalmologie 2016; 39: 771-779 (IGR: 18-2)


70529 Activity Limitation in Glaucoma: Objective Assessment by the Cambridge Glaucoma Visual Function Test
Goldberg I
Investigative Ophthalmology and Visual Science 2016; 57: 6158-6166 (IGR: 18-2)


70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Pesudovs K
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)


70096 Vision impairment and major eye diseases reduce vision-specific emotional well-being in a Chinese population
Lamoureux EL
British Journal of Ophthalmology 2017; 101: 686-690 (IGR: 18-2)


70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
White RA
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)


70529 Activity Limitation in Glaucoma: Objective Assessment by the Cambridge Glaucoma Visual Function Test
McCluskey P
Investigative Ophthalmology and Visual Science 2016; 57: 6158-6166 (IGR: 18-2)


70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Wong TY; Resnikoff S; Jonas JB;
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Pleet A
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


69432 Vision Loss in Older Adults
Pelletier AL
American Family Physician 2016; 94: 219-226 (IGR: 18-1)


68900 Changes in Visual Function in the Elderly Population in the United States: 1995-2010
Chen Y
Ophthalmic Epidemiology 2016; 23: 137-144 (IGR: 18-1)


68920 Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C
Kashiwagi K
Acta Ophthalmologica 2016; 94: e561-e570 (IGR: 18-1)


69006 The Prevalence of Visual Impairment in Retirement Home Residents
Thederan L
Deutsches Ärzteblatt international 2016; 113: 323-327 (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Sulewski M
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


69006 The Prevalence of Visual Impairment in Retirement Home Residents
Steinmetz S
Deutsches Ärzteblatt international 2016; 113: 323-327 (IGR: 18-1)


68920 Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C
Kogure S
Acta Ophthalmologica 2016; 94: e561-e570 (IGR: 18-1)


69432 Vision Loss in Older Adults
Rojas-Roldan L
American Family Physician 2016; 94: 219-226 (IGR: 18-1)


68900 Changes in Visual Function in the Elderly Population in the United States: 1995-2010
Hahn P
Ophthalmic Epidemiology 2016; 23: 137-144 (IGR: 18-1)


69432 Vision Loss in Older Adults
Coffin J
American Family Physician 2016; 94: 219-226 (IGR: 18-1)


68900 Changes in Visual Function in the Elderly Population in the United States: 1995-2010
Sloan FA
Ophthalmic Epidemiology 2016; 23: 137-144 (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Salowe RJ
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


68920 Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C
Mabuchi F
Acta Ophthalmologica 2016; 94: e561-e570 (IGR: 18-1)


69006 The Prevalence of Visual Impairment in Retirement Home Residents
Kampmann S; Koob-Matthes AM
Deutsches Ärzteblatt international 2016; 113: 323-327 (IGR: 18-1)


68920 Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C
Chiba T
Acta Ophthalmologica 2016; 94: e561-e570 (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Fertig R
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


68920 Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C
Yamamoto T
Acta Ophthalmologica 2016; 94: e561-e570 (IGR: 18-1)


69006 The Prevalence of Visual Impairment in Retirement Home Residents
Grehn F
Deutsches Ärzteblatt international 2016; 113: 323-327 (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Salinas J
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


68920 Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C
Kuwayama Y
Acta Ophthalmologica 2016; 94: e561-e570 (IGR: 18-1)


69006 The Prevalence of Visual Impairment in Retirement Home Residents
Klink T
Deutsches Ärzteblatt international 2016; 113: 323-327 (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Rhodes A
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


68920 Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C
Araie M
Acta Ophthalmologica 2016; 94: e561-e570 (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Merritt Iii W; Natesh V
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


68920 Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C

Acta Ophthalmologica 2016; 94: e561-e570 (IGR: 18-1)


69218 Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population
Huang J; Gudiseva HV; Collins DW; Chavali VR; Tapino P; Lehman A; Regina-Gigiliotti M; Miller-Ellis E; Sankar P; Ying GS; O'Brien JM
Ophthalmic Epidemiology 2016; 23: 248-256 (IGR: 18-1)


67520 Glaucoma, "the silent thief of sight": patients' perspectives and health seeking behaviour in Bauchi, northern Nigeria
Abdull MM
BMC Ophthalmology 2016; 16: 44 (IGR: 17-4)


67289 Impact of Peripheral Field Loss on the Execution of Natural Actions: A Study With Glaucomatous Patients and Normally Sighted People
Dive S
Journal of Glaucoma 2016; 25: e889-e896 (IGR: 17-4)


66757 A Systematic Review of End-of-Life Visual Impairment in Open-Angle Glaucoma: An Epidemiological Autopsy
Mokhles P
Journal of Glaucoma 2016; 25: 623-628 (IGR: 17-4)


67273 Course of Glaucomatous Visual Field Loss Across the Entire Perimetric Range
Otarola F
JAMA ophthalmology 2016; 0: (IGR: 17-4)


66757 A Systematic Review of End-of-Life Visual Impairment in Open-Angle Glaucoma: An Epidemiological Autopsy
Schouten JS
Journal of Glaucoma 2016; 25: 623-628 (IGR: 17-4)


67289 Impact of Peripheral Field Loss on the Execution of Natural Actions: A Study With Glaucomatous Patients and Normally Sighted People
Rouland JF
Journal of Glaucoma 2016; 25: e889-e896 (IGR: 17-4)


67520 Glaucoma, "the silent thief of sight": patients' perspectives and health seeking behaviour in Bauchi, northern Nigeria
Chandler C
BMC Ophthalmology 2016; 16: 44 (IGR: 17-4)


67273 Course of Glaucomatous Visual Field Loss Across the Entire Perimetric Range
Chen A; Morales E
JAMA ophthalmology 2016; 0: (IGR: 17-4)


66757 A Systematic Review of End-of-Life Visual Impairment in Open-Angle Glaucoma: An Epidemiological Autopsy
Beckers HJ
Journal of Glaucoma 2016; 25: 623-628 (IGR: 17-4)


67289 Impact of Peripheral Field Loss on the Execution of Natural Actions: A Study With Glaucomatous Patients and Normally Sighted People
Lenoble Q
Journal of Glaucoma 2016; 25: e889-e896 (IGR: 17-4)


67520 Glaucoma, "the silent thief of sight": patients' perspectives and health seeking behaviour in Bauchi, northern Nigeria
Gilbert C
BMC Ophthalmology 2016; 16: 44 (IGR: 17-4)


67289 Impact of Peripheral Field Loss on the Execution of Natural Actions: A Study With Glaucomatous Patients and Normally Sighted People
Szaffarczyk S
Journal of Glaucoma 2016; 25: e889-e896 (IGR: 17-4)


67273 Course of Glaucomatous Visual Field Loss Across the Entire Perimetric Range
Yu F
JAMA ophthalmology 2016; 0: (IGR: 17-4)


66757 A Systematic Review of End-of-Life Visual Impairment in Open-Angle Glaucoma: An Epidemiological Autopsy
Azuara-Blanco A; Tuulonen A
Journal of Glaucoma 2016; 25: 623-628 (IGR: 17-4)


67273 Course of Glaucomatous Visual Field Loss Across the Entire Perimetric Range
Afifi A
JAMA ophthalmology 2016; 0: (IGR: 17-4)


67289 Impact of Peripheral Field Loss on the Execution of Natural Actions: A Study With Glaucomatous Patients and Normally Sighted People
McKendrick AM
Journal of Glaucoma 2016; 25: e889-e896 (IGR: 17-4)


67273 Course of Glaucomatous Visual Field Loss Across the Entire Perimetric Range
Caprioli J
JAMA ophthalmology 2016; 0: (IGR: 17-4)


66757 A Systematic Review of End-of-Life Visual Impairment in Open-Angle Glaucoma: An Epidemiological Autopsy
Webers CA
Journal of Glaucoma 2016; 25: 623-628 (IGR: 17-4)


67289 Impact of Peripheral Field Loss on the Execution of Natural Actions: A Study With Glaucomatous Patients and Normally Sighted People
Boucart M
Journal of Glaucoma 2016; 25: e889-e896 (IGR: 17-4)


66502 Novel ultra-thin near-eye augmented-view device (UNAD)
Zhu Y
Optics express 2016; 24: 1305-1313 (IGR: 17-3)


65881 A view on glaucoma-are we seeing it clearly?
Crabb DP
Eye 2016; 30: 304-313 (IGR: 17-3)


66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Quartilho A
Eye 2016; 30: 602-607 (IGR: 17-3)


66495 Sociodemographic status of severely disabled and visually impaired elderly people in Turkey
Kıvanç SA
Arquivos Brasileiros de Oftalmologia 2016; 79: 24-29 (IGR: 17-3)


66366 A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Kyari F
BMC Ophthalmology 2015; 15: 176 (IGR: 17-3)


66478 Social Law Entitlements and Compensations for Visually Impaired Patients in Germany, Focussed on Glaucoma
Stamm CC
Klinische Monatsblätter für Augenheilkunde 2016; 233: 167-171 (IGR: 17-3)


65942 Glaucoma Severity and Participation in Diverse Social Roles: Does Visual Field Loss Matter?
Yang Y
Journal of Glaucoma 2016; 25: e697-e703 (IGR: 17-3)


66232 Prevalence and causes of visual impairment in patients seen at Nkhensani Hospital Eye Clinic, South Africa
Maake MM
African journal of primary health care & family medicine 2015; 7: E1-6 (IGR: 17-3)


66487 Prevalence of visual hallucinations in a national low vision client population
Gordon KD
Canadian Journal of Ophthalmology 2016; 51: 3-6 (IGR: 17-3)


65894 Are Eye Clinics Safe For The Road? An Observational Report
Papamichael E
Journal of Glaucoma 2016; 25: e384-e385 (IGR: 17-3)


66481 Aids for Patients with Glaucoma and Visual Impairment
Zimmermann N
Klinische Monatsblätter für Augenheilkunde 2016; 233: 143-147 (IGR: 17-3)


65894 Are Eye Clinics Safe For The Road? An Observational Report
Mathew R
Journal of Glaucoma 2016; 25: e384-e385 (IGR: 17-3)


66481 Aids for Patients with Glaucoma and Visual Impairment
Erb C
Klinische Monatsblätter für Augenheilkunde 2016; 233: 143-147 (IGR: 17-3)


66502 Novel ultra-thin near-eye augmented-view device (UNAD)
Chang J
Optics express 2016; 24: 1305-1313 (IGR: 17-3)


65942 Glaucoma Severity and Participation in Diverse Social Roles: Does Visual Field Loss Matter?
Trope GE
Journal of Glaucoma 2016; 25: e697-e703 (IGR: 17-3)


66232 Prevalence and causes of visual impairment in patients seen at Nkhensani Hospital Eye Clinic, South Africa
Oduntan OA
African journal of primary health care & family medicine 2015; 7: E1-6 (IGR: 17-3)


66495 Sociodemographic status of severely disabled and visually impaired elderly people in Turkey
Akova-Budak B
Arquivos Brasileiros de Oftalmologia 2016; 79: 24-29 (IGR: 17-3)


66366 A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Entekume G
BMC Ophthalmology 2015; 15: 176 (IGR: 17-3)


66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Simkiss P
Eye 2016; 30: 602-607 (IGR: 17-3)


65942 Glaucoma Severity and Participation in Diverse Social Roles: Does Visual Field Loss Matter?
Buys YM
Journal of Glaucoma 2016; 25: e697-e703 (IGR: 17-3)


66502 Novel ultra-thin near-eye augmented-view device (UNAD)
Niu YJ
Optics express 2016; 24: 1305-1313 (IGR: 17-3)


65894 Are Eye Clinics Safe For The Road? An Observational Report
Kamal D
Journal of Glaucoma 2016; 25: e384-e385 (IGR: 17-3)


66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Zekite A
Eye 2016; 30: 602-607 (IGR: 17-3)


66366 A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Rabiu M
BMC Ophthalmology 2015; 15: 176 (IGR: 17-3)


66495 Sociodemographic status of severely disabled and visually impaired elderly people in Turkey
Olcaysü OO
Arquivos Brasileiros de Oftalmologia 2016; 79: 24-29 (IGR: 17-3)


66366 A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Spry P
BMC Ophthalmology 2015; 15: 176 (IGR: 17-3)


66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Xing W
Eye 2016; 30: 602-607 (IGR: 17-3)


66495 Sociodemographic status of severely disabled and visually impaired elderly people in Turkey
Çevik SG
Arquivos Brasileiros de Oftalmologia 2016; 79: 24-29 (IGR: 17-3)


66502 Novel ultra-thin near-eye augmented-view device (UNAD)
Chen WL
Optics express 2016; 24: 1305-1313 (IGR: 17-3)


65894 Are Eye Clinics Safe For The Road? An Observational Report
Murdoch IE
Journal of Glaucoma 2016; 25: e384-e385 (IGR: 17-3)


65942 Glaucoma Severity and Participation in Diverse Social Roles: Does Visual Field Loss Matter?
Badley EM
Journal of Glaucoma 2016; 25: e697-e703 (IGR: 17-3)


66502 Novel ultra-thin near-eye augmented-view device (UNAD)
Du XY
Optics express 2016; 24: 1305-1313 (IGR: 17-3)


66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Wormald R
Eye 2016; 30: 602-607 (IGR: 17-3)


66366 A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Wormald R
BMC Ophthalmology 2015; 15: 176 (IGR: 17-3)


65942 Glaucoma Severity and Participation in Diverse Social Roles: Does Visual Field Loss Matter?
Gignac MA; Shen C
Journal of Glaucoma 2016; 25: e697-e703 (IGR: 17-3)


66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Bunce C
Eye 2016; 30: 602-607 (IGR: 17-3)


66366 A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Nolan W; Murthy GV
BMC Ophthalmology 2015; 15: 176 (IGR: 17-3)


65942 Glaucoma Severity and Participation in Diverse Social Roles: Does Visual Field Loss Matter?
Jin YP
Journal of Glaucoma 2016; 25: e697-e703 (IGR: 17-3)


66366 A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Gilbert CE;
BMC Ophthalmology 2015; 15: 176 (IGR: 17-3)


61026 Trends in the incidence and causes of severe visual impairment and blindness in children from Israel
Mezer E
Journal of AAPOS 2015; 19: 260-5.e1 (IGR: 17-1)


61027 Causes of visual impairment in children seen at a university-based hospital low vision service in Brazil
de Paula CH
Journal of AAPOS 2015; 19: 252-256 (IGR: 17-1)


61017 Progression to Legal Blindness in Patients With Normal Tension Glaucoma: Hospital-Based Study
Sawada A
Investigative Ophthalmology and Visual Science 2015; 56: 3635-3641 (IGR: 17-1)


61169 Fear of falling in vision impairment
White UE
Optometry and Vision Science 2015; 92: 730-735 (IGR: 17-1)


60975 Functional low vision in adults from Latin America: findings from population-based surveys in 15 countries
Limburg H
Revista panamericana de salud pública = Pan American journal of public health 2015; 37: 371-378 (IGR: 17-1)


61017 Progression to Legal Blindness in Patients With Normal Tension Glaucoma: Hospital-Based Study
Rivera JA
Investigative Ophthalmology and Visual Science 2015; 56: 3635-3641 (IGR: 17-1)


60975 Functional low vision in adults from Latin America: findings from population-based surveys in 15 countries
Espinoza R
Revista panamericana de salud pública = Pan American journal of public health 2015; 37: 371-378 (IGR: 17-1)


61026 Trends in the incidence and causes of severe visual impairment and blindness in children from Israel
Chetrit A
Journal of AAPOS 2015; 19: 260-5.e1 (IGR: 17-1)


61169 Fear of falling in vision impairment
Black AA
Optometry and Vision Science 2015; 92: 730-735 (IGR: 17-1)


61027 Causes of visual impairment in children seen at a university-based hospital low vision service in Brazil
Vasconcelos GC
Journal of AAPOS 2015; 19: 252-256 (IGR: 17-1)


61026 Trends in the incidence and causes of severe visual impairment and blindness in children from Israel
Kalter-Leibovici O
Journal of AAPOS 2015; 19: 260-5.e1 (IGR: 17-1)


61169 Fear of falling in vision impairment
Wood JM
Optometry and Vision Science 2015; 92: 730-735 (IGR: 17-1)


60975 Functional low vision in adults from Latin America: findings from population-based surveys in 15 countries
Lansingh VC
Revista panamericana de salud pública = Pan American journal of public health 2015; 37: 371-378 (IGR: 17-1)


61017 Progression to Legal Blindness in Patients With Normal Tension Glaucoma: Hospital-Based Study
Takagi D
Investigative Ophthalmology and Visual Science 2015; 56: 3635-3641 (IGR: 17-1)


61027 Causes of visual impairment in children seen at a university-based hospital low vision service in Brazil
Nehemy MB
Journal of AAPOS 2015; 19: 252-256 (IGR: 17-1)


61169 Fear of falling in vision impairment
Delbaere K
Optometry and Vision Science 2015; 92: 730-735 (IGR: 17-1)


61027 Causes of visual impairment in children seen at a university-based hospital low vision service in Brazil
Granet D
Journal of AAPOS 2015; 19: 252-256 (IGR: 17-1)


61017 Progression to Legal Blindness in Patients With Normal Tension Glaucoma: Hospital-Based Study
Nishida T
Investigative Ophthalmology and Visual Science 2015; 56: 3635-3641 (IGR: 17-1)


60975 Functional low vision in adults from Latin America: findings from population-based surveys in 15 countries
Silva JC
Revista panamericana de salud pública = Pan American journal of public health 2015; 37: 371-378 (IGR: 17-1)


61026 Trends in the incidence and causes of severe visual impairment and blindness in children from Israel
Kinori M; Ben-Zion I
Journal of AAPOS 2015; 19: 260-5.e1 (IGR: 17-1)


61017 Progression to Legal Blindness in Patients With Normal Tension Glaucoma: Hospital-Based Study
Yamamoto T
Investigative Ophthalmology and Visual Science 2015; 56: 3635-3641 (IGR: 17-1)


61026 Trends in the incidence and causes of severe visual impairment and blindness in children from Israel
Wygnanski-Jaffe T
Journal of AAPOS 2015; 19: 260-5.e1 (IGR: 17-1)


60442 Risk of perimetric blindness among juvenile glaucoma patients
Gupta V
Ophthalmic and Physiological Optics 2015; 35: 206-211 (IGR: 16-4)


60095 Through the Looking Glass: A Review of the Literature Investigating the Impact of Glaucoma on Crash Risk, Driving Performance, and Driver Self-Regulation in Older Drivers
Blane A
Journal of Glaucoma 2016; 25: 113-121 (IGR: 16-4)


60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Zatic T
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)


60169 Threat to Fixation at Diagnosis and Lifetime Risk of Visual Impairment in Open-Angle Glaucoma
Peters D
Ophthalmology 2015; 122: 1034-1039 (IGR: 16-4)


60529 Survey on avoidable blindness and visual impairment in Panama
López M
Revista panamericana de salud pública = Pan American journal of public health 2014; 36: 355-360 (IGR: 16-4)


60411 Age-related eye disease and cognitive function
Harrabi H
Investigative Ophthalmology and Visual Science 2015; 56: 1217-1221 (IGR: 16-4)


60192 The relationship between central visual field damage and motor vehicle collisions in primary open-angle glaucoma patients
Yuki K
PLoS ONE 2014; 9: e115572 (IGR: 16-4)


60207 Driving Self-restriction and Motor Vehicle Collision Occurrence in Glaucoma
Ono T
Optometry and Vision Science 2014; 0: (IGR: 16-4)


60573 An assessment of driving fitness in patients with visual impairment to understand the elevated risk of motor vehicle accidents
Kunimatsu-Sanuki S
BMJ open 2015; 5: e006379 (IGR: 16-4)


60783 Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon
Jingi AM
Journal of diabetes and metabolic disorders 2015; 14: 21 (IGR: 16-4)


60472 Prevalence of blindness and diabetic retinopathy in northern Jordan
Rabiu MM
European Journal of Ophthalmology 2015; 0: 0 (IGR: 16-4)


60388 Binocular visual field impairment in glaucoma and at-fault motor vehicle collisions
McGwin G
Journal of Glaucoma 2015; 24: 138-143 (IGR: 16-4)


60406 Long-term results from cyclocryotherapy applied to the 3o'clock and 9o'clock positions in blind refractory glaucoma patients
Kim BS
Korean Journal of Ophthalmology 2015; 29: 47-52 (IGR: 16-4)


60772 Aiming for zero blindness
Nakazawa T
Nippon Ganka Gakkai Zasshi 2015; 119: 168-93; discussion 194 (IGR: 16-4)


60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Isipradit S
PLoS ONE 2014; 9: e114245 (IGR: 16-4)


60192 The relationship between central visual field damage and motor vehicle collisions in primary open-angle glaucoma patients
Asaoka R
PLoS ONE 2014; 9: e115572 (IGR: 16-4)


60207 Driving Self-restriction and Motor Vehicle Collision Occurrence in Glaucoma
Yuki K
Optometry and Vision Science 2014; 0: (IGR: 16-4)


60529 Survey on avoidable blindness and visual impairment in Panama
Brea I
Revista panamericana de salud pública = Pan American journal of public health 2014; 36: 355-360 (IGR: 16-4)


60573 An assessment of driving fitness in patients with visual impairment to understand the elevated risk of motor vehicle accidents
Iwase A
BMJ open 2015; 5: e006379 (IGR: 16-4)


60472 Prevalence of blindness and diabetic retinopathy in northern Jordan
Al Bdour MD
European Journal of Ophthalmology 2015; 0: 0 (IGR: 16-4)


60388 Binocular visual field impairment in glaucoma and at-fault motor vehicle collisions
Huisingh C
Journal of Glaucoma 2015; 24: 138-143 (IGR: 16-4)


60442 Risk of perimetric blindness among juvenile glaucoma patients
Devi K S
Ophthalmic and Physiological Optics 2015; 35: 206-211 (IGR: 16-4)


60783 Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon
Nansseu JR
Journal of diabetes and metabolic disorders 2015; 14: 21 (IGR: 16-4)


60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Sirimaharaj M
PLoS ONE 2014; 9: e114245 (IGR: 16-4)


60406 Long-term results from cyclocryotherapy applied to the 3o'clock and 9o'clock positions in blind refractory glaucoma patients
Kim YJ
Korean Journal of Ophthalmology 2015; 29: 47-52 (IGR: 16-4)


60411 Age-related eye disease and cognitive function
Kergoat MJ
Investigative Ophthalmology and Visual Science 2015; 56: 1217-1221 (IGR: 16-4)


60169 Threat to Fixation at Diagnosis and Lifetime Risk of Visual Impairment in Open-Angle Glaucoma
Bengtsson B
Ophthalmology 2015; 122: 1034-1039 (IGR: 16-4)


60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Bendelic E
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)


60529 Survey on avoidable blindness and visual impairment in Panama
Yee R
Revista panamericana de salud pública = Pan American journal of public health 2014; 36: 355-360 (IGR: 16-4)


60388 Binocular visual field impairment in glaucoma and at-fault motor vehicle collisions
Jain SG
Journal of Glaucoma 2015; 24: 138-143 (IGR: 16-4)


60411 Age-related eye disease and cognitive function
Rousseau J
Investigative Ophthalmology and Visual Science 2015; 56: 1217-1221 (IGR: 16-4)


60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Charukamnoetkanok P
PLoS ONE 2014; 9: e114245 (IGR: 16-4)


60783 Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon
Noubiap JJ
Journal of diabetes and metabolic disorders 2015; 14: 21 (IGR: 16-4)


60207 Driving Self-restriction and Motor Vehicle Collision Occurrence in Glaucoma
Awano-Tanabe S
Optometry and Vision Science 2014; 0: (IGR: 16-4)


60442 Risk of perimetric blindness among juvenile glaucoma patients
Kumar S
Ophthalmic and Physiological Optics 2015; 35: 206-211 (IGR: 16-4)


60472 Prevalence of blindness and diabetic retinopathy in northern Jordan
Abu Ameerh MA
European Journal of Ophthalmology 2015; 0: 0 (IGR: 16-4)


60169 Threat to Fixation at Diagnosis and Lifetime Risk of Visual Impairment in Open-Angle Glaucoma
Heijl A
Ophthalmology 2015; 122: 1034-1039 (IGR: 16-4)


60406 Long-term results from cyclocryotherapy applied to the 3o'clock and 9o'clock positions in blind refractory glaucoma patients
Seo SW
Korean Journal of Ophthalmology 2015; 29: 47-52 (IGR: 16-4)


60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Paduca A
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)


60192 The relationship between central visual field damage and motor vehicle collisions in primary open-angle glaucoma patients
Tsubota K
PLoS ONE 2014; 9: e115572 (IGR: 16-4)


60573 An assessment of driving fitness in patients with visual impairment to understand the elevated risk of motor vehicle accidents
Araie M
BMJ open 2015; 5: e006379 (IGR: 16-4)


60529 Survey on avoidable blindness and visual impairment in Panama
Yi R
Revista panamericana de salud pública = Pan American journal of public health 2014; 36: 355-360 (IGR: 16-4)


60411 Age-related eye disease and cognitive function
Boisjoly H
Investigative Ophthalmology and Visual Science 2015; 56: 1217-1221 (IGR: 16-4)


60783 Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon
Bilong Y
Journal of diabetes and metabolic disorders 2015; 14: 21 (IGR: 16-4)


60472 Prevalence of blindness and diabetic retinopathy in northern Jordan
Jadoon MZ
European Journal of Ophthalmology 2015; 0: 0 (IGR: 16-4)


60388 Binocular visual field impairment in glaucoma and at-fault motor vehicle collisions
Girkin CA
Journal of Glaucoma 2015; 24: 138-143 (IGR: 16-4)


60573 An assessment of driving fitness in patients with visual impairment to understand the elevated risk of motor vehicle accidents
Aoki Y
BMJ open 2015; 5: e006379 (IGR: 16-4)


60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Rabiu M
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)


60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Thonginnetra O
PLoS ONE 2014; 9: e114245 (IGR: 16-4)


60406 Long-term results from cyclocryotherapy applied to the 3o'clock and 9o'clock positions in blind refractory glaucoma patients
Yoo JM
Korean Journal of Ophthalmology 2015; 29: 47-52 (IGR: 16-4)


60442 Risk of perimetric blindness among juvenile glaucoma patients
Pandey RM
Ophthalmic and Physiological Optics 2015; 35: 206-211 (IGR: 16-4)


60207 Driving Self-restriction and Motor Vehicle Collision Occurrence in Glaucoma
Fukagawa K
Optometry and Vision Science 2014; 0: (IGR: 16-4)


60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Corduneanu A
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)


60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Wongsawad W
PLoS ONE 2014; 9: e114245 (IGR: 16-4)


60406 Long-term results from cyclocryotherapy applied to the 3o'clock and 9o'clock positions in blind refractory glaucoma patients
Kim SJ
Korean Journal of Ophthalmology 2015; 29: 47-52 (IGR: 16-4)


60207 Driving Self-restriction and Motor Vehicle Collision Occurrence in Glaucoma
Shimoyama M
Optometry and Vision Science 2014; 0: (IGR: 16-4)


60529 Survey on avoidable blindness and visual impairment in Panama
Carles V
Revista panamericana de salud pública = Pan American journal of public health 2014; 36: 355-360 (IGR: 16-4)


60388 Binocular visual field impairment in glaucoma and at-fault motor vehicle collisions
Owsley C
Journal of Glaucoma 2015; 24: 138-143 (IGR: 16-4)


60783 Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon
Ellong A
Journal of diabetes and metabolic disorders 2015; 14: 21 (IGR: 16-4)


60573 An assessment of driving fitness in patients with visual impairment to understand the elevated risk of motor vehicle accidents
Hara T
BMJ open 2015; 5: e006379 (IGR: 16-4)


60442 Risk of perimetric blindness among juvenile glaucoma patients
Sihota R
Ophthalmic and Physiological Optics 2015; 35: 206-211 (IGR: 16-4)


60411 Age-related eye disease and cognitive function
Schmaltz H
Investigative Ophthalmology and Visual Science 2015; 56: 1217-1221 (IGR: 16-4)


60442 Risk of perimetric blindness among juvenile glaucoma patients
Sharma A
Ophthalmic and Physiological Optics 2015; 35: 206-211 (IGR: 16-4)


60783 Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon
Mvogo CE
Journal of diabetes and metabolic disorders 2015; 14: 21 (IGR: 16-4)


60573 An assessment of driving fitness in patients with visual impairment to understand the elevated risk of motor vehicle accidents
Nakazawa T
BMJ open 2015; 5: e006379 (IGR: 16-4)


60411 Age-related eye disease and cognitive function
Moghadaszadeh S
Investigative Ophthalmology and Visual Science 2015; 56: 1217-1221 (IGR: 16-4)


60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Garaba A
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)


60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Sathornsumetee B
PLoS ONE 2014; 9: e114245 (IGR: 16-4)


60207 Driving Self-restriction and Motor Vehicle Collision Occurrence in Glaucoma
Ozawa Y
Optometry and Vision Science 2014; 0: (IGR: 16-4)


60529 Survey on avoidable blindness and visual impairment in Panama
Broce A
Revista panamericana de salud pública = Pan American journal of public health 2014; 36: 355-360 (IGR: 16-4)


60573 An assessment of driving fitness in patients with visual impairment to understand the elevated risk of motor vehicle accidents
Yamaguchi T
BMJ open 2015; 5: e006379 (IGR: 16-4)


60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Somboonthanakij S
PLoS ONE 2014; 9: e114245 (IGR: 16-4)


60207 Driving Self-restriction and Motor Vehicle Collision Occurrence in Glaucoma
Ozeki N
Optometry and Vision Science 2014; 0: (IGR: 16-4)


60411 Age-related eye disease and cognitive function
Roy-Gagnon MH
Investigative Ophthalmology and Visual Science 2015; 56: 1217-1221 (IGR: 16-4)


60442 Risk of perimetric blindness among juvenile glaucoma patients
Gupta S
Ophthalmic and Physiological Optics 2015; 35: 206-211 (IGR: 16-4)


60529 Survey on avoidable blindness and visual impairment in Panama
Limburg H
Revista panamericana de salud pública = Pan American journal of public health 2014; 36: 355-360 (IGR: 16-4)


60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Novac V
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)


60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Soomsawasdi P
PLoS ONE 2014; 9: e114245 (IGR: 16-4)


60411 Age-related eye disease and cognitive function
Freeman EE
Investigative Ophthalmology and Visual Science 2015; 56: 1217-1221 (IGR: 16-4)


60529 Survey on avoidable blindness and visual impairment in Panama
Silva JC
Revista panamericana de salud pública = Pan American journal of public health 2014; 36: 355-360 (IGR: 16-4)


60207 Driving Self-restriction and Motor Vehicle Collision Occurrence in Glaucoma
Shiba D
Optometry and Vision Science 2014; 0: (IGR: 16-4)


60573 An assessment of driving fitness in patients with visual impairment to understand the elevated risk of motor vehicle accidents
Ono H
BMJ open 2015; 5: e006379 (IGR: 16-4)


60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Curca C; Sorbala I
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)


60573 An assessment of driving fitness in patients with visual impairment to understand the elevated risk of motor vehicle accidents
Sanuki T
BMJ open 2015; 5: e006379 (IGR: 16-4)


60207 Driving Self-restriction and Motor Vehicle Collision Occurrence in Glaucoma
Tsubota K
Optometry and Vision Science 2014; 0: (IGR: 16-4)


60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Jitawatanarat U
PLoS ONE 2014; 9: e114245 (IGR: 16-4)


60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Chiaburu A
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)


60573 An assessment of driving fitness in patients with visual impairment to understand the elevated risk of motor vehicle accidents
Itoh M
BMJ open 2015; 5: e006379 (IGR: 16-4)


60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Taweebanjongsin W; Arayangkoon E
PLoS ONE 2014; 9: e114245 (IGR: 16-4)


60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Verega F; Andronic V
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)


60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Arame P
PLoS ONE 2014; 9: e114245 (IGR: 16-4)


60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Guzun I
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)


60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Kobkoonthon C; Pangputhipong P
PLoS ONE 2014; 9: e114245 (IGR: 16-4)


60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Căpăţină O; Zamă-Mardari I
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)


58904 Baseline risk factors for incidence of blindness in a South Indian population: the chennai eye disease incidence study
Vijaya L; Asokan R; Panday M; Choudhari NS; Ramesh SV; Velumuri L; Boddupalli SD; Sunil GT; George R
Investigative Ophthalmology and Visual Science 2014; 55: 5545-5550 (IGR: 16-3)


59049 Ocular morbidity among refugees in Southwest Ethiopia
Gelaw Y; Abateneh A
Ethiopian journal of health sciences 2014; 24: 227-234 (IGR: 16-3)


59164 The role of occupational therapy in vision rehabilitation of individuals with glaucoma
Livengood HM; Baker NA
Disability and rehabilitation 2014; 0: 1-7 (IGR: 16-3)


58975 A comparison of methods used to evaluate mobility performance in the visually impaired
Warrian KJ; Katz LJ; Myers JS; Moster MR; Pro MJ; Wizov SS; Spaeth GL
British Journal of Ophthalmology 2015; 99: 113-118 (IGR: 16-3)


59130 Blindness and Visual Impairment among Adults in a Tertiary Eye Clinic, in Osogbo S W Nigeria
Isawumi M; Ubah J; Olomola B; Afolabi O
Annals of medical and health sciences research 2014; 4: 594-597 (IGR: 16-3)


59055 New insights into blindness; mechanical fatigue of optic nerve head in glaucomatous optic neuropathy
Norouzpour A; Mehdizadeh A
Journal of Medical Engineering and Technology 2014; 38: 367-371 (IGR: 16-3)


59439 Comparison of primary open angle glaucoma patients in rural and urban Ghana
Francis AW; Gyasi ME; Adjuik M; Kesse E; Chen Y; Harrison RS; Kodjo RA
African health sciences 2014; 14: 729-735 (IGR: 16-3)


59597 Semi-automated kinetic perimetry provides additional information to static automated perimetry in the assessment of the remaining visual field in end-stage glaucoma
Nowomiejska K; Wrobel-Dudzinska D; Ksiazek K; Ksiazek P; Rejdak K; Maciejewski R; Juenemann AG; Rejdak R
Ophthalmic and Physiological Optics 2015; 35: 147-154 (IGR: 16-3)


59566 Impact of superior and inferior visual field loss on hazard detection in a computer-based driving test
Glen FC; Smith ND; Crabb DP
British Journal of Ophthalmology 2015; 99: 613-617 (IGR: 16-3)


59077 Retinal dystrophy and congenital glaucoma as major causes of vision loss in students attending two institutions for the visually disabled in Tunis city, Tunisia
Chouchene I; Derouiche K; Ben Halim N; Merdassi A; Limaiem R; Abdelhak S; El Matri L
Journal Français d'Ophtalmologie 2014; 37: 695-701 (IGR: 16-3)


59171 Blindness following bleb-related infection in open angle glaucoma
Yamada H; Sawada A; Kuwayama Y; Yamamoto T
Japanese Journal of Ophthalmology 2014; 58: 490-495 (IGR: 16-3)


57495 Causes and prevalence of visual impairment in Japan
Wako R; Yasukawa T; Kato A; Omori T; Ishida S; Ishibashi T; Ogura Y
Nippon Ganka Gakkai Zasshi 2014; 118: 495-501 (IGR: 16-2)


56116 Prevalence and causes of vision loss in Southeast Asia and Oceania: 1990-2010
Keeffe J; Taylor HR; Fotis K; Pesudovs K; Flaxman SR; Jonas JB; Leasher J; Naidoo K; Price H; White RA; Wong TY; Resnikoff S; Bourne RR;
British Journal of Ophthalmology 2014; 98: 586-591 (IGR: 16-1)


56176 Prevalence and causes of vision loss in Central and South Asia: 1990-2010
Jonas JB; George R; Asokan R; Flaxman SR; Keeffe J; Leasher J; Naidoo K; Pesudovs K; Price H; Vijaya L; White RA; Wong TY; Resnikoff S; Taylor HR; Bourne RR;
British Journal of Ophthalmology 2014; 98: 592-598 (IGR: 16-1)


56213 Posterior segment eye disease in sub-Saharan Africa: review of recent population-based studies
Bastawrous A; Burgess PI; Mahdi AM; Kyari F; Burton MJ; Kuper H
Tropical medicine & international health : TM & IH 2014; 19: 600-609 (IGR: 16-1)


56155 Glaucoma in southwest Nigeria: clinical presentation, family history and perceptions
Adekoya BJ; Shah SP; Onakoya AO; Ayanniyi AA
International Ophthalmology 2014; 34: 1027-1036 (IGR: 16-1)


56323 Impact of better and worse eye damage on quality of life in advanced glaucoma
Okamoto M; Sugisaki K; Murata H; Hirasawa H; Mayama C; Asaoka R
Scientific reports 2014; 4: 4144 (IGR: 16-1)


56354 Prevalence and causes of vision loss in sub-Saharan Africa: 1990-2010
Naidoo K; Gichuhi S; Basáñez MG; Flaxman SR; Jonas JB; Keeffe J; Leasher JL; Pesudovs K; Price H; Smith JL; Turner HC; White RA; Wong TY; Resnikoff S; Taylor HR; Bourne RR;
British Journal of Ophthalmology 2014; 98: 612-618 (IGR: 16-1)


56380 Prevalence and causes of vision loss in North Africa and the Middle East: 1990-2010
Khairallah M; Kahloun R; Flaxman SR; Jonas JB; Keeffe J; Leasher J; Naidoo K; Pesudovs K; Price H; White RA; Wong TY; Resnikoff S; Taylor HR; Bourne RR;
British Journal of Ophthalmology 2014; 98: 605-611 (IGR: 16-1)


56492 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010
Bourne RR; Jonas JB; Flaxman SR; Keeffe J; Leasher J; Naidoo K; Parodi MB; Pesudovs K; Price H; White RA; Wong TY; Resnikoff S; Taylor HR;
British Journal of Ophthalmology 2014; 98: 629-638 (IGR: 16-1)


56424 Prevalence, causes of blindness, visual impairment and cataract surgical services in Sindhudurg district on the western coastal strip of India
Patil S; Gogate P; Vora S; Ainapure S; Hingane RN; Kulkarni AN; Shammanna BR
Indian Journal of Ophthalmology 2014; 62: 240-245 (IGR: 16-1)


55997 Examining visual field loss in patients in glaucoma clinics during their predicted remaining lifetime
Saunders LJ; Russell RA; Kirwan JF; McNaught AI; Crabb DP
Investigative Ophthalmology and Visual Science 2014; 55: 102-109 (IGR: 16-1)


56274 Prospective evaluation of early visual loss following glaucoma-filtering surgery in eyes with split fixation
Balekudaru S; George R; Panday M; Singh M; Neog A; Lingam V
Journal of Glaucoma 2014; 23: 211-218 (IGR: 16-1)


55235 Impact of visual impairment on vision-specific quality of life among older adults living in nursing home
Dev MK; Paudel N; Joshi ND; Shah DN; Subba S
Current Eye Research 2014; 39: 232-238 (IGR: 15-4)


55115 Alteration of travel patterns with vision loss from glaucoma and macular degeneration
Curriero FC; Pinchoff J; van Landingham SW; Ferrucci L; Friedman DS; Ramulu PY
JAMA ophthalmology 2013; 131: 1420-1426 (IGR: 15-4)


55308 Mayombian ethnic, vegetables low intake, insulin treatment, diabetic nephropathy and severe diabetic retinopathy are determinants of blindness in diabetic Africans
Moise MM; Benjamin LM; Enoch CY; Igor LP
International Journal of Ophthalmology 2013; 6: 727-732 (IGR: 15-4)


55730 The role of diabetic retinopathy in blindness and poor sight in Split-Dalmatia County 2000-2010
Galetović D; Olujić I; Znaor L; Bućan K; Karlica D; Lesin M; Susac T
Acta Clinica Croatica 2013; 52: 448-452 (IGR: 15-4)


55658 Causes of blindness and career choice among pupils in a blind school; South Western Nigeria
Fadamiro CO
Annals of African medicine 2014; 13: 16-20 (IGR: 15-4)


55580 Dual sensory loss and depressive symptoms: the importance of hearing, daily functioning, and activity engagement
Kiely KM; Anstey KJ; Luszcz MA
Frontiers in human neuroscience 2013; 7: 837 (IGR: 15-4)


55778 Long-term trends in glaucoma-related blindness in olmsted county, Minnesota
Malihi M; Moura Filho ER; Hodge DO; Sit AJ
Ophthalmology 2014; 121: 134-141 (IGR: 15-4)


55725 Blindness and Visual Impairment among Egyptian Glaucoma Patients
Eldaly MA; Salama MM; Abu Eleinen KG; Ghalwash D; Youssef M; El-Shiaty AF
Journal of Ophthalmology 2014; 2014: 437548 (IGR: 15-4)


55707 Changed trends of major causes of visual impairment in Sichuan, China from 1987 to 2006
Chen H; Fan YC; He QH; Wu XY; Wei M; Eichner JE; Farris BK; Hildebrand PL; Lei CT; Wu SH; Yang JY
International Journal of Ophthalmology 2014; 7: 139-144 (IGR: 15-4)


55690 New trends in visual rehabilitation with MP-1 microperimeter biofeedback: optic neural dysfunction
Verboschi F; Domanico D; Nebbioso M; Corradetti G; Zaccaria Scalinci S; Vingolo EM
Functional neurology 2013; 28: 285-291 (IGR: 15-4)


54416 Factors associated with lifetime risk of open-angle glaucoma blindness
Peters D; Bengtsson B; Heijl A
Acta Ophthalmologica 2014; 92: 421-425 (IGR: 15-3)


54551 Lifetime risk of blindness in open-angle glaucoma
Peters D; Bengtsson B; Heijl A
American Journal of Ophthalmology 2013; 156: 724-730 (IGR: 15-3)


54463 Unilateral permanent loss of vision after nefopam administration
Corbonnois G; Iohom G; Lazarescu C; Hubert I; Bouaziz H
Annales françaises d'anesthèsie et de rèanimation 2013; 32: e113-e115 (IGR: 15-3)


54029 Unrecognized and unregistered blindness in people 70 or older in Jing'an district, Shanghai, China
Wu LC; Sun XH; Zhou XT; Wen CH
International Journal of Ophthalmology 2013; 6: 321-326 (IGR: 15-2)


53955 Age-related eye diseases and visual impairment among u.s. Adults
Chou CF; Frances Cotch M; Vitale S; Zhang X; Klein R; Friedman DS; Klein BE; Saaddine JB
American journal of preventive medicine 2013; 45: 29-35 (IGR: 15-2)


52790 Prevalence and risk factors for eye diseases, blindness, and low vision in Lhasa, Tibet
Wang GQ; Bai ZX; Shi J; Luo S; Chang HF; Sai XY
International Journal of Ophthalmology 2013; 6: 237-241 (IGR: 15-1)


53153 The association between diagnosed glaucoma and cataract and cognitive performance in very old people: cross-sectional findings from the newcastle 85+ study
Jefferis JM; Taylor JP; Collerton J; Jagger C; Kingston A; Davies K; Kirkwood T; Clarke MP
Ophthalmic Epidemiology 2013; 20: 82-88 (IGR: 15-1)


52950 Driving patterns in older adults with glaucoma
van Landingham SW; Hochberg C; Massof RW; Chan E; Friedman DS; Ramulu PY
BMC Ophthalmology 2013; 13: 4 (IGR: 15-1)


52634 Causes of moderate to severe visual impairment and blindness in population aged 50 years or more in rural Shandong province
Li Y; Bi HS; Wang LH; Wang T; Yang SY; Liu LP; Zhou CC
Chinese Journal of Ophthalmology 2013; 49: 144-150 (IGR: 15-1)


52602 Advanced glaucoma: management pearls
Gessesse GW; Damji KF
Middle East African Journal of Ophthalmology 2013; 20: 131-141 (IGR: 15-1)


52678 Acute visual changes in the elderly
Addis VM; DeVore HK; Summerfield ME
Clinics in Geriatric Medicine 2013; 29: 165-180 (IGR: 15-1)


52373 Ocular Hypertension and the Risk of Blindness
Gestel AV; Webers CA; Beckers HJ; Peeters A; Severens JL; Schouten JS
Journal of Glaucoma 2015; 24: 9-11 (IGR: 15-1)


52905 Causes of blindness in students at the school for blind children in Ilvesheim. Changes between 1885 and 2008
Rohrschneider K; Mackensen I
Ophthalmologe 2013; 110: 331-338 (IGR: 15-1)


52397 Glaucoma Awareness in a Hospital Presenting Population in Eastern Nepal
Gyawali R; Sarkar N
Journal of Glaucoma 2014; 23: 594-598 (IGR: 15-1)


53073 Charles bonnet syndrome, management with simple behavioral technique
Issa BA; Yussuf AD
Journal of neurosciences in rural practice 2013; 4: 63-65 (IGR: 15-1)


52056 Prevalence and causes of visual impairment and blindness, cataract surgical coverage and outcomes of cataract surgery in Libya
Rabiu MM; Jenf M; Fituri S; Choudhury A; Agbabiaka I; Mousa A
Ophthalmic Epidemiology 2013; 20: 26-32 (IGR: 14-4)


51817 Vision impairment and major causes of vision loss impacts on vision-specific functioning independent of socioeconomic factors
Chiang PP; Zheng Y; Wong TY; Lamoureux EL
Ophthalmology 2013; 120: 415-422 (IGR: 14-4)


52016 Prevalence of end-of-life visual impairment in patients followed for glaucoma
Ernest PJ; Busch MJ; Webers CA; Beckers HJ; Hendrikse F; Prins MH; Schouten JS
Acta Ophthalmologica 2013; 91: 738-743 (IGR: 14-4)


52072 Visual Acuity of commercial motor drivers in Ogun State of Nigeria
Onabolu OO; Bodunde OT; Otulana TO; Ajibode HA; Awodein OG; Onadipe OJ; Jagun OA
The Nigerian postgraduate medical journal 2012; 19: 225-229 (IGR: 14-4)


51948 Vision Insurance, Eye Care Visits, and Vision Impairment Among Working-Age Adults in the United States
Li YJ; Xirasagar S; Pumkam C; Krishnaswamy M; Bennett CL
Archives of Ophthalmology 2012; 0: 1-8 (IGR: 14-4)


51816 Neural stimulation for visual rehabilitation: Advances and challenges
Lorach H; Marre O; Sahel JA; Benosman R; Picaud S
Journal of physiology, Paris 2013; 107: 421-431 (IGR: 14-4)


51239 Prevalence and causes of visual impairment in elderly Amis aborigines in eastern Taiwan (the Amis Eye Study)
Chen N; Huang TL; Tsai RK; Sheu MM
Japanese Journal of Ophthalmology 2012; 56: 624-630 (IGR: 14-3)


50873 The prevalence and causes of visual impairment in an elderly Chinese Bai ethnic rural population: the Yunnan minority eye study
Zhong H; Cai N; Luo T; Li J; Su X; Li X; Qiu X; Yang Y; Yuan Y; Yu M
Investigative Ophthalmology and Visual Science 2012; 53: 4498-4504 (IGR: 14-3)


51361 Blindness and visual impairment in Remo, Ogun State, Nigeria: A hospital-based study
Otulana TO
The Nigerian postgraduate medical journal 2012; 19: 153-156 (IGR: 14-3)


51209 Glaucoma in developing countries
Thomas R
Indian Journal of Ophthalmology 2012; 60: 446-450 (IGR: 14-3)


50432 Five year incidence of visual field loss in adult Chinese. The Beijing Eye Study
Wang YX; Xu L; Sun XY; Zou Y; Zhang HT; Jonas JB
PLoS ONE 2012; 7: e37232 (IGR: 14-2)


50447 Disparities in Adult Vision Health in the United States
Zambelli-Weiner A; Crews JE; Friedman DS
American Journal of Ophthalmology 2012; 154: S23-30.e1 (IGR: 14-2)


50500 Blindness and Visual Impairment in an Urban West African Population: The Tema Eye Survey
Budenz DL; Bandi JR; Barton K; Nolan W; Herndon L; Whiteside-De Vos J; Hay-Smith G; Kim H; Tielsch J;
Ophthalmology 2012; 119: 1744-1753 (IGR: 14-2)


50560 Evidence for a considerable decrease in total and cause-specific incidences of blindness in Germany
Claessen H; Genz J; Bertram B; Trautner C; Giani G; Zö,llner I; Icks A
European Journal of Epidemiology 2012; 27: 519-524 (IGR: 14-2)


50511 Review of the publications of the Nigeria national blindness survey: methodology, prevalence, causes of blindness and visual impairment and outcome of cataract surgery
Rabiu MM; Kyari F; Ezelum C; Elhassan E; Sanda S; Murthy GV; Sivasubramaniam S; Glibert C; Abdull MM; Abiose A; Bankole O; Entekume G; Faal H; Imam A; Sang LP; Abubakar T
Annals of African medicine 2012; 11: 125-130 (IGR: 14-2)


50533 Causes of visual impairment in Thai diabetic patients in the visual rehabilitation clinic
Singalavanija A; Luangsawang K; Chotikavanich S; Tanterdtham J; Samsen P
Journal of the Medical Association of Thailand 2012; 95: S24-29 (IGR: 14-2)


50509 Visual impairment and blindness in rural central India: the Central India Eye and Medical Study
Nangia V; Jonas JB; Gupta R; Khare A; Sinha A
Acta Ophthalmologica 2013; 91: 483-486 (IGR: 14-2)


50216 Avoidable sight loss from glaucoma: is it unavoidable?
Kotecha A; Fernandes S; Bunce C; Franks WA
British Journal of Ophthalmology 2012; 96: 816-820 (IGR: 14-2)


49977 Clinical forms of macular glaucoma using optical coherence tomography
Zeitoun M
Journal Français d'Ophtalmologie 2012; 35: 319-332 (IGR: 14-2)


49323 Causes of Visual Impairment among Patients Referred to a Visual Rehabilitation Clinic in Iran
Ramezani A; Pardis M; Rafati N; Kazemi-Moghaddam M; Katibeh M; Rostami P; Dehghan MH; Javadi MA; Rabbanikhah Z
Korean Journal of Ophthalmology 2012; 26: 80-83 (IGR: 14-1)


48928 Time trends in the incidence and causes of blindness in Israel
Skaat A; Chetrit A; Belkin M; Kinori M; Kalter-Leibovici O
American Journal of Ophthalmology 2012; 153: 214-221.e1 (IGR: 14-1)


48737 Causes of blindness and visual impairment in Latin America
Furtado JM; Lansingh VC; Carter MJ; Milanese MF; Peñ,a BN; Ghersi HA; Bote PL; Nano ME; Silva JC
Survey of Ophthalmology 0; 57: 149-177 (IGR: 14-1)


49128 Magnitude and Causes of Low Vision Disability (Moderate and Severe Visual Impairment) among Students of Al-Noor Institute for the Blind in Al-Hassa, Saudi Arabia: A case series
Al-Wadani F; Khandekar R; Al-Hussain MA; Alkhawaja AA; Khan MS; Alsulaiman RA
Sultan Qaboos University Medical Journal 2012; 12: 62-68 (IGR: 14-1)


49126 Severe loss and recovery of vision after glaucoma filtration surgery
Chen BH; Gordon HB; Shah CP; Spaeth GL
Journal of Glaucoma 2012; 21: 144-146 (IGR: 14-1)


48301 Visual impairment and quality of life in the older European population, the EUREYE study
Seland JH; Vingerling JR; Augood CA; Bentham G; Chakravarthy U; deJong PT; Rahu M; Soubrane G; Tomazzoli L; Topouzis F
Acta Ophthalmologica 2011; 89: 608-613 (IGR: 13-4)


47938 The meaning of leisure for older adults living with vision loss
Berger S
OTJR Occupation, Participation and Health 2011; 31: 193-199 (IGR: 13-4)


47932 Causes and 3-year-incidence of blindness in Jing-An District, Shanghai, China 2001-2009
Wu L; Sun X; Zhou X; Weng C
BMC Ophthalmology 2011; 11: 10 (IGR: 13-4)


47759 Blindness in Iraq: Leading causes, target patients, and barriers to treatment
Al-Shakarchi FI
Middle East African Journal of Ophthalmology 2011; 18: 199-203 (IGR: 13-4)


47863 Prevalence and causes of blindness at a tertiary hospital in Douala, Cameroon
Eballe AO; Mvogo CE; Koki G; Moune N; Teutu C; Ellong A; Bella AL
Clinical Ophthalmology 2011; 5: 1325-1331 (IGR: 13-4)


47517 Outcomes of pediatric cataract surgery at a tertiary care center in rural southern Ethiopia
Tomkins O; Ben-Zion I; Moore DB; Helveston EE
Archives of Ophthalmology 2011; 129: 1293-1297 (IGR: 13-4)


47966 Incidence of blindness and severe visual impairment in Germany: projections for 2030
Finger RP; Fimmers R; Holz FG; Scholl HP
Investigative ophthalmology & visual science 2011; 52: 4381-4389 (IGR: 13-4)


48349 Lifetime visual prognosis of patients with glaucoma
Goh YW; Ang GS; Azuara-Blanco A
Clinical and Experimental Ophthalmology 2011; 39: 766-770 (IGR: 13-4)


47638 Causes of blindness in a special education school
Onakpoya OH; Adegbehingbe BO; Omotoye OJ; Adeoye AO
West African Journal of Medicine 2011; 30: 47-50 (IGR: 13-4)


47643 Prevalence and causes of visual impairment among Saudi adults attending primary health care centers in northern Saudi Arabia
Al-Shaaln FF; Bakrman MA; Ibrahim AM; Aljoudi AS
Annals of Saudi Medicine 2011; 31: 473-480 (IGR: 13-4)


47673 Rehabilitation of vision disorder and improved quality of life in patients with primary open angle glaucoma
Luo R-J; Liu S-R; Tian Z; Zhu W-H; Zhuo Y-H; Liao R-D
Chinese Medical Journal 2011; 124: 2687-2691 (IGR: 13-4)


47594 Epidemiology of Major Eye Diseases Leading to Blindness in Europe: A Literature Review
Prokofyeva E; Zrenner E
Ophthalmic Research 2011; 47: 171-188 (IGR: 13-4)


47977 Prevalence, causes, and risk factors for functional low vision in Nigeria: results from the national survey of blindness and visual impairment
Entekume G; Patel J; Sivasubramaniam S; Gilbert CE; Ezelum CC; Murthy GV; Rabiu MM; Nigeria National Blindness and Visual Impairment Study Group
Investigative ophthalmology & visual science 2011; 52: 6714-6719 (IGR: 13-4)


46340 Prevalence and causes of visual impairment and blindness in an urban Indian population: the singapore Indian eye study
Zheng Y; Lavanya R; Wu R; Wong WL; Wang JJ; Mitchell P; Cheung N; Cajucom-Uy H; Lamoureux E; Aung T
Ophthalmology 2011; 118: 1798-1804 (IGR: 13-3)


46341 Risk factors for four-year incident visual impairment and blindness: the los angeles latino eye study
Yonekawa Y; Varma R; Choudhury F; Torres M; Azen SP; Los Angeles Latino Eye Study Group
Ophthalmology 2011; 118: 1790-1797 (IGR: 13-3)


47129 Profile of the glaucomas and intervention in a large eye care centre in south-east Nepal
Sarkar S; Mardin C; Hennig A
Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH 2010; 2: 3-9 (IGR: 13-3)


46438 Factors influencing self-reported vision-related activity limitation in the visually impaired
Tabrett DR; Latham K
Investigative Ophthalmology and Visual Science 2011; 52: 5293-5302 (IGR: 13-3)


46425 Age-Related Eye Disease and Mobility Limitations in Older Adults
Popescu ML; Boisjoly H; Schmaltz H; Kergoat MJ; Rousseau J; Moghadaszadeh S; Djafari F; Freeman EE
Investigative Ophthalmology and Visual Science 2011; (IGR: 13-3)


46659 Five-year incidence of visual impairment and blindness in adult Chinese: The Beijing eye study
You QS; Xu L; Yang H; Wang YX; Jonas JB
Ophthalmology 2011; 118: 1069-1075 (IGR: 13-3)


46472 Visual impairment in children in middle- and lower-income countries
Courtright P; Hutchinson AK; Lewallen S
Archives of Disease in Childhood 2011; (IGR: 13-3)


46512 Prevalence and causes of registered blindness in the largest federal state of Germany
Finger RP; Fimmers R; Holz FG; Scholl HPN
British Journal of Ophthalmology 2011; 95: 1061-1067 (IGR: 13-3)


46938 Glaucoma--threatening in darkness
Turki MA; Craiu AM
Oftalmologia 2010; 54: 27-33 (IGR: 13-3)


46793 A population-based study of care-seeking behavior in rural tanzanians with glaucoma blindness
Lewallen S; Hassan HG; Al Attas AH; Courtright P
Journal of Glaucoma 2011; 20: 361-365 (IGR: 13-3)


47003 Inferior visual field reductions are associated with poorer functional status among older adults with glaucoma
Black AA; Wood JM; Lovie-Kitchin JE
Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians 2011; 31: 283-291 (IGR: 13-3)


46467 Blindness and long-term progression of visual field defects in Chinese patients with primary angle-closure glaucoma
Quek DTL; Koh VT; Tan GS; Perera SA; Wong TT; Aung T
American Journal of Ophthalmology 2011; 152: 463-469 (IGR: 13-3)


46603 Vision restoration after brain and retina damage: The "residual vision activation theory"
Sabel BA; Henrich-Noack P; Fedorov A; Gall C
Progress in Brain Research 2011; 192: 199-262 (IGR: 13-3)


46166 Prevalence of visual impairment, cataract surgery and awareness of cataract and glaucoma in Bhaktapur district of Nepal: the Bhaktapur Glaucoma Study
Thapa SS; Berg RV; Khanal S; Paudyal I; Pandey P; Maharjan N; Twyana SN; Paudyal G; Gurung R; Ruit S
BMC Ophthalmology 2011; 11: 2 (IGR: 13-2)


46146 Assessing the diagnostic validity of a blind register
Crewe JM; Morgan WH; Morlet N; Spilsbury K; Mukhtar A; Clark A; Ng JQ; Crowley M; Semmens JB
Clinical and Experimental Ophthalmology 2011; 39: 494-500 (IGR: 13-2)


45839 Is glaucoma blindness a disease of deprivation and ignorance? A case-control study for late presentation of glaucoma in India
Gogate P; Deshpande R; Chelerkar V; Deshpande S; Deshpande M
Indian Journal of Ophthalmology 2011; 59: 29-35 (IGR: 13-2)


46293 Neurodegeneration: Accelerated ageing or inadequate healthcare?
Golubnitschaja O
The EPMA Journal 2010; 1: 211-215 (IGR: 13-2)


46316 Glaucoma and blindness, an early axonal diagnosis and prevention by MRI
Iba-Zizen M-T; Cabanis EA; Istoc A; Yoshida M
Neuroradiology Journal 2010; 23: 276 (IGR: 13-2)


46300 Findings from a rapid assessment of avoidable blindness (RAAB) in Southern Malawi
Kalua K; Lindfield R; Mtupanyama M; Mtumodzi D; Msiska V
PLoS ONE 2011; 6: e19226 (IGR: 13-2)


45935 Overcoming gender inequity in prevention of blindness and visual impairment in Africa
Mganga H; Lewallen S; Courtright P
Middle East African Journal of Ophthalmology 2011; 18: 98-101 (IGR: 13-2)


45933 Prevalence and causes of blindness and visual impairment in Sokoto State, Nigeria: Baseline data for Vision 2020: The right to sight eye care programme
Muhammad N; Mansur R; Dantani A; Elhassan E; Isiyaku S
Middle East African Journal of Ophthalmology 2011; 18: 123-128 (IGR: 13-2)


45756 Prevalence and Causes of Visual Impairment and Blindness in an Urban Indian Population. The Singapore Indian Eye Study
Zheng Y; Lavanya R; Wu R; Wong W-L; Wang JJ; Mitchell P; Cheung N; Cajucom-Uy H; Lamoureux E; Aung T
Ophthalmology 2011; (IGR: 13-2)


46145 Lifetime visual prognosis of patients with glaucoma in Aberdeen, Scotland
Goh YW; Ang GS; Azuara-Blanco A
Clinical and Experimental Ophthalmology 2011; (IGR: 13-2)


28196 Low vision simulator goggles in pharmacy education
Zagar M; Baggarly S
American journal of pharmaceutical education 2010; 74:5 (IGR: 13-1)


28056 Causes of blindness in people aged 50 years and over: Community-based versus hospital-based study
Al-Akily SA; Bamashmus MA; Al-Mohammadi KA
Eastern Mediterranean health journal 2010; 16:9 (IGR: 13-1)


28146 International vision requirements for driver licensing and disability pensions: Using a milestone approach in characterization of progressive eye disease
Bron AM; Viswanathan AC; Thelen U; De Natale R; Ferreras A; Gundgaard J; Schwartz G; Buchholz P
Clinical Ophthalmology 2010; 4: 1361-1369 (IGR: 13-1)


27821 Low vision service at the Instituto Brasileiro de Oftalmologia e Prevencao da Cegueira (IBOPC): Analysis of the patients examined on the first year of the department (2004)
Da Costa Pinto Silva AMT; De Matos MHBR; De Castro Lima H
Arquivos Brasileiros de Oftalmologia 2010; 73: 266-270 (IGR: 13-1)


27933 Five-Year Incidence of Visual Impairment and Blindness in Adult Chinese. The Beijing Eye Study
You QS; Xu L; Yang H; Wang YX; Jonas JB
Ophthalmology 2011; 118:1069-1075 (IGR: 13-1)


27847 The silent enemy: A review of cataract in relation to glaucoma and trabeculectomy surgery
Mathew RG; Murdoch IE
British Journal of Ophthalmology 2011; (IGR: 13-1)


27640 Prevalence and causes of visual impairment in a rural North-east China adult population: A population-based survey in Bin County, Harbin
Song W; Sun X; Shao Z; Zhou X; Kang Y; Sui H; Yuan H
Acta Ophthalmologica 2010; 88: 669-674 (IGR: 12-4)


27368 Creating synergies for health systems strengthening through partnerships in Pakistan - a case study of the national eye health programme
Khan AA; Khan NU; Bile KM; Awan H
Eastern Mediterranean health journal 2010; 16: S61-68 (IGR: 12-4)


27320 Prevalence and causes of blindness, low vision and status of cataract in 50 years and older citizen of Qatar-A community based survey
Gamra HA; Mansouri FA; Khandekar R; Elshafei M; Qahtani OA; Singh R; Hashim SP; Mujahed A; Makled A; Pai A
Ophthalmic Epidemiology 2010; 17: 292-300 (IGR: 12-4)


27335 Visual loss and falls: A review
Dhital A; Pey T; Stanford MR
Eye 2010; 24: 1437-1446 (IGR: 12-4)


27612 Epidemiological survey on blindness and low vision among adults aged 50 years or above in Sanya outskirts
Wen X-F; Fan X-Q
International Journal of Ophthalmology 2010; 10: 1797-1798 (IGR: 12-4)


27215 Causes of blindness and low vision in Bayelsa State, Nigeria: a clinic based study
Richard AI
Nigerian quarterly journal of hospital medicine 2010; 20: 125-128 (IGR: 12-4)


27253 Prevalence and determinants of blindness, low vision, deafness and major bone fractures among elderly Omani population of Nizwa Wilayat (Nizwa elderly population study - 2005)
Khandekar R; Al Riyami A; Attiya M; Morsi M
Indian Journal of Ophthalmology 2010; 58: 313-319 (IGR: 12-4)


27584 The effect of color filters on the visual acuity and contrast sensitivity in low vision patients
Mahjoob M; Heravian J; Validad MH; Momeni Moghadam H; Hosini T; Tavakoli R
Journal of Babol University of Medical Sciences 2010; 11: 53-57 (IGR: 12-4)


26329 Incidence of Glaucomatous Visual Field Loss: A Ten-Year Follow-up from the Rotterdam Study
Czudowska MA; Ramdas WD; Wolfs RC; Hofman A; De Jong PT; Vingerling JR; Jansonius NM
Ophthalmology 2010; 117: 1705-1712 (IGR: 12-3)


26491 Ophthalmic hypertension and glaucoma: mechanisms of development (a theoretical and clinical study)
Rudkovskaia OD; Pishak VP
Vestnik Oftalmologii 2010; 126: 40-43 (IGR: 12-3)


26707 Survey of childhood blindness and visual impairment in Botswana
Nallasamy S; Anninger WV; Quinn GE; Nkomazana O
Journal of AAPOS 2010; 14: 23-24 (IGR: 12-3)


26472 Causes of visual impairment in Mie Prefecture during a 5-year period
Ikesugi K; Tsukitome H; Yagi T; Yamaguchi T; Tamei I; Sasoh M; Uji Y
Nippon Ganka Gakkai Zasshi 2010; 114: 505-511 (IGR: 12-3)


26641 Profile of childhood blindness and low vision in yemen: A hospital-based study
Bamashmus MA; Al-Akily SA
Eastern Mediterranean health journal 2010; 16: 425-428 (IGR: 12-3)


26848 Analysis of the factors of low visual acuity after phacoemulsification on senile cataract
Wei X-L; Liu L; Qiao T-Y; Wang J
International Journal of Ophthalmology 2010; 10: 1413-1414 (IGR: 12-3)


26413 The Increased Cost of Medical Services for People Diagnosed With Primary Open-Angle Glaucoma: A Decision Analytic Approach
Kymes SM; Plotzke MR; Li JZ; Nichol MB; Wu J; Fain J
American Journal of Ophthalmology 2010; 150: 74-81 (IGR: 12-3)


26060 Prevalence of major eye diseases and causes of visual impairment in the adult Finnish population: A nationwide population-based survey
Laitinen A; Laatikainen L; Harkanen T; Koskinen S; Reunanen A; Aromaa A
Acta Ophthalmologica 2010; 88: 463-471 (IGR: 12-2)


25703 Vision impairment and eye care utilization among Americans 50 and Older
McGwin G; Khoury R; Cross J; Owsley C
Current Eye Research 2010; 35: 451-458 (IGR: 12-2)


25766 Relationships in glaucoma patients between standard vision tests, quality of life, and ability to perform daily activities
Richman J; Lorenzana LL; Lankaranian D; Dugar J; Mayer JR; Wizov SS; Spaeth GL
Ophthalmic Epidemiology 2010; 17: 144-151 (IGR: 12-2)


26065 Visual impairment secondary to congenital glaucoma in children: Visual responses, optical correction and use of low vision AIDS
Haddad MAO; Sampaio MW; Oltrogge EW; Kara-Jose N; Betinjane AJ
Clinics 2009; 64: 725-730 (IGR: 12-2)


25280 Early but not late-blindness leads to enhanced auditory perception
Wan C Y; Wood A G; Reutens D C; Wilson S J
Neuropsychologia 2010; 48: 344-348 (IGR: 12-1)


25309 Presentation of glaucoma in an urban tertiary care hospital in South America: legal blindness and prevalence
Osaki T H; Kasahara N; Paolera M D; Cohen R; Nishiwaki-Dantas M C
International Ophthalmology 2010; 1-6 (IGR: 12-1)


25092 Readability of prescription labels and medication recall in a population of tertiary referral glaucoma patients
O'Hare F; Jeganathan VS; Rokahr CG; Rogers SL; Crowston JG
Clinical and Experimental Ophthalmology 2009; 37: 849-854 (IGR: 12-1)


25096 The Effect of Socioeconomic Deprivation on Severity of Glaucoma at Presentation
Ng WS; Agarwal PK; Sidiki S; Mackay L; Townend J; Azuara Blanco A
British Journal of Ophthalmology 2010; 94: 85-87 (IGR: 12-1)


25190 Fixation behavior in advanced stage glaucoma assessed by the MicroPerimeter MP-1
Kameda T; Tanabe T; Hangai M; Ojima T; Aikawa H; Yoshimura N
Japanese Journal of Ophthalmology 2009; 53: 580-587 (IGR: 12-1)


24988 Prevalence of glaucoma types and legal blindness from glaucoma in the western region of Saudi Arabia: a hospital-based study
Eid TM; el-Hawary I; El-Menawy W
International Ophthalmology 2009; 29: 477-483 (IGR: 11-4)


24976 Visual function in working-age adults: early life influences and associations with health and social outcomes
Rahi JS; Cumberland PM; Peckham CS
Ophthalmology 2009; 116: 1866-1871 (IGR: 11-4)


24866 Prevalence and causes of visual impairment in Chinese adults in urban southern China
Huang S; Zheng Y; Foster PJ; Huang W; He M; Liwan Eye Study
Archives of Ophthalmology 2009; 127: 1362-1367 (IGR: 11-4)


24773 Causes of vision impairment and assessment of need for low vision services for students of blind schools in Nepal
Kansakar I; Thapa HB; Salma KC; Ganguly S; Kandel RP; Rajasekaran S
Kathmandu University Medical Journal 2009; 7: 44-49 (IGR: 11-4)


24520 Prognosis of glaucoma in relation to blindness at a university hospital
Cronemberger S; Lourenco LFS; Silva LC; Calixto N; Pires MC
Arquivos Brasileiros de Oftalmologia 2009; 72: 199-204 (IGR: 11-4)


24161 Causes of blindness and visual impairment in Nigeria: the Nigeria national blindness and visual impairment survey
Abdull MM; Sivasubramaniam S; Murthy GV; Gilbert C; Abubakar T; Ezelum C; Rabiu MM; Nigeria National Blindness and Visual Impairment Study Group
Investigative Ophthalmology and Visual Science 2009; 50: 4114-4120 (IGR: 11-3)


24092 Nine-year incidence of visual impairment in the Barbados Eye Studies
Hennis AJ; Wu SY; Nemesure B; Hyman L; Schachat AP; Leske MC; Barbados Eye Studies Group
Ophthalmology 2009; 116: 1461-1468 (IGR: 11-3)


24291 Visual impairment and eye care among Alaska native people
Haymes SA; Leston JD; Ferucci ED; Etzel RA; Lanier AP
Ophthalmic Epidemiology 2009; 16: 163-174 (IGR: 11-3)


24437 A survey of blindness and low vision oculopathy in rural areas of Tianjin
Li Y; Wei R-H; Wu S-Y; Zhao S-Z
International Journal of Ophthalmology 2009; 9: 1206-1207 (IGR: 11-3)


24197 Vision loss in older persons
Pelletier AL; Thomas J; Shaw FR
American Family Physician 2009; 79: 963-970 (IGR: 11-3)


24389 The ageing eye - Threats to vision and their treatments
Welch S; Eckstein M
CME Journal Geriatric Medicine 2008; 10: 58-61 (IGR: 11-3)


23433 Gender differences in adult blindness and low vision, Central Ethiopia
Woldeyes A; Adamu Y
Ethiopian medical journal 2008; 46: 211-218 (IGR: 11-2)


23931 Prevalence of blindness and visual impairment in Nigeria: the National Blindness and Visual Impairment Study
Kyari F; Gudlavalleti MV; Sivsubramaniam S; Gilbert CE; Abdull MM; Entekume G; Foster A; Nigeria National Blindness and Visual Impairment Study Group
Investigative Ophthalmology and Visual Science 2009; 50: 2033-2039 (IGR: 11-2)


22542 Glaucoma and disability: which tasks are affected, and at what stage of disease?
Ramulu P
Current Opinions in Ophthalmology 2009; 20: 92-98 (IGR: 11-1)


23052 Rapid Assessment of Avoidable Blindness in India
Neena J; Rachel J; Praveen V; Murthy GV
PLoS ONE 2008; 3: e2867 (IGR: 11-1)


22979 Sight for seniors: A summary of findings and challenges to providing community-based eye care to low-income seniors
Winters JE; Pihos AM
Optometry 2008; 79: 718-723 (IGR: 11-1)


22563 Glaucoma and reading speed: the Salisbury Eye Evaluation project
Ramulu PY; West SK; Munoz B; Jampel HD; Friedman DS
Archives of Ophthalmology 2009; 127: 82-87 (IGR: 11-1)


21507 Spectrum of ocular diseases at a military hospital in Ladakh, North India
Jha KN
Journal of Clinical and Diagnostic Research 2008; 2: 843-846 (IGR: 10-3)


21505 Causes of blind certifications in England and Wales: April 1999-March 2000
Bunce C; Wormald R
Eye 2008; 22: 905-911 (IGR: 10-3)


21770 Assessment of the effect of visual impairment on mortality through multiple health pathways: Structural equation modeling
Christ SL; Lee DJ; Lam BL; Zheng DD; Arheart KL
Investigative Ophthalmology and Visual Science 2008; 49: 3318-3323 (IGR: 10-3)


21620 Sampling survey of prevalence and cause of visual impairment in Shaanxi Province
Chu M-F; Ai H; Peng J; Wang Y; Yang X-G
International Journal of Ophthalmology 2008; 8: 1412-1415 (IGR: 10-3)


21426 The visually impaired patient
Rosenberg EA; Sperazza LC
American Family Physician 2008; 77: 1431-1436 (IGR: 10-3)


21648 Epidemiological survey of blindness in Foping of Shaanxi province
Zhang J
International Journal of Ophthalmology 2008; 8: 1416-1417 (IGR: 10-3)


21472 Late-stage, primary open-angle glaucoma in Europe: social and health care maintenance costs and quality of life of patients from 4 countries
Thygesen J; Aagren M; Arnavielle S; Bron A; Frohlich SJ; Baggesen K; Azuara-Blanco A; Buchholz P; Walt JG
Current Medical Research and Opinion 2008; 24: 1763-1770 (IGR: 10-3)


21042 'Vision through the hands': Experience of a project
Ventura R; Ventura L; Brandt C; Ferraz D; Ventura B
Arquivos Brasileiros de Oftalmologia 2007; 70: 823-826 (IGR: 10-2)


21080 Assessing the visual status of truck drivers in a developing country
Onabolu OO; Otulana TO; Awodein OG
Tropical Doctor 2008; 38: 54-55 (IGR: 10-2)


21406 Rapid assessment of avoidable blindness in Kunming, China
Wu M; Yip JL; Kuper H
Ophthalmology 2008; 115: 969-974 (IGR: 10-2)


21373 Glaucoma and fitness to drive: using binocular visual fields to predict a milestone to blindness
Owen VM; Crabb DP; White ET; Viswanathan AC; Garway-Heath DF; Hitchings RA
Investigative Ophthalmology and Visual Science 2008; 49: 2449-2455 (IGR: 10-2)


21082 Self-reported age-related eye diseases and visual impairment in the United States: Results of the 2002 National Health Interview Survey
Ryskulova A; Turczyn K; Makuc DM; Cotch MF; Klein RJ; Janiszewski R
American Journal of Public Health 2008; 98: 454-461 (IGR: 10-2)


20431 Visual impairment, causes of vision loss, and falls: the singapore malay eye study
Lamoreux EL; Chong E; Wang JJ; Saw SM; Aung T; Mitchell P; Wong TY
Investigative Ophthalmology and Visual Science 2008; 49: 528-533 (IGR: 10-1)


20362 Prevalence of Major Eye Diseases Among US Civil War Veterans, 1890-1910
Sloan FA; Belsky DW; Boly IA
Archives of Ophthalmology 2008; 126: 246-250 (IGR: 10-1)


20777 Review of recent surveys on blindness and visual impairment in Latin America
Limburg H; Barria von-Bischhoffshausen F; Gomez P; Silva JC; Foster A
British Journal of Ophthalmology 2008; 92: 315-319 (IGR: 10-1)


20327 Trends in blind and low vision registrations in Taipei City
Tsai IL; Woung LC; Tsai CY; Kuo LL; Liu SW; Lin S; Wang IJ
European Journal of Ophthalmology 2008; 18: 118-124 (IGR: 10-1)


20589 Poverty and blindness in Pakistan: Results from the Pakistan national blindness and visual impairment survey
Gilbert CE; Shah SP; Jadoon MZ; Bourne R; Dineen B; Khan MA; Johnson GJ; Khan MD
British Medical Journal (Clinical Research Edition) 2008; 336: 29-32 (IGR: 10-1)


20427 Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data
Broman AT; Quigley HA; West SK; Katz J; Munoz B; Bandeen-Roche K; Tielsch JM; Friedman DS; Crowston J; Taylor HR
Investigative Ophthalmology and Visual Science 2008; 49: 66-76 (IGR: 10-1)


20692 Costs of vision impairment: Present and future issues
Keeffe JE
Expert Review of Pharmacoeconomics and Outcomes Research 2007; 7: 523-527 (IGR: 10-1)


20006 Prevalence and causes of visual impairment in rural myanmar the Meiktila Eye Study
Casson RJ; Newland HS; Muecke J; McGovern S; Durkin S; Sullivan T; Oo TZ; Aung TH; Shein WK; Selva D
Ophthalmology 2007; 114: 2302-2308 (IGR: 9-4)


19747 Age-specific changes in the prevalence of best-corrected visual impairment in an Italian population
Cedrone C; Ricci F; Nucci C; Cesareo M; Macri G; Culasso F
Ophthalmic Epidemiology 2007; 14: 320-326 (IGR: 9-4)


19996 Fear of blindness in the Collaborative Initial Glaucoma Treatment Study patterns and correlates over time
Janz NK; Wren PA; Guire KE; Musch DC; Gillespie BW; Lichter PR; Collaborative Initial Glaucoma Treatment Study
Ophthalmology 2007; 114: 2213-2220 (IGR: 9-4)


19961 A survey of blindness and low vision in Motuo county of Tibet
Luobuciren ; Li JF
Zhonghua Yan Ke Za Zhi 2007; 43: 803-805 (IGR: 9-4)


19737 Prevalence of blindness and visual impairment in Atakunmosa West Local Government area of southwestern Nigeria
Onakpoya OH; Adeoye AO; Akinsola FB; Adegbehingbe BO
Tanzan Health Res Bull 2007; 9: 126-131 (IGR: 9-4)


19733 Self-management programs for adults with low vision: Needs and challenges
Rees G; Saw CL; Lamoureux EL; Keeffe JE
Patient Education and Counseling 2007; 69: 39-46 (IGR: 9-4)


19956 Pay more attention to early diagnosis and intervention for patients with primary glaucoma
Zhao JL
Zhonghua Yan Ke Za Zhi 2007; 43: 769-771 (IGR: 9-4)


19268 Low vision and rehabilitation: Knowledge of ophthalmology residentes
Nobre MIRDS; Temporini ER; Montilha RDCL; Gasparetto MERF; Kara-Jose N
Medicina 2006; 39: 253-259 (IGR: 9-3)


17472 Prevalence and causes of visual impairment and blindness in Sistan-va-Baluchestan Province, Iran: Zahedan Eye Study
Shahriari H-A; Izadi S; Rouhani M-R; Ghasemzadeh F; Maleki A-R
British Journal of Ophthalmology 2007; 91: 579-584 (IGR: 9-2)


18123 Lifetime visual disability in open-angle glaucoma and ocular hypertension
Forsman E; Kivelä T; Vesti E
Journal of Glaucoma 2007; 16: 313-319 (IGR: 9-2)


17571 Prevalence and causes of blindness & low vision; before and five years after 'VISION 2020' initiatives in Oman: A review
Khandekar R; Mohammed AJ; Raisi AA
Ophthalmic Epidemiology 2007; 14: 9-15 (IGR: 9-2)


17628 The pattern of glaucoma in Menelik II hospital Addis Ababa, Ethiopia
Melka F; Alemu B
Ethiopian medical journal 2006; 44: 159-165 (IGR: 9-2)


17487 Characterization of the living environments of end-stage glaucoma patients and use of low-vision care services: A physician survey study
Walt JG; Chiang TH; Stern LS; Doyle JJ
Visual Impairment Research 2007; 9: 23-31 (IGR: 9-2)


17647 Pediatric and adolescent population with visual impairment: Study of 385 cases
Haddad MAO; Lobato FJC; Sampaio MW; Kara-Jose N
Clinics 2006; 61: 239-246 (IGR: 9-2)


17156 Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998-2003
Avisar R; Friling R; Snir M; Avisar I; Weinberger D
Israeli Medical Association Journal 2006; 8: 880-881 (IGR: 9-1)


17124 Leading causes of blindness and visual impairment in the region of Eastern Herzegovina
Ceklic L; Latinovic S; Aleksic P
Medicinski Pregled 2006; 59: 15-18 (IGR: 9-1)


17195 The analysis of visual invalidity causes based on medical-court opinions
Czepita D; Zejmo M
Klinika Oczna 2005; 107: 300-303 (IGR: 9-1)


14889 Blindness
Faschinger Chr
Spektrum der Augenheilkunde 2006; 20: 158-163 (IGR: 8-4)


15159 Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study
Gieser DK; Tracy Williams R; O'Connell W; Pasquale LR; Rosenthal BP; Walt JG; Katz LM; Siegartel LR; Wang L; Rosenblatt LC
Journal of Glaucoma 2006; 15: 419-425 (IGR: 8-4)


14114 Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study
Xu L; Wang Y; Li Y; Cui T; Li J; Jonas JB
Ophthalmology 2006; 113: 1134e1-1134e11 (IGR: 8-3)


13564 Leading causes of certification for blindness and partial sight in England & Wales
Bunce C; Wormald R
BMC Public Health 2006; 6: 7P (IGR: 8-2)


13768 Prevalence and causes of blindness in the rural population of the Chennai Glaucoma Study
Vijaya L; George R; Arvind H; Baskaran M; Raju P; Ramesh SV; Paul PG; Kumaramanickavel G; McCarty C
British Journal of Ophthalmology 2006; 90: 407-410 (IGR: 8-2)


13643 Trends in registered blindness and its causes over 19 years in Western Australia
Yong VK; Morgan WH; Cooper RL; Shaw M; Bremner AP; Bulsara M; Yu D-Y
Ophthalmic Epidemiology 2006; 13: 35-42 (IGR: 8-2)


13456 The number of people with glaucoma worldwide in 2010 and 2020
Quigley HA; Broman AT
British Journal of Ophthalmology 2006; 90: 262-267 (IGR: 8-1)


13284 Epidemiology of primary open angle glaucoma in a rural population in Shaanxi Province of China
Bai ZL; Ren BC; He Y; Yang JG; Chen L; Sun NX
International Journal of Ophthalmology 2005; 5: 864-871 (IGR: 8-1)


13302 Epidemiology of primary angle-closure glaucoma in a rural population in Shaanxi Province of China
Bai ZL; Ren BC; Yan JG; He Y; Chen L; Sun NX
International Journal of Ophthalmology 2005; 5: 872-880 (IGR: 8-1)


13470 Causes of blindness among hospital outpatients in Ecuador
Cass H; Landers J; Benitez P
Clinical and Experimental Ophthalmology 2006; 34: 146-151 (IGR: 8-1)


13450 Trends in blind registration in the adult population of the Republic of Ireland 1996-2003
Kelliher C; Kenny D; O'Brien C
British Journal of Ophthalmology 2006; 90: 367-371 (IGR: 8-1)


13444 The economic impact and cost of visual impairment in Australia
Taylor HR; Pezzullo ML; Keeffe JE
British Journal of Ophthalmology 2006; 90: 272-275 (IGR: 8-1)


12987 The impact of Vision 2020 on global blindness
Foster A; Resnikoff S
Eye 2005; 19: 1133-1135 (IGR: 7-3)


12580 The probability of blindness in patients treated for glaucoma
Chang LC; Teng MC; Chang HW; Lai IC; Lin PW; Tsai JC
Chang Gung medical journal 2005; 28: 492-497 (IGR: 7-3)


12505 Visual impairment in elderly patients with hip fracture: causes and associations
Cox A; Blaikie A; MacEwen CJ; Jones D; Thompson K; Holding D; Sharma T; Miller S; Dobson S; Sanders R
Eye 2005; 19: 652-656 (IGR: 7-2)


12338 The progress in the prevention of blindness in China
Zhao JL
Chinese Journal of Ophthalmology 2005; 41: 697-701 (IGR: 7-2)


11661 Prevalence and causes of blindness in a tropical African population
Adeoti CO
West African Journal of Medicine 2004; 23: 249-252 (IGR: 7-1)


11948 Global data on visual impairment in the year 2002
Resnikoff S; Pascolini D; Etya'ale D; Kocur I; Pararajasegaram R; Pokharel GP; Mariotti SP
Bulletin of the World Health Organisation 2004; 82: 844-851 (IGR: 7-1)


12142 To intensify the activities for prevention of blindness is the social responsibility of Chinese ophthalmologists
Zhao JL
Chinese Journal of Ophthalmology 2005; 41: 3-5 (IGR: 7-1)


11479 Ten years of glaucoma blindness in Fife 1990-99 and the implications for ophthalmology, optometry and rehabilitation services
Sinclair A; Hinds A; Sanders R
Ophthalmic and Physiological Optics 2004; 24: 313-318 (IGR: 6-3)


9648 Prevalence of glaucoma in Thailand: a population based survey in Rom Klao District, Bangkok
Bourne RR; Sukudom P; Foster PJ; Tantisevi V; Jitapunkul S; Lee PS; Johnson GJ; Rojanapongpun P
British Journal of Ophthalmology 2003; 87: 1069-1074 (IGR: 5-3)


9656 Five-year incidence of bilateral cause-specific visual impairment in the Melbourne Visual Impairment Project
Dimitrov PN; Mukesh BN; McCarty CA; Taylor HR
Investigative Ophthalmology and Visual Science 2003; 44: 5075-5081 (IGR: 5-3)


9658 National registry for the blind in Israel: estimation of prevalence and incidence rates and causes of blindness
Farber MD
Ophthalmic Epidemiology 2003; 10: 267-277 (IGR: 5-3)


9657 Causes of visual impairment in two older population cross-sections: the Blue Mountains Eye Study
Foran S; Wang JJ; Mitchell P
Ophthalmic Epidemiology 2003; 10: 215-225 (IGR: 5-3)


8913 Rate and amount of visual loss in 102 patients with open-angle glaucoma followed up for at least 15 years
Eid TM; Spaeth GL; Bitterman A; Steinmann WC
Ophthalmology 2003; 110: 900-907 (IGR: 5-2)


8916 Measurement of indirect costs for people with vision impairment
Chou SL; Misajon RA; Gallo J; Keeffe JE
Clinical and Experimental Ophthalmology 2003; 31: 336-340 (IGR: 5-2)


8611 Blindness in patients with treated open-angle glaucoma
Chen PP
Ophthalmology 2003; 110: 726-733 (IGR: 5-1)


8640 The magnitude and cost of global blindness: an increasing problem that can be alleviated
Frick KD; Foster A
American Journal of Ophthalmology 2003; 135: 471-476 (IGR: 5-1)


8379 Incidence of blindness in southern Germany due to glaucoma and degenerative conditions
Trautner C; Haastert B; Richter B; Berger M; Giani G
Investigative Ophthalmology and Visual Science 2003; 44: 1031-1034 (IGR: 5-1)


3392 Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision
Oliver JE; Hattenhauer MG; Herman D; Hodge DO; Kennedy R; Fang Yen M; Johnson DH
American Journal of Ophthalmology 2002; 133: 764-772 (IGR: 4-2)


3393 Causes of childhood blindness in Malaysia: results from a national study of blind school students
Reddy SC; Tan BC
International Ophthalmology 2002; 24: 53-59 (IGR: 4-2)


6608 Causes of blindness among adult Jordanians: a hospital-based study
Al-Bdour MD; Al Till MI; Abu Khader IB
European Journal of Ophthalmology 2002; 12: 5-10 (IGR: 4-1)


6609 Estimation of blindness in India from 2000 through 2020: implications for the blindness control policy
Dandona L; Dandona R; John RK
National Medical Journal of India 2001; 14: 327-334 (IGR: 4-1)


6610 Survey of blindness and visual impairment in Bioko, Equatorial Guinea
Moser CL; Martin Baranera M; Vega F; Draper V; Gutierrez J; Mas J
British Journal of Ophthalmology 2002; 86: 257-260 (IGR: 4-1)


6611 Visual loss in urban and rural chronic glaucoma patients in Ghana
Ntim Amponsah CT
Tropical Doctor 2002; 32: 102-104 (IGR: 4-1)


18520 Glaucoma in China: how big is the problem?
Foster PJ; Johnson GJ
British Journal of Ophthalmology 2001; 85: 1271-1272 (IGR: 3-3)


18936 Blindness in the Indian state of Andhra Pradesh
Dandona L; Dandona R; Srinivas M; Giridhar P; Vilas K; Prasad MN; John RK; McCarty CA; Rao GN
Investigative Ophthalmology and Visual Science 2001; 42: 908-916 (IGR: 3-1)


18937 An epidemiological survey of blindness and low vision in Meixian County
Liang X; Li F; Qui Wet al.
Chinese Journal of Ophthalmology 2001; 37: 12 (IGR: 3-1)


18938 World blindness: a 21st century perspective
Taylor HR; Keeffe JE
Bulletin de la Société Belge d'Ophtalmologie 2001; 85: 261-266 (IGR: 3-1)


5969 Characteristics of a paediatric low vision population in a private eye hospital in India
Gothwal VK; Herse P
Ophthalmic and Physiological Optics 2000; 20: 212-219 (IGR: 2-2)


5970 Causes of blindness in Israel
Hod Y; Corcia Y; Yassur Y; Geyer O
Harefuah 2000; 138: 276-278 (IGR: 2-2)


5971 The rate of blindness and of partial sight registration in glaucoma patients
King AJ; Reddy A; Thompson JR; Rosenthal AR
Eye 2000; 14: 613-619 (IGR: 2-2)


5576 Age-specific causes of bilateral visual impairment
Weih LM; VanNewkirk MR; McCarty CA; Taylor HR
Archives of Ophthalmology 2000; 118:264-269 (IGR: 2-1)


15336 Risk factors for late presentation in chronic glaucoma
Fraser S; Bunce CV; Wormald RP
Investigative Ophthalmology and Visual Science 1999; 40: 2251-2257 (IGR: 1-3)


15340 Causes of visual impairment among students at the Alabama School for the Blind
DeCarlo DK; Nowakowski R
Journal of the American Optometric Association 1999; 70: 647-652 (IGR: 1-3)


15341 Glaucoma care in Olmsted County, Minnesota, 1965-1980: filtering surgery and vision outcomes (editorial; comment)
Gaasterland DE
Archives of Ophthalmology 1999; 117: 1236-7 (IGR: 1-3)


15342 Proportion of those with Open-angle glaucoma who become blind (letter to the editor).
Quigley HA
Ophthalmology 1999; Ophthalmology 1999; (IGR: 1-3)


5183 Blindness incidence in Germany. A population-based study from Wuerttemberg-Hohenzollern.
Krumpaszky HG; Luedtke R; Mickler A; Klauss V; Selbmann HK
Ophthalmologica 1999; 213: 176-182 (IGR: 1-2)


Issue 20-1

Select Issue


advertisement

Oculus